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Resistance to malaria is known to occur both in humans and animal models. 
However, studies have shown that immunity is strain-specific, i.e. it develops mainly 
against the genotype with which the host was originally infected. Furthermore, there 
is a great degree of variation among hosts in their efficiency in mounting a protective 
immune response, with some individuals or inbred animal strains being more 
susceptible to infection than others. Understanding the genetic mechanisms 
underlying resistance in the host can lead to a better understanding of immunity to 
malaria and to more efficient vaccine strategies. 
In the study within which this thesis project has been conducted, we aim to identify 
strain-specific antigens in Plasmodium chabaudi chabaudi, which are responsible for 
the phenomenon of strain-specific immunity (SSI). We plan to achieve this by 
generating genetic markers closely linked to genes encoding antigens under immune 
selection and then observing their disappearance or reduction in proportion in a 
cross-progeny generated using two strains of the parasite. We then plan to identify 
the corresponding genes in human malaria parasites through conserved gene synteny 
between Plasmodium species. 
The thesis project presented here was concerned with developing the approaches 
necessary for achieving the aims of this study. In order to achieve this, a recently 
developed technique, called amplified length fragment polymorphism (AFLP), was 
used to generate genetic markers. The technique was first optimised for use with P. c. 
chabaudi. Subsequently, several hundreds of AFLP markers were identified between 
two strains of P. c. chabaudi, AS and AJ. These were ordered in an AFLP genetic 
atlas that provided information on the mutation rate in P. c. chabaudi. A genetic 
linkage map was subsequently produced based on the analysis of the inheritance 
pattern of the AFLP markers among 28 recombinant progeny clones between the AS 
and AJ strains. The genetic linkage map provided a tool to initially locate AFLP 
markers on the genome. The linkage map also allowed the identification of alleles of 
AFLP markers. Allele identification was also attempted using various molecular 
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methods. The next step involved the development of AFLP as a proportional 
technique (called "proportional AFLP"). This was an essential step in order to 
identify markers linked to genes encoding antigens under strain-specific immune 
selection. It showed that band intensity of AFLP markers was dependent on the 
proportion of template DNA present in an artificial mixture of the DNA of two 
strains of the parasite. Finally, proportional AFLP was tested on a mixture of the two 
parasite strains, as well as on the recombinant progeny obtained from crossing AS 
and AJ. Mixture and cross-progeny were grown both in naïve mice and mice 
rendered immune to the AJ strain. Proportional AIFLP proved reliable in measuring 
differences in the proportions of specific alleles in the different samples. The results 
of the mixtures agreed with measurements of the proportions of alleles in such 
mixtures as obtained using other methods, including Real Time PCR. 
The approach needed to achieve the aim of the study has been successfully 
developed and tested in the course of this project. It is now ready to be applied for 
the analysis of cross-progeny parasites exposed to SSI to identify genes encoding 




1.1) General Overview 
1.1.1) The impact of malaria 
Malaria is a wide spread disease in tropical countries and is the cause of more than 1 
million deaths every year, most of which are children (World Health Organisation, 
1999). Almost half of the world population is at risk of contracting the disease, 
mainly in Third World Countries, where it also has a major effect on the economy. 
The high prevalence of malaria in these countries is dictated mainly by favourable 
climatic conditions, as well as poor living and economic standards (World Health 
Organisation, 1999). 
1. 1.2) The parasite and its vector 
Malaria is caused by a protozoan parasite belonging to the phylum Apicomplexa, 
Plasmodium, of which various species are known. There are four species of 
Plasmodium parasites that can infect humans: P. falciparum, P. malariae, P. ovale 
and P. vivax. P. falciparum is the most harmful, as it can induce the potentially lethal 
form of malaria, cerebral malaria, with young children particularly at risk. The 
disease is transmitted by the bite of an infected female Anopheles mosquito, which 
becomes infected by ingesting the blood of individuals carrying the parasite. 
1. 1.3) Current strategies for prevention and treatment of malaria 
Malaria prevention involves various approaches, aimed at the mosquito vector or at 
the parasite itself. Environmental control, including drainage of swamps, use of 
insecticides, most notably DDT, and use of bed nets have been among the main 
approaches used to control mosquitoes. However, there have been causes for concern 
regarding the safety of DDT to humans and wild life and the rapid spread of 
insecticide-resistance in mosquitoes, which has led to resurgence of malaria (World 
Health Organisation, 1999). Drainage and general environmental planning are not 
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always possible in endemic areas and bed nets have proved difficult to implement, 
especially in African countries (World Health Organisation, 1999). 
Malaria infections are currently treated with a variety of drugs. Most of these are 
directed against the replicating blood stage of the parasite and include 
pyrimethamine, sulfadoxine, quinine, chloroquine, mefloquine, artemisinin and 
antibiotics such as tetracycline. Pyrimethamine and sulfadoxine are antifolates that 
prevent the synthesis of pyrimidines for the production of DNA in the parasite 
(Hyde, 2002). Quinine, chloroquine and mefloquine have been shown to act on the 
malaria parasite food vacuole, by interfering with the proper digestion of 
haemoglobin and resulting in the accumulation of toxic haem moieties that 
eventually kill the parasite. Artemisinin has a similar mode of action, but also affects 
gametocytes (Hyde, 2002). Drug-resistance, however, has been spreading at an 
alarming rate in P. falciparum, being recorded first with quinine in the 1910's and 
starting in the 1950's against chloroquine, which had been introduced just before 
World War H, then rapidly developing against antifolates after their introduction in 
the 1950's. While resistance to chioroquine is now widespread across the globe, 
antifolate resistance, having originated in South America and South-East Asia is now 
spreading to Africa (Hyde, 2002). Resistant strains to artemisinin have already been 
isolated in the laboratory (Inselburg, 1985) and it is only a question of time before 
they develop in the wild. New drugs need to be constantly developed to guarantee 
effective treatment in many areas of the world (World Health Report, 1999). 
However, another main problem with new drugs is that they are often far too 
expensive for the countries most affected by malaria and cannot thus be implemented 
there. 
1.1.4) Vaccine development 
The difficulties encountered in the various attempts to control malaria require the 
development of new approaches. This includes the development of a protective 
malaria vaccine, which has thus far not been achieved. Two of the reasons behind the 
failure to develop an effective malaria vaccine are a lack of knowledge on how 
acquisition of immunity to malaria develops and which antigens expressed on the 
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surface of the parasite are involved in eliciting an effective immune response. 
Previous attempts at blood-stage vaccine development might have failed due to the 
wrong choice of antigens. An example was the synthetic malaria vaccine developed 
by Patarroyo et al. (1987), which was later shown to have poor to no protective 
effects in field trials (Marshall, 1996). DNA vaccines currently undergoing field trial 
have shown promising results in animal models (Aguiar et al., 2001; Bhardwaj et al., 
2002), although their effect seems to be restricted to lowering the level of secondary 
parasitaemia, without any considerable effect on the more pathological stage of the 
infection. This again stresses the importance of identifying the relevant antigens for 
development of an effective protective vaccine. 
In order to identify parasite antigens that may one day lead to the development of an 
effective vaccine, it is important to understand the immune reactions elicited during a 
malaria infection. Malaria has a complex life cycle, as will be shown in Section 1.2, 
with several antigens being expressed at each stage and resulting in a plethora of 
immune reactions that are slowly being unravelled. The malaria parasite stage 
responsible for most of the pathological effects of the disease is found in the blood of 
the infected host and it is against this stage that a vaccine aimed at reducing the 
pathological effects of the disease should be developed. It is known that people 
living in endemic areas of P. falciparum transmission develop partial immunity, 
called premunition, against malaria after several years of constant exposure to the 
parasite. Premunition controls, but does not eliminate, the infection, which persists at 
low density without any symptoms (McGregor and Wilson, 1988). Premunition is 
directed only at the asexual blood stage of malaria and disappears if continuous 
boosting by re-infection is removed. Furthermore, immunity is strongest in 
individuals who have been re-infected with homologous genotypes ("strains") of 
malaria (Ciuca et al., 1934; Jeffrey, 1966; Powell et al., 1972), resulting in an effect 
called strain-specific immunity (SSI). This means that individuals are particularly 
capable of mounting a strong and effective immune response against re-infections 
with the same strain of malaria. 
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SSI appears thus to be an important aspect of the immune mechanism protecting 
individuals against the most severe symptoms of the disease. Understanding the basis 
of SSI will not only offer a better insight in the immune responses against malaria 
but will also lead to the identification of the antigens on the surface of the malaria 
parasite responsible for the development of such a strong immune response. These 
antigens in turn could be suitable candidates for the development of an effective 
vaccine. Structural study of such antigens might reveal epitopes conserved across all 
the various malaria strains, which could become potential vaccine candidates. 
Furthermore, understanding the complex relationship between SSI and the causative 
antigens might lead to a more efficient strategy for the development of a malaria 
vaccine. 
1.1.5) Aim of this project 
The life cycle of the malaria parasite is complex (Section 1.2) and involves a variety 
of different environments in which the parasite must survive. The need for the 
parasite to adapt to different environments resulted in the expression of a wide range 
of antigens on its surface. This not only explains the complex nature of immune 
responses being raised against the parasite (Section 1.3), but also illustrates how well 
adapted the parasite has become to survive within the host. This adaptation is also 
shown by the mechanisms that the parasite adopts to avoid them, such as the high 
level of polymorphism among the most exposed antigens which most likely results in 
the development of SSI, a highly effective early immune response against the strains 
that originally caused an infection (Sections 1.4 and 1.5). Thus, parasite antigen 
polymorphism, maintained by the genetic nature of parasite replication (Section 1.6), 
is a major feature in immunity against malaria. Studying antigens causing SSI offers 
the best opportunity for developing a strategy leading to a protective vaccine against 
the most debilitating effects of malaria. 
In the study, within which this thesis project has been conducted, we plan to identify 
those antigens responsible for SSI based on the antigenic polymorphism between 
genotypes of a mouse malaria parasite, Plasmodium chabaudi chabaudi, where SSI 
is a well-characterised phenomenon (Jarra and Brown, 1985). These antigens could 
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then possibly be identified in human malaria parasites through the high level of 
synteny (same arrangement of gene order) between species of Plasmodium (Carlton 
et al., 1998a; see also Section 1.6). Furthermore, the recent completion of the 
Malaria Genome Project and the availability of a genetic database for P. c. chabaudi 
(Section 1.6) will facilitate the identification of antigens involved in SSI. 
The project of this thesis was aimed at developing the approach required to achieve 
this aim. This included the development of a large number of genetic markers and a 
proportional technique to detect the effect of SSI through reduction in proportion of 
genetic markers linked to genes encoding antigens under selection in the cross-
progeny of two P. c. chabaudi strains (Section 1.7). The successful development of 
the approach will be presented in this thesis. 
1.2) Life Cycle of Malaria Parasites 
Fig. 1.1 shows the life cycle for all species of Plasmodium parasites infecting 
mammals. Two distinct phases in the malaria parasite life cycle can be recognised: a 
sexual phase (sporogony) in a female Anopheles mosquito and an asexual phase 
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Fig. 1.1: The life cycle of a mammalian malaria parasite and immune mechanisms elicited. Adapted 
from Good et al. (1998). 
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Mosquitoes ingest male and female gametocytes when feeding on an infected host. 
Inside the mosquito's gut, male gametocytes undergo three rounds of DNA 
replication resulting in eight motile, haploid microgametes. These are released during 
a process called exflagellation. Each female gametocyte leaves the red blood cell and 
matures into a single, haploid macrogamete. Fertilisation of a macrogamete by a 
microgamete produces a zygote. This is the only diploid stage in malaria. Soon after 
fertilisation, meiosis takes place and 18-24 hours later the zygote develops into an 
invasive ookinete, which penetrates the midgut wall of the vector and becomes an 
oocyst. Growth and further, probably mitotic, nuclear division take place over the 
next 8-16 days, after which thousands of haploid sporozoites are released, which then 
proceed to invade the salivary glands of the mosquito (Gilles, 1993). 
At the next blood meal, sporozoites are injected into the new host through a mosquito 
bite. They then rapidly invade parenchymal cells in the liver where they mature into 
liver schizonts, replicating asexually in what is known as the exo-erythrocytic stage. 
Depending on the species of Plasmodium, 6 to 16 days (52 to 53 hours for P. c. 
chabaudi, Landau and Boulard, 1978) post infection, schizonts burst and release 
thousands of merozoites. Both merozoites and sporozoites are characterised by the 
presence of the apical complex. This consists of several organelles (i.e. rhoptries, 
dense granules and micronemes), which are involved in host cell invasion (Aikawa, 
1988; Preiser et al., 2000). Merozoites invade red blood cells, giving start to the 
erythrocytic stage of the infection. Following invasion of a red blood cell, each 
merozoite develops into a so-called ring form first and then to the trophozoite. 
Trophozoites feed on haemoglobin and undergo asexual cell division to mature into 
schizonts. Asexual multiplication in the erythrocytes results in 8 to 24 daughter 
merozoites per original invading merozoite in the species of Plasmodium infecting 
humans and between 4-8 in P. c. chabaudi (Landau and Boulard, 1978). Merozoites 
are released into the blood when the schizont ruptures. The cycle of merozoite 
release in malaria parasites is highly synchronous and gives rise to periodic fevers. 
The intraerythrocytic cycle takes between 48 (P. falciparum, P. vivax and P. ovale) 
and 72 hours (P. malariae) to complete in humans. In P. c. chabaudi, the cycle is 
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faster, requiring only 24 hours to complete (Landau and Boulard, 1978). The asexual 
erythrocytic cycle can be repeated several times, with high levels of parasitaemia 
developing, until the immune system controls the infection. Blood infections induce 
febrile paroxysms and can cause severe pathology. After several generations, some 
invading merozoites develop into micro- or macro-gametocytes, which represent the 
sexual stages of the malaria parasites and are ingested by mosquitoes (Gilles, 1993). 
1.3) Overview of Host Immune Responses against Malaria infections 
As previously mentioned, Plasmodium has a complex life cycle. Inside the host, 
several stages are present and immune responses are mounted against each one of 
them (Fig. 1.1). Two main stages are present inside the vertebrate host and induce 
significant immune responses: the first is the pre-erythrocytic stage, culminating in 
the release of merozoites from the liver and leading to the second, the erythrocytic 
stage, involving a round of asexual replications inside red blood cells. The sexual 
stage is also present in the blood in the form of gametocytes. A distinct, stage-
specific immune response is raised against them. 
1.3. 1) Immune responses to the pre-erythrocytic stages 
1.3.1.1) Immune responses against sporozoites 
There is evidence that an antibody-mediated immune response is mounted against 
invading sporozoites in animal models and in humans, and that antigen-specific 
monoclonal antibodies can prevent hepatocyte invasion in P. falciparum and P. vivax 
in vitro (Danforth et al., 1980; Tapchaisri et al., 1983; Hollingdale et al., 1984). 
Immunisation experiments with irradiated sporozoites have induced full protection 
against subsequent challenges (Clyde et al., 1975), which has led to the search for 
sporozoite antigens as potential vaccine candidates. Several antigens have been 
identified on the surface of sporozoites, such as the Circumsporozoite Protein (CSP), 
the Thrombospondin-related Adhesive Protein (TRAP), the Sporozoite Threonine 
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and Asparagine-Rich Protein (STARP) and the Sporozoite and the Sporozoite- and 
Liver-stage Antigen (SALSA) (Carvalho et al., 2002). However, as sporozoites are 
only present in the circulation for 2-30 minutes, antibodies need to be present at high 
titres and act almost immediately after infection, suggesting that antibody mediated 
immunity may not be completely effective (Saul, 1987). In fact, it has been shown 
that the potent protective immune response generated by irradiated sporozoites is due 
to CD8+ T cells, not antibodies (Weiss et al., 1988). It has been postulated recently 
that the immune response thus induced is not directed against sporozoite antigens, 
but rather the antigens expressed on the surface of infected hepatocytes (Silvie et al., 
2002). 
1.3.1.2) Immune responses to the liver stage 
Evidence suggests that the major target of protective immunity in the pre-
erythrocytic stage is the parasite developing within the hepatocyte. At this stage, 
immunity is mainly mediated by cellular-dependent mechanisms involving CD8+ T 
cells, CD4+ T cells and Natural Killer (NK) cells (Carvalho et al., 2002). yö T cells 
have also been demonstrated to be involved in early immunity against pre-
erythrocytic stages of murine malaria parasites, although it is not yet known whether 
against sporozoites or the liver-stage (McKenna et al., 2000). The most important 
mechanism appears to be the production of Interferon-gamma (IFN1) by activated 
CD8+ T cells, which induces the synthesis of Nitric Oxide (NO), a parasiticidal 
molecule, in infected hepatocytes (Carvalho et al., 2002). Cytotoxic CD8+ T cells 
also kill infected cells after recognition of antigens presented via Major 
Histocompatibility Complex (MHC) I molecules via secretion of perforin and 
granzyme B and induce cell apoptosis via cross-linking of Fas ligands (Carvaiho et 
al., 2002). CD8+ T cells secretion of IFN7 also induces IL-12, which in turn initiates 
production of additional 1FNy by NK cells and other cells (Good and Doolan, 1999). 
Experiments with in vivo depletion of CD8+ cells (Weiss et al., 1988) and adoptive 
transfer (Romero et al., 1989) and mice genetically deficient for the production of 
major histocompatibility complex class I molecules (MHC-I), which are needed to 
present antigens to CD8+ T cells (White et al., 1996), have demonstrated the 
importance of these cells in animal models. 
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Recognition of parasite antigens associated with MHC-II molecules by CD4+ T cells 
of the T-helper 1 (Thi) phenotype has also been shown to induce protective immune 
responses which do not involve cytotoxicity and are not dependent on IIFNy (Renia et 
al., 1993; Wang et al., 1996). It has been shown that immunisation of mice with the 
pre-erythrocytic antigen Liver Stage Antigen-3 (LSA-3) of P. falciparum is 
associated with Thi T-cell activity, which induces IgG2a production (Sauzet et al., 
2001). The production of antibodies against the liver-stage antigens can mediate 
antibody-dependent cellular cytotoxicity (ADCC), especially by NK cells, which is 
another possible protective mechanism (Carvalho et al., 2002). 
Several antigens have been identified on the surface of infected human hepatocytes: 
CSP, SALSA and STARP (all also expressed on the sporozoites) and LSA- 1, LSA-2 
and LSA-3 (Carvalho et al., 2002). CSP, LSA-1 and LSA-3 have been particularly 
well studied and used in vaccine trials. CSP induces antibodies (mainly IgG) 
(Tapchaisri et al., 1983) and CD8+ activity in mice immunised with a synthetic 
vaccine (Renia et al., 1991). LSA-1 and LSA-3 elicit cytotoxic, MHC-I restricted 
immune responses in humans (Hill etal., 1991; Aidoo etal., 2000). 
1.3.2) Immune Responses to the Blood Stage of malaria 
1.3.2.1) Course of malaria infection in the blood 
Following release of merozoites from the liver and invasion of erythrocytes, the 
blood stage of the infection with P. falciparurn has an incubation period (usually 
between 9-14 days), in which parasitaemia in the blood increases until it reaches a 
sufficient density to cause paroxysm. This is termed the primary attack. This is 
followed by a latent period of low parasitaemia after control of the primary attack by 
the immune system, during which antigenic variation can occur. If this takes place, 
recrudescence of parasitaemia in P. falciparum can develop (Miller et al., 1994). The 
parasite can stay in the blood up to two years after the primary attack and develop a 
recrudescent infection in this period (Gamham, 1988). Protective immunity to the 
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blood stage eventually arises in the form of premunition after several infections, and 
is largely or partly strain-specific, reflecting that antigenic diversity among strains 
influences immunity (McGregor and Wilson, 1988). However, while this immunity 
is effective at preventing re-infections with homologous strains, the original infection 
can still survive at low levels through within-clone antigenic variation. 
In the murine malaria parasite P. c. chabaudi, the infected mouse develops a primary 
peak of parasitaemia lasting between days 5 and 15 after infection (Fig. 1.2). As the 
immune response controls the infection, parasitaemia falls below detectable levels 
after day 15, with a second, lower peak appearing around day 30 and reflecting the 
fact that mice do not completely clear the infection, due to the antigenic variation 
within a parasitic strain. This was clearly shown when parasites were induced not to 
undergo antigenic variation following splenectomy of mice. These parasites, which 
would have normally undergone antigenic variation in untreated mice and induced 
chronic parasitaemia, did not form a chronic recrudescing infection (Gilks et al., 
1990). Antigenic variation in P. c. chabaudi in mice starts as early as during the 
decline of the primary peak of parasitaemia (McLean et al., 1990). Recrudescence 
keeps occurring thereafter at least up to 70 days after infection (J. de Roode, personal 
communication) and it is likely that mice never completely eliminate parasites from 
the blood. They do, however, develop SSI that protects against homologous re-
infections (Jarra and Brown, 1985). 
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Fig. 1.2. Course of infection in the blood and immune responses to blood-stages of P. c. chabaudi in 
mice (adapted from Phillips et al., 1997). Parasitaemia reaches a primary peak at around day 10 post-
infection. During this phase, Thi immune responses (usually associated with cell mediated immunity) 
are induced, which then switch to Th2 immune responses (associated with antibody mediated 
immunity) and result in the decline of parasitaemia and control of the infection. After 25-30 days post-
infection, a recrudescence in parasitaemia takes place (secondary parasitaemia), due to antigenic 
variation within individual parasite genotypes. This is controlled by a Th2-type response, mediated 
mainly by antibodies. Recrudescence keeps occurring thereafter. 
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1.3.2.2) Antibody-mediated immunity 
In humans, antibodies play an essential role in protective immunity against the blood 
stage parasites. This was shown in a study where immunity was passively transferred 
between humans by injection of serum from immune to susceptible individuals 
(Cohen et al., 1961). Similar experiments were also conducted in mice where, in P. 
yoelii infections, antibodies from immunised mice transferred immunity to naïve 
recipients (Freeman and Parish, 1981). Furthermore, experiments with mice 
genetically deficient for B-cells (responsible for the production of antibodies), 
showed that while they controlled the early acute infection to some extent, they gave 
rise to elevated, chronic, relapsing infections. The chronic infections thus developed 
could, however, be reduced to normal, sub-patent levels by adoptive transfer of B-
cells, stressing the importance of antibodies in controlling blood stage infections 
(Langhorne et al., 1998). 
B cells are known to produce antigen-specific Immunoglobulin G (IgG) upon 
stimulation in vitro (Garraud et al., 2001). IgG antibodies appear to be one of the 
main protective immunoglobulins involved in malarial immunity. This was shown by 
the successful phagocytosis by THP-1 cells (derived from leukaemic human 
monocytes) and ex-vivo monocytes of infected red blood cells (iRBC) coated in 
immune serum obtained from patients previously infected with P. falciparum (Tebo 
et al., 2002). Phagocytosis was facilitated via recognition of the Fc portion of IgG 
antibodies bound to iRBC by the phagocytes, a process known as opsonisation. 
There is evidence in humans that IgGi and IgG3, which promote activation of 
monocytes and phagocytes (Groux and Gysin, 1990) mediate protection against 
malaria, while IgG2 and IgG4 are associated with an elevated risk of developing 
severe malaria disease (Ndungu et al., 2002). In mice, IgG2a (also promoting 
phagocytosis) is associated with protection against P. berghei (Waki et al., 1995), 
whereas in P. c. chabaudi there seems to be a requirement for both IgG2a and IgGi 
(Taylor-Robinson, 1995). 1gM antibodies against malaria are also produced, both in 
humans (King et al., 2002) and in mice (Taylor-Robinson, 1995). 
Antibodies have various modes of action against malaria. Other than promoting 
phagocytosis (Tebo et al., 2002), antibodies in humans are also known to inhibit 
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invasion of erythrocytes (Blackman et al., 1990). Antibodies also play an important 
role in preventing adhesion of iRBC to the placenta in multigravidae women, thus 
protecting against placental malaria, common in primegravidae women (O'Neil-
Dunne et al., 2001). Antibodies bound on the surface of merozoites also trigger the 
production of Tumor Necrosis Factor alpha (TNFa) by monocytes binding to the Fc 
portion of bound antibodies (Bouharoun-Tayoun et al., 1995). TNFa is associated 
with rapid cure in patients (Kremsner et al., 1995), however it has also been 
associated with increased severity of disease and cerebral malaria (Singh et al., 
2000). Association between TNFa and cerebral malaria was also observed in mice 
(de Souza and Riley, 2002). Antibodies also trigger the activation of complement via 
the classical pathway in P. falciparum infections (Wenisch et al., 1997), which 
inhibits parasite growth by attacking schizonts (Pang and Horii, 1998). In mouse 
models, complement activation by antibodies did not contribute greatly to protection 
against the acute phase of parasitaemia, however it seems to play a role in protecting 
against re-infection (Taylor et al., 2001). Finally, it should be mentioned that 
antibodies have also been associated with protection against the effects of malaria 
toxins (Good and Doolan, 1999). 
1.3.2.3) Cell-Mediated Immunity (CMI) 
There is evidence for the involvement of components of the CMI defence mechanism 
against malaria. CD4+ T cells are the most notable example, in spite of the lack of 
MHC II molecule expression on the surface of erythrocytes, which are required for 
the presentation of antigens to CD4+ T cells. However, antigen presentation by 
antigen presenting cells (APC) probably does occur. This is supported by 
observations made in mouse models, where erythrocytic stages of P. c. chabaudi are 
able to activate dendritic cells (which belong to the APC category) directly (Seixas et 
al., 2001). The rapid activation of Thi cells could follow, as APC's can present 
parasite antigens through their MHC II surface molecules, which are readily 
recognised by CD4+ cells. This would result in the induction of immunity. 
In humans, CD4+ T cells have been shown to have a role in controlling malaria 
Exposing in vitro cultures of erythrocytes infected with P. falciparum infections to 
CD4+ T cells purified from malaria-infected donors in the presence of adherent cells 
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inhibited parasite growth. Furthermore it was shown that CD8+ T cells could inhibit 
parasite growth as well, though the mechanism was not established (Fell et al., 
1994). In vivo, proliferation of CD4+ T cells has been observed in response to P. 
falciparum erythrocyte membrane protein-1 (Pfemp-1) in patients (Sanni et al., 
2002), and also an experiment where volunteers were immunised with ultra-low 
doses of iRBC. This experiment also showed the involvement of CD4+ and CD8+ T 
cells, IFNy production and Nitric Oxide (NO) activity, but most notably no IL-4 or 
IL-10 or antibody production (Pombo et al., 2002). Also supporting the role of CMI 
in protection against malaria is the discovery that a polymorphism in a promoter of 
the NO synthase gene was associated with increased NO production and reduced 
incidence of cerebral malaria and severe malarial anaemia (Hobbs et al., 2002). 
Thus, it seems that CMI acting through the production of NO induced by CD4+ T 
cell cytokines plays a protective role in human malaria infections. Other cells of the 
immune system have also been observed to play a role in immune reactions against 
human malaria. NK cells are a component of the innate immune system and are 
effective at binding, among others, to complement molecules, binding to IgG 
antibodies bound to antigens and directly recognising at least some foreign antigens 
of viral origin expressed on the surface of infected cells. Interestingly, their activity 
is inhibited by the presence of MEC I molecules, which are absent on the surface of 
erythrocytes (Colucci et al., 2002). NK cells play a cytotoxic role by lysing infected 
erythrocytes (Orago and Facer, 1991) and more recently the implication of NK cells 
secreting IFNy has been suggested in children infected with P. falciparum 
(Artavanis-Tsakonas and Riley, 2002). NK cells have also been shown to have a 
protective role in P. c. chabaudi infections in mice (Kitaguchi et al., 1996), although 
this role appears to be based on the secretion of cytokines (especially IFNy) rather 
than cytotoxicity (Mohan et al., 1997). 
In murine malaria there is evidence that in some species, CMI induced by CD4+ 
might be an important protective mechanism, as in the case of P. vinckei, where cell-
mediated immunity with high release of IFNy is the main protective mechanism 
(Perlmann et al., 1995). Mice depleted of B cells could still clear parasite infections, 
but failed to do so following CD4+ T cells depletion in various murine malaria 
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infections, including P. c. chabaudi (van der Heyde et al., 1994). Furthermore, a 
study on re-infection to malaria with murine malaria parasites in B-cell-deficient 
mice, showed that they resisted an homologous challenge infection (Grun and 
Weidanz, 1983). In P. yoelii, CD4+ I cells specific for malaria infections can 
transfer protection to athyinic mice without any antibody-activity and, interestingly, 
also without NO production (Amante and Good, 1997). They might have mediated 
immunity through y8 T-cells, which have been shown to be involved in immunity 
against P. c. adarni infections independently of antibodies and B cells and to be 
required by CD4+ -mediated immunity (van der Heyde et al., 1995). Interestingly, 
T-cells have been suggested to play an immunomodulatory role during human 
malaria infections through the secretion of IFNy (Hviid et al., 2001). 
1.3.2.4) The Thi vs. Th2 dichotomy in malaria blood stage immunity 
CD4+ T cells are pivotal in orchestrating immune responses. CD4+ I-cells can 
function as effector or regulatory cells. In the latter role, they are referred to as T 
helper cells and subdivided in two categories: Thi and Th2. Thi are associated with 
cell-mediated immunity (CMI) and secrete Interferon-gamma (IFNy) (which 
activates macrophages), IL-2 and TNF. Thi responses in humans also induce 
production of IgG2a antibodies. Conversely, Th2 T cells are associated with 
antibody-mediated immunity and secrete various cytokines including IL-4, IL-5, IL-
10 and IL-13, leading to the activation of eosinophils, B cells and mast cells. Typical 
antibodies associated with Th2 responses in humans are IgGi and IgE. Furthermore, 
Thi inhibits the proliferation of Th2, and vice versa (Balkwill, 2001; Feldman and 
Marini, 2001). 
From the information presented above, there seems to be a role in immune protection 
in the asexual blood stage both for Th2-type responses (i.e. antibody-mediated) and 
Thi -type responses (i.e. CMI). This seems to contradict the current axiom that Thi 
and Th2 responses are mutually exclusive. However, this apparent contradiction can 
be explained by the existence of a Thl/Th2 switch during different phases of the 
infection, which was first discovered in P. c. chabaudi infections. Control of acute 
primary parasitaemia is dominated by Thi cells, while recrudescence and later 
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infections are controlled by Th2 cells (Taylor-Robinson, 1995). Several mechanisms 
are thought to play a role: thus the Thi pathway is thought to be initiated by the 
presentation of antigens via macrophages or dendritic cells. These APC's in turn can 
activate macrophages and secrete several cytokines, which can trigger the production 
of NO and TNFa. The Th2 pathway is thought to be mediated via B cells and 
induces the production of several cytokines (IL-10 and IL-4 among others), as well 
as activation of B cells to produce IgGi antibodies (Taylor-Robinson, 1995). 
Experiments with mice depleted of B cells showed that recovery from acute primary 
parasitaemia was followed by a persistent patent infection and lack of significant Th2 
response (Taylor-Robinson and Phillips, 1994), while in control mice an initial high 
production of IFN7 and IL-2, correlated with the presence of parasite-specific IgG2a 
and elevated NO activity, followed by an increase in IL-4, IL-10 and IgGi 
production and a decrease in IFN'y and IL-2. These data suggest that while Thi acts 
in limiting infection during the initial acute phase, a subsequent Th2 response is 
required to eliminate parasitaemia. Furthermore, rescuing B-cell-depleted mice with 
B cells restored Th2 immune response against the chronic stage of infection, 
indicating the essential role of antibody production in controlling chronic 
parasitaemia (Taylor-Robinson and Phillips, 1996). 
In humans, it has been suggested that a switch takes place as well. Winkler et al. 
(1998) suggested that, in contrast to the P. c. chabaudi model, a shift from a more 
pronounced Th2-driven immune response during acute infection towards Thi 
responsiveness induced by parasite clearance takes place in P. falciparum infections. 
However, conflicting data have been recently published that show an increased 
production of cytokines associated with Thi activity, i.e. IL-12 and IFN'y, during the 
acute phase of P. falciparum infection. This may reflect an early and effective 
immune response regulated by Thi cytokines, in contrast to what was observed 
previously by Winkler et al. (Tone et al., 2002). Thus, although in the murine model 
both arms of the immune system are activated and effective in clearing infection, the 
existence of a possible switch in immune response in humans has still to be 
confirmed. 
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1.3.2.5) Surface antigens expressed at the blood stage 
Several antigens expressed on the surface of the merozoite and of the iRBC have 
been identified and characterised. They all show a considerable degree of 
polymorphism and immune responses have been described against several of these 
antigens (Carvaiho et al., 2002). On the merozoite surface: there are eight Merozoite 
Surface Proteins (MSP's), which are proteins that are believed to play a role in the 
invasion of erythrocytes. The Apical Membrane Antigen 1 (AMA-1) and the 
Rhoptry-Associated Protein 1 and 2 (RAP-1 and-2) are expressed in the rhoptry 
organelle of the merozoite and also play a role in erythrocyte invasion. Other 
antigens expressed on the merozoite surface include the Erythrocyte-Binding 
Antigen 175 (EBA-175), the Acidic-Basic Repeat Antigen (ABRA) and in P. vivax, 
the Duffy-binding Protein (DBP). On the iRBC, the Ring Erythrocyte Surface 
Antigen (RESA), the Serine-rich protein (SERP) and the Erythrocyte Membrane 
Protein 1, 2 and 3 (EMP- 1 ,-2,-3) are among the identified surface antigens (Carvalho 
et al., 2002). RESA and EMP's are released from the parasite inside the erythrocyte 
and expressed on the surface of iRBC's, with EMP-1 known to play a role in 
adhesion to red blood cells and endothelial cells. SERP, on the other hand, is 
expressed in the parasitophorous vacuole during the schizont stage of the parasite in 
the erythrocyte (Debrabant et al., 1992). The most important of these antigens and 
the immune responses they elicit will be looked more in detail in Section 1.5. 
1.3.3) Immune responses against gametocytes 
Immune responses against antigens expressed on gametocytes occur in humans and 
are antibody mediated. These occur against antigens expressed in the gametocytes 
and the gametes (Stowers and Carter, 2001). Ps230 and Ps48/45 are major target 
antigens expressed on P. falciparum gametocytes, gametes and early zygotes. 
Monoclonal antibodies raised against them have been shown to be effective against 
gametes inside the mosquito gut, thus preventing transmission of malaria (Rener et 
al., 1983). In particular, antibodies against the P. falciparum Pfs230 have been 
shown to fix complement and lyse gametes inside the mosquito gut (Read et al., 
1994), while antibodies occurring in natural infections against the P. falciparum 
Pfs48/45 block fertilisation of gametes (Verineulen et al., 1985). 
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Ps25 and Ps28 are two antigens expressed on the surface of zygotes and ookinetes 
(Stowers and Carter, 2001). A monoclonal antibody raised against Pfs25 in P. 
falciparum has been shown to block infectivity in the mosquitoes (Vermeulen et al., 
1985). Antisera raised against Pfs28 were shown to block infectivity of P. 
falciparum in the mosquito gut, where the zygote and the ookinete occur (Duffy and 
Kaslow, 1997). The responses raised against these antigens probably do not occur in 
a natural malaria infection, as these antigens are not expressed inside the vertebrate 
host. However, they have a considerable potential as transmission-blocking vaccines. 
Not having experienced selection pressure from the immune system for both 
antigenic diversity and low immunogenicity, they are less likely to be polymorphic 
and more likely to induce strong immune responses (Stowers and Carter, 2001). 
1.4) SSI in malaria 
Protective, but not sterilising, immunity to malaria parasites in humans is known to 
take years to build up. One of the reasons for this is that when immunity develops, it 
is strain-specific, i.e. each infecting genotype induces an immune response that will 
protect against homologous challenges, but will only have a weak-to-mild effect 
against heterologous challenges (Ciuca et al., 1934; Jeffrey, 1966; Powell et al., 
1972). SSI is directed against the asexual blood stage of the parasite. SSI is supposed 
to be antibody-mediated. Evidence for this comes firstly from the transfer of 
immunity by sera in humans and animal models (Cohen et al., 1961; Freeman and 
Parish, 1981). Secondly, different known surface antigens do generate protective 
antibody responses that are specific to the antigen allele expressed by a particular 
parasite genotype (see Section 1.5). However, a study on re-infection with murine 
malaria parasites in B-cell-deficient mice (Grun and Weidanz, 1983) and a similar 
study made in humans immunised with low doses of iRBC (Pombo et al., 2002) 
suggest that SSI might be more complex and possibly involve redundant immune 
responses. 
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Jarra and Brown (1985) showed the existence of SSI in a rodent model of malaria, P. 
c. chabaudi, by immunising mice with one or other of two strains of the parasite 
(namely AS and CB) and then giving them homologous or heterologous challenge 
infections. While mice developed a strong immune response against the homologous 
challenge, a much weaker immune response was directed against the heterologous 
challenge (Jarra and Brown, 1985). The experiment was more recently repeated in 
our laboratory using several different strains of P. c. chabaudi (namely AS, AJ, AQ 
and CB) (Raza and Carter, unpublished). Mice were immunised using the different 
strains and then given either homologous or heterologous challenges. In addition, 
immunised mice were also challenged with a mixture of parasites (i.e. the 
homologous strain plus a heterologous strain). Results are shown for two 
experiments using the AS (Fig. 1.3) and the AJ (Fig. 1.4) clones as immunising 
agents. In both cases, immunity against the homologous challenge following two or 
three rounds of immunisation is almost sterilising, while the heterologous challenge, 
although also partially affected by immunity, grows in the mice. When immune mice 
were challenged with a mixture (AS + CB or AJ + AS, for example), parasites also 
thrived. An enzyme-based genotyping assay, using electrophoretic allelic variants of 
lactate dehydrogenase (LDH) as a strain marker, revealed that the surviving parasites 
present in the mixture post-challenge were of the heterologous strain, while no trace 
of the homologous strain could be detected (Fig. 1.5, lanes 4 and 5). Some degree of 
cross-reactivity was observed, however, among the other strains and it varied 
according to the immunising strain used. Thus there was relatively strong SSI 
between CB and AJ, but it was relatively weaker between AS and AJ (Fig. 1.4). Mice 
immunised with the AS strain were also challenged with the progeny of a cross 
between AS and CB (AS X CB) (Fig. 1.3). Among the surviving parasites, enzyme 
assay revealed the presence of enzyme alleles derived from both parents. This 
suggested that surviving parasites expressing the AS enzyme allele had picked 
enough CB alleles of genes of targets of SSI through genetic recombination to 
survive in AS-immune mice (see also Fig. 1.5, lane 6). 
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Fig. 1.3. P. c. chabaudi strain-specific immunisation by injection in mice. Results for experiments 
using the AS clone as immunising agent. Arrows at the bottom indicate infection challenge. Mice 
were given two immunising infections (treated with chloroquine (CQ) or mefloquine (MQ), as 
indicated on top), before being challenged with AS, the heterologous clone CB as well as the mixture 
AS + CB and the progeny of an AS X CB cross. Recrudescence of the first infection, due to 
chioroquine resistance, prompted a switch to mefloquine. (Raza and Carter, unpublished.) 
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Fig. 1.4. P. c. chabaudi strain-specific immunisation by injection in mice. Results for experiments 
using the AJ clone as immunising agent. Arrows at the bottom indicate infection challenge. Mice were 
given three immunising infections (treated with mefloquine (MQ), as indicated on top), before being 
challenged with the AJ clone as well as different mixtures (AJ +AS, AJ + AQ and AJ + CB). (Raza 


















C) a) C) 
C 
E E E 
E E E 
V 
g 0 4 4 
C) 0 C) 0 
+ + )< 
o 
E 





blood — _ 
- CB type 
- 
- AS type 
—sample origin 
lane  2 	3 	4 5 6 
Lactate dehydrogenase 
(LDH) 
Fig. 1.5. Genotype analysis of mixed and recombinant P. c. chabaudi infections in mice immunised 
with either the AS or CB clones. Enzyme essay using Lactate Dehydrogenase on blood of mice 
infected with AS, CB, parasite mixture (AS + CB) and cross-progeny (AS X CB). The enzyme is 
polymorphic in the two parasite strains. Note absence of the enzyme allele of the immunising strain in 
the mixtures grown in mice immunised with AS or CB. Also note presence of both alleles in AS-
immune mice infected with the cross-progeny, indicating genetic recombination (Raza and Carter, 
unpublished.) 
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1.5) Antigens of the erythrocytic stage and their potential role in SSI 
Surface antigens are expressed both on the surface of the merozoite, as well as on the 
surface of the iRBC. Most induce immune responses usually involving antibodies 
and among them must be the targets of SSI. Several antigens of blood stage malaria 
parasites have been identified and extensively studied. They include important 
candidate antigens for targets of SSI. An important distinction must be made here 
between "antigen diversity" and "antigenic variation" in malaria parasites. SSI must 
be due to a polymorphism or "antigen diversity" occurring between antigens from 
genetically different clones of malaria parasites. Antigenic variation, on the other 
hand, is used to refer to a situation in which a switch occurs within a single clone of 
parasites in the blood and causes it to express a different form of an antigen. While 
most known antigens in malaria show diversity to one degree or another, there are 
only some antigens expressed on the surface of infected red blood cells (most notably 
the Erythrocyte Membrane protein-1, of which Pfemp-i is the equivalent on P. 
falciparum) which undergo antigenic variation. 
The following sections will present the major antigens expressed during the blood 
stage of malaria infections and the type of immune responses they elicit. The 
antigens are divided into the ones expressed on the surface of the merozoite and the 
ones expressed during the intra-erythrocytic stage of the parasite. 
1.5.1) Merozoite antigens 
Several studies have shown that protective antibody responses against merozoite 
antigens are involved in causing agglutination and opsonisation of the merozoites. 
Anti-merozoite antibodies can prevent invasion of erythrocytes and can even affect 
growth of parasites within the red blood cells (Wipasa et al., 2002). There are now 
several antigens that have been identified on the surface of merozoites. These include 
the eight MSP molecules, most notably MSP-1, AMA-1, EBA-175, RAP-1 and -2, 
ABRA and in P. viva, DBP (Carvalho et al., 2002). Among these antigens there are 
major candidates for inducing SSI, such as MSP-1 or AMA-1. Some of these 
antigens are highly polymorphic, while some others have been more recently 
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discovered and are not yet fully characterised. Polymorphism is common in MSP-1, 
MSP-2, MSP-3 and AMA-1, and to a lesser extent in EBA-175 and RAP-1. 
Furthermore, there is some genetic evidence that polymorphism in these six antigens 
is the result of immune selection pressure (Escalante et al., 1998). MSP- 1, MSP-2, 
MSP-3, AMA-i (Carvaiho et al., 2002), Rap-1 and-2 (Collins et al., 2000) and EBA-
175 (Sim et al., 2001) all elicit protective antibodies in animal models. Furthermore, 
it has been shown, at least in the case of MSP- 1 in the mouse model P. yoelii, that 
antibody-independent immunity plays a protective role through effector T cells 
(Wipasa etal., 2001). 
1.5.1.1) The MSP antigens 
The MSP antigens are the most studied potential vaccine candidates in malaria. They 
are proteins that are believed to play a role in the invasion of erythrocytes (Wipasa et 
al., 2002). MSP- 1 is a primary candidate of SSI and is the best-known surface 
antigen of the merozoite. It has also been used in several candidate vaccines 
currently on trial (Carvaiho et al., 2002). A strain-specific monoclonal antibody has 
been raised against MSP-1 of P. c. chabaudi and has been shown to be capable of 
inhibiting the onset of parasitaemia of the immunising clone, but not against a 
different clone (McKean et al., 1993). Protective immune responses in humans are 
also thought to be associated with antibody production against MSP-1 (Hogh et al., 
1995; Branch et al., 1998). More recently, polymorphisms found within MSP-1 
(Ekala et al., 2002) have been correlated to SSI in P. falciparum. 
MSP-2 and MSP-3 have also been extensively studied. MSP-2 induces IgG2 
antibodies in P. falciparum infections that are associated with protection (Aucan et 
al., 2000). A study conducted on several MSP-2 and AMA-1 antigen alleles showed 
that there was a change in the frequency of malaria genotypes over time in the 
population studied. It was suggested that the observed alteration in allele frequency 
was due to the development of SSI (Eisen et al., 2002). MSP-3 also induces the 
production of protective IgG antibodies that may protect people against P. 
falciparum through antibody-dependent cellular inhibition (Oeuvray et al., 1994). 
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1.5.1.2) Antigens of the rhoptry organelle 
Both AMA-1 and RAP-1 and -2 are associated with the rhoptry organelle of the 
merozoite and AMA-i is presumed to play a major role in erythrocyte invasion 
(Carvalho et al., 2002). AMA-1 is known to induce protective antibodies in mice and 
monkey models (Narum et al., 2000; Kocken et al., 1999). In immunisation 
experiments with P. falciparum AMA-i in rabbits, protection was associated with 
IgG production (Kocken et al., 2002). A recombinant form of P. c. adami AMA-1 
was used to immunise mice against parasite challenges. While mice were partially 
protected after challenge with the immunising strain, no protection was observed 
with the heterologous challenge (Crewther et al., 1996). In another experiment, 
rabbit and human antibodies directed against a recombinant form of the AMA-1 
antigen from P. falczparum were found to inhibit erythrocyte invasion by merozoites 
from both the homologous strain and from two different heterologous strains of P. 
falciparum. However, invasion by merozoites from the two heterologous strains used 
in the experiment was inhibited by different degrees, with the merozoites from the 
less inhibited strain having an AMA-i antigen more genetically distant from the 
immunising antigen, suggesting a strain-specific effect of antibody-mediated 
inhibition (Hodder et al., 2001). Mechanisms independent of antibody production are 
also present, as shown by experiments in mice immunised with a recombinant form 
of the P. c. adami AMA-1 antigen, where a protective role for antibody-independent 
immunity mediated by CD4+ T cells was observed (Xu et al., 1999). RAP-1 and —2 
also induce protective, antibody-mediated immune responses, as shown by 
immunisation experiments in monkeys using P. falciparum RAP-1 and -2 antigens 
(Collins et al., 2000). In humans, clinical protection in children was associated with 
elevated antibody levels against RAP-i (Migot-Nabias et al., 1999). 
1.5.1.3) Other antigens 
Other antigens have been characterised on the surface of merozoite and might be 
potential targets of SSI. EBA-175 is an antigen associated with the microneme in 
Plasmodium species and is involved in binding to erythrocytes. A protective, 
antibody-mediated immune response that blocked binding to erythrocytes has been 
observed in mice, rabbits and monkeys immunised with a vaccine based on the P. 
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falciparum antigen (Sim et al., 2001). However, not much is yet known about the 
level of polymorphism present in EBA- 175. Another antigen, ABRA, has shown 
potential as a vaccine candidate by immunisation studies in mice and rabbits, where 
P. falciparum growth was prevented by the induction of IgG antibodies. The same 
study also observed that the same recombinant proteins used in the immunisation 
experiments were recognised in humans (Kushwaha et al., 2001). However, ABRA 
seems to be highly conserved across different laboratory strains of P. falciparum 
(Weber et al., 1988), which suggests it might not be a potential target of SSI. Finally, 
DBP is an antigen present only in one human malaria species, namely on P. vivax. It 
binds to the Duffy blood group, an essential requirement for erythrocyte invasion in 
P. vivax infections (Arevalo-Herrera and Herrera, 2001). Antibodies induced by 
vaccine and natural infection have been shown to block invasion of erythrocytes 
(Michon et al., 1998). However, since this antigen is unique to P. vivax, its relevance 
as a target of SSI across Plasmodium species is limited, although it is still a potential 
vaccine candidate against P. vivax infections. 
1.5.2) The intra-erythrocytic stage antigens 
In the case of the intra-erythrocytic stage of malaria, immunity is thought to involve 
both protective antibodies and cell-mediated immunity, mainly through CD4+ (both 
as effectors and helpers) and 'yS T cells, as shown in animal models (see Section 
1.2.2). However, the lack of expression of Major Histocompatibility Complex 
(MHC) I molecules on the surface of mammalian red blood cells precludes a 
cytotoxic role for CD8+ T cells. Several antigens on the surface of infected 
erythrocytes have been characterised. Among those are the Ring Erythrocyte Surface 
Antigen (RESA), the Serine-rich protein (SERP) and the Erythrocyte Membrane 
Proteins 1,2 and 3 (EMP-1,-2,-3) (Carvaiho et al., 2002). PfEMP-3 is not exclusive 
to the blood stage and is also expressed on sporozoites at the liver stage (Gruner et 
al., 2001). This group of antigens also contains antigens involved in antigenic 
variation in the blood stage of malaria infections, such as EMP- 1. 
RESA is present in granules located in the apical region of the merozoite and is 
secreted during invasion, ending on the surface of infected red blood cells (Wipasa et 
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al., 2002). P. falciparum RESA displays allelic polymorphism both in laboratory 
clones and in the field (Kun et al., 1994; Sueblinvong et al., 1996). It induces both 
humoral and cellular immune responses in humans (Fievet et al., 1995)), as well as 
protective antibodies inhibiting parasite growth in vitro in mice (Chopra et al., 2000). 
Antibodies of the IgG type specific against RESA have been found more commonly 
in patients treated successfully with antimalarial drugs, suggesting a possible 
protective role of this antibody (Mayxay et al., 2001). Evidence of immunity and 
allelic polymorphism make RESA an attractive candidate antigen for SSI. SERP is 
expressed at a later stage than RESA, namely during the schizont stage inside the 
infected erythrocyte. It is found in the parasitophorous vacuole created by the 
parasite inside the iRBC (Debrabant et al., 1992). Anti-SERP antibodies have been 
detected and postulated to play a role in inhibiting merozoite dispersal from mature 
schizonts (Lyon et al., 1989). A protective role of anti-SERP human antibodies in 
vitro has been recently demonstrated (Aoki et al., 2002), thus making it an attractive 
candidate for vaccine development. Furthermore, polymorphism has been detected 
that has allowed the division of allelic forms of SERP in three major groups (Liu et 
al., 2000), making SERP a potential candidate antigen for inducing SSI. 
Plasmodiumfalciparum EMP-1 (PfEMP-1) and its equivalents on other Plasmodium 
species belong to a family of proteins encoded by the var genes (Craig and Scherf, 
200 1) and is involved in adhesion to red blood cells and endothelial cells. Due to its 
association with antigenic variation, it needs to be considered separately from other 
malaria surface antigens. Expression of any one of the 40-50 var genes present in a 
single parasite is switched on randomly during an infection, so that parasites can 
express antigenically different PfEMP- 1 molecules on their surface at different time 
points (Craig and Scherf, 2001). Although PfEMP-1 elicits protective, variant-
specific antibody immune responses (mediated by IgG) (Piper et al., 1999), it takes a 
long time (5-10 years) for human hosts to develop an immune response against all 
the variants expressed by the parasite. This allows the parasite to escape the immune 
system and to induce recrudescence of parasitaemia (Miller et al., 1994). The 
frequency of antigenic variation within a clone during an infection does not make 
PfEMP-1 an ideal candidate for vaccine development unless conserved regions 
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shared by all variants of the antigen can be found. Furthermore, since antigenic 
switch can occur even in the absence of immune pressure (Roberts et al., 1992), it is 
unlikely that PfEMIP-1 is involved in such a solid and repeatable response as SSI, as 
the same clone might express a different PfTEIvIP- 1 antigen at the next re-infection. 
1.6) Genetics of Plasmodium 
Several aspects of the genetics of the parasite have greatly simplified the work 
conducted to develop the approach aimed at identifying antigens target of SSI. Thus, 
the haploid nature of the genome facilitates the identification and analysis of genetic 
markers, which are pivotal for the successful completion of the study. The high 
recombination rate at meiosis allows the generation of large number of genetic 
recombinant progenies between two parental genotypes of Plasmodium parasites, 
which will be subjected to immune selective pressure, as described in Section 1.7. 
The recent completion of the Malaria Genome Project has furthermore provided an 
invaluable tool that will facilitate the work being carried out and has already found 
some use in this project with the identification of alleles of genetic markers (Chapter 
5). In this section, an overview on the main aspects of the genetics of malaria will be 
presented, with attention being given to both the Malaria Genome Project and its 
potential impact and the existence of gene synteny among various Plasmodium 
species, which will allow the transfer of any relevant findings in P. c. chabaudi to the 
human malaria species. 
1.6.1) Ploidy and recombination 
Malaria parasites are haploid throughout the vertebrate and invertebrate host stages, 
with the notable exclusion of the zygote formed after fusion of the male and female 
gametes in the mosquito gut (Sinden and Hartley, 1985). It is during meiosis after 
fertilisation that genetic recombination between the chromosomes of the two gametes 
occurs. This occurs at a high rate and contributes in generating novel parasite 
genotypes (Conway et al., 1999). After fertilisation a diploid nucleus is present. This 
becomes tetraploid after meiosis in the ookinete. Nuclear division begins in the 
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oocysts, where haploid sporozoites are generated (Janse et al., 1986). The haploid 
nature of the blood stage parasites implies that genetic analysis is not complicated by 
the presence of heterozygotes for specific alleles, as each parasite will only carry one 
allele for any specific polymorphic DNA sequence. This has been a major advantage 
when creating genetic linkage maps in Plasmodium species and for the entire genetic 
analysis conducted here. 
1.6.2) Genome structure and size 
The malaria genome is divided into three components. These are a large nuclear 
genome of approximately 22.8 megabases (Mb) for P. falciparum (Gardner et al., 
2002), a linear mitochondrial genome of approximately 6 kb (kilobase), which 
encodes an electron transport system (Sharma et al., 2001) and a circular 35 kb 
organellar genome, known as the apicoplast (Gardner et al., 2002). The P. 
falciparum nuclear genome is highly rich in Adenine-Thymine (A + T) base pairs, 
which constitute 80.6% of its genome (Gardner et al., 2002). It contains 5,268 genes, 
whose average size is approximately 2.3 kb (Gardner et al., 2002). The size of the P. 
c. chabaudi genome is very similar to that of P. falciparum. Its size has been 
estimated at around 22.89 Mb by pulsed-field gel electrophoresis (PFGE) (Canton, 
1995; http ://www.ncbi.nlm.nih. gov/proj  ects/MalarialRodentichabaudi.html). The 
genome is also (A + T)-rich, with approximately 82% of its genome composed of A 
or T nucleotides (McCutchan etal., 1984). 
The malaria nuclear genome is carried by 14 chromosomes. These are ordered 
according to their sizes, with chromosome 1 being the smallest and chromosomes 13 
and 14 the largest. In P. falciparuin, chromosome sizes vary between 0.643 and 3.29 
Mb (Gardner et al., 2002). In P. c. chabaudi, size variation is between 0.9 and 3.2 
Mb (Carlton, 1995; http://www.ncbi.nlm.nih.gov/projects/Malafia/Rodent/  
chabaudi.html). Furthermore, homologous chromosomes from different isolates 
display a high degree of size polymorphism (Lanzer etal., 1994). 
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1.6.3) The Malaria Genome Project 
The recent completion of the P. falciparum genome project (Gardner et al., 2002) 
has provided an invaluable tool for malaria research. The project was started in 1996 
by a consortium of genome centres including The Institute for Genomic Research 
and Naval Medical Research Centre (TIGRINMRC), the Sanger Institute and 
Stanford University (Hoffman et al., 2002). The sequences of chromosomes 2 and 3 
were published prior to the completion of the project in 2002, although small gaps 
are still present, mainly due to the instability of large genomic fragments in 
Escherichia coli caused by the high A + T content of P. falciparum DNA (Gardner et 
al., 2002). At the same time, a fivefold shotgun sequence of the P. yoelii genome, a 
murine parasite, has been completed (Carlton et al., 2002). Work is also in progress 
at the Sanger Institute to provide a threefold shotgun coverage of the genome of P. c. 
chabaudi, with data already available for viewing and analysis at their website: 
(http://www.sanger.ac.uk/Projects/P —chabaudi/). 
The impact of the various genome projects will be enormous in malaria research, 
especially in the fields of drug research, vaccine development and evolutionary 
studies. The P. falciparum genome project has already been used prior to its 
completion to identify new potential drug targets by sequence homology to known 
genes. It has also provided insight into the regulation of var genes as well as the 
identification of paralogous sequences of known antigens, such as Duffy-binding 
protein and EBA-175, which could be potential vaccine candidates (Hoffman et al., 
2002). The complete P. falciparum genome contains 5,268 predicted proteins, 
approximately 60% of which are unique to P. falciparum (Gardner et al., 2002). The 
development of a complete proteome based on the genome will be a task that will 
allow a better understanding of the structure and function of these proteins, as well as 
allowing the identification of potential vaccine candidates based on their expression 
as proteins. The availability of data on several malaria genomes will also have an 
impact on this study, which will be discussed in more detail in Section 1.5. 
33 
1.6.4) Conserved gene synteny in Plasmodium species 
Conserved gene synteny refers to the degree of conservation of gene order between 
two genomes. Even more distantly related species, such as P. falciparum and P. c. 
chabaudi, have shown good levels of conserved gene synteny (Carlton et al., 1998a). 
However, synteny occurs mainly with closely linked loci. The further apart two loci, 
the less likely they are to be located in the same syntenic group. The recent 
completion of the P. falciparum genome project and the P. yoelii shotgun sequence 
has allowed the construction of a genome-wide synteny map between the two species 
(Carlton et al., 2002). Approximately 70% of the P. yoe!ii genome contigs could be 
aligned to P. falciparum chromosomes. Conserved syntenic groups ranged from a 
few kilobases (kb) to more than 800 kb and the gene order within syntenic groups 
was found to match 73% between the two species. This further underlines the 
importance of gene synteny in malaria as a strategy to allow direct application of 
discoveries done in animal models to human parasites by comparative mapping. 
1.7) Experimental Approach 
As discussed in the previous sections, the malaria parasite is an organism with a 
complex life cycle that places it in different environments. At the antigenic level, 
several molecules are expressed on the surface of the malaria parasite in the different 
life cycle stages. They provide numerous targets for immune responses, which make 
the parasite more vulnerable. One strategy the parasite adopts to escape immune 
responses is by showing a high degree of polymorphism at the antigenic level. The 
antigenic polymorphism is particularly marked at the blood stage level, which is the 
main cause of the deleterious symptoms associated with malaria and where immune 
reactions are very pronounced. The antigens expressed at the blood stage are 
particularly immunogenic and induce a strong immune response in the vertebrate 
host. Since these antigens are highly polymorphic, the immune response that is 
developed tends to be specific for a particular genotype. This specificity is known as 
Strain-Specific Immunity (SSI). SSI is defined as the development of a strong 
immune response against a specific malaria parasite genotype, which is however 
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considerably less effective against other genotypes or strains. The search for a 
malaria vaccine that can protect against the deleterious effects of the blood stage of 
the disease has produced interesting results, but not yet an effective vaccine. A 
reason could be the lack of knowledge on immunity to malaria and the antigens 
involved in it. The strong immune responses elicited during SSI could be exploited 
for the development of a better vaccine, either through the discovery of novel 
antigens or through a better understanding of the mechanisms involved in mounting a 
protective immune response to malaria. 
The aim of this project is to identify genes encoding target antigens responsible for 
SSI in P. c. chabaudi and eventually in P. falciparum. Although several potential 
candidates antigens for SSI are known, there is no biological proof that any of them 
is involved in SSI. Furthermore, about 60% of the proteins identified in the P. 
falciparum genome are of unknown function, among which novel antigens are likely 
to be present (Gardner et al., 2002). The approach proposed in this study is based on 
the selective filtration under SSI pressure of the recombinant progeny of a genetic 
cross between two genetically distinct clones (also known as strains) of P. c. 
chabaudi (Fig. 1.6). This is achieved by immunising mice with one of the strains of 
P. c. chabaudi (Strain 1 in Fig. 1.6) and allowing the mouse to recover from the 
infection. The uncloned recombinant progeny of a genetic cross between the two 
clones is used to challenge a strain-specifically immunised mouse. Those 
recombinant progeny clones that have inherited alleles of genes encoding target 
antigens of the immunising strain (located within the red locus of Fig. 1.6) are 
expected to be removed or at least reduced in the population following exposure to 
SSI, compared to the original, unselected cross progeny. 
Using this approach, two strategies are possible to allow the identification of genes 
linked with SSI. Firstly, since there are known candidate antigens for SSI (e.g. MSP-
1 and AMA-1), quantitative methods such as Real Time PCR and an AFLP method 
developed in this thesis can be applied to allele-specific probes for these genes which 
can be used to analyse their behaviour in immune-selected material as compared to 
alleles of other presumed neutral genes. In S SI-selected cross-progeny, targeted 
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alleles of genes that are involved in SSI should decrease in relation to alleles of loci 
not under selection. Secondly, in order to try to detect if otherwise unknown genes 
are involved in SSI, the generation of a large number of genetic markers covering the 
whole genome should allow the identification of unknown loci under selection. It is 
expected that markers linked to loci under selection should also display a reduction 
in proportion compared to neutral genes or compared to the same material not 
exposed to immune selection. Both strategies are currently being pursued in our lab. 
This study is concerned with the development of the second strategy, i.e. the 
discovery of unknown genes for SSI. This involves, as mentioned above, the 
generation of a large number of genetic markers, which can be organised in a linkage 
map. Furthermore, the possibility of using these markers to measure the proportion 
of their alleles present in the parasites (both under selection and grown in naïve 
conditions) needs to be established. The next sections describe the technique chosen 











x 0 x 0 
Th4vLNS1U 
SAll' 1 
IMECflcX4 	 x 
SR 
X Strain I Allele 




Chalkngpd NN 	s-Fo 
%Mth a nixttze of 











Fig. 1.6 Identification of loci for targets of SSI in P. c. chobaudi in mice using strain–specific immune 
selection on the progeny of a genetic cross between an immunising clone (strain 1) and a genetically 
unrelated clone (strain 2). Immunisation of mice with strain 1 will result in the mouse being able to 
recognise antigens specific for that strain and resist any future infection with the same strain. 
However, the mouse still remains relatively susceptible to other genetically unrelated strains. In the 
recombinant cross-progeny between strain I and 2, only those clones carrying the susceptible allele at 
loci under immune selection (indicated by a d cross and an arrow) are removed or greatly reduced in 
the population, while progeny clones carrying the resistant allele (indicated by circles) are 
unaffected or only mildly so compared to the susceptible clones. This will result in the lack or under-
representation of such alleles in the inunune selected recombinant cross-progeny. 
1.7.1) The Amplified Fragment Length Polymorphism (AFLP) technique 
In a relatively short amount of time without any previous knowledge of genomic 
sequence, AFLP allows the generation of a large number of markers distinguishing 
between two clones of parasite. AFLP involves digesting genomic DNA into a large 
number of fragments with two restriction endonucleases (a frequent and a rare cutter) 
and then ligating the resulting cut DNA ends with specifically designed 
oligonucleotide adapters. Adapters are needed to allow the amplification of the 
resulting DNA fragments by PCR, using primers matching the adapters. The AFLP 
procedure results in predominant amplification of those restriction fragments, which 
have a rare cutter sequence on one end and a frequent cutter sequence on the other 
end (Vos et al., 1995). Radiolabeling of one primer allows visualisation of the 
products. In a comparison between two different parasite lines, DNA sequence 
differences between them at a cutting site result in fragments of different sizes. These 
can then be identified on a gel as the presence of a band in one line and its absence in 
the other strain (Fig. 1.7). In a haploid genome such as the malaria parasite, allelic 
differences show up as the presence or absence of a band and lead to much simpler 
analysis of results than would be the case in diploid organisms. Previous work on P. 
falciparurn has used AFLP to identify polymorphic loci in malaria parasites (Rubio 
etal., 2001). In Chapter 3, the generation of a large number of AFLP markers in P. c. 
chabaudi will be described. 
In the course of this work, a genetic linkage map based on the AFLP markers was 
generated, as shown in Chapter 4. Although not strictly required for the identification 
of target genes, a linkage map based on AFLP markers has several advantages. These 
include distinguishing between AFLP markers linked or not linked to the genes for 
antigens such as MSP-1 or AMA-I. Furthermore, a genetic linkage map can provide 
information to partially compensate for the limitations in the use of AFLP as a 
proportional method (see next section and Chapter 6) and also help clarify 
difficulties in interpreting data from cross-progeny parasites (Chapter 7). 
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Fig. 1.7 Example of an AFLP band pattern for P. c. chabaudi cloned isolates AS and AJ. The AFLP 
reactions were performed using EcoRl primer with selective 3' nucleotides A and T. Two 
combinations of MseI primers (Indicated by a capital "M") with different selective nucleotides (capital 
letters following the primer letter, e.g. M.XY) at their 3'-end are shown, as indicated in the Figure 
(M.CT and M.GA). Arrows indicate AFLP markers unique to AS or AJ. 
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1.7.2) Proportional AFLP 
A crucial aspect of this project is the ability to detect reductions (or increases) in the 
proportion of parasites carrying specific genetic markers in the recombinant parasite 
population under a selection pressure. The AFLP technique can be used as a 
proportional quantitative technique for this purpose, because all DNA fragments 
generated by the AFLP technique share the same adapters, which act as template for 
the primers, all AFLP fragments (both strain-specific markers and non-polymorphic 
bands) compete with each other for the primers. There are many reasons why one 
fragment will be amplified more or less efficiently than another. In particular, if 
some fragments are present at a higher proportion, they are also more likely to be 
amplified and should therefore yield stronger bands. Conversely, fragments that are 
present at a lower proportion should also be less likely to be amplified and thus yield 
fainter bands. The latter should also be the case for markers that have been reduced 
in proportion following SSI. Furthermore, since the PCR amplification occurs in the 
same reaction for all fragments, the effect of different PCR reaction efficiencies is 
effectively removed. In fact, a technique called "balanced PCR" and based on a 
strikingly similar principle to AFLP (Makrigiorgos et al., 2002), has been shown to 
be a reliable quantitative technique. 
The intensity of AFLP marker intensities has been shown to be double in a 
homozygous compared to a heterozygous individual in diploid organisms (Peleman, 
1999). This reflects the fact that heterozygous individuals contain 50% DNA from 
one parent and 50% from the other, while a homozygote for a particular AFLP 
marker contains 100% DNA of one parent. For the approach presented here, it was 
essential to establish the limits on sensitivity of the AFLP technique in detecting the 
proportions of parasites carrying a specific AFLP marker in a genetically mixed 
population of parasites. For this purpose I have developed a proportional AFLP 
method applicable to the P. c. chabaudi genome. 
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1.7.3) Study's objectives 
The aim of the study presented here was to lay the groundwork for the molecular and 
genetic aspects of the approach for the identification of targets of SSI. 
Genetic crosses of P. c. chabaudi clones are already available or can be readily 
generated for the strains chosen for this approach. The immune selection experiments 
have also been developed and perfected in the lab. 
The work performed during this study consisted of the development of the AFLP 
technique in P. c. chabaudi, the generation of AFLP markers and their ordering in a 
genetic linkage map, the identification of alleles of AFLP markers (which could 
provide a useful confirmation of results of interest), the development of AFLP as a 
proportional technique and its subsequent testing in cross-progeny parasites exposed 
to SSI. 
This thesis will present how the various molecular and genetic aspects of the 
approach have been successfully developed and are now ready to be used for the 
achievement of the main aim of the project of our lab, i.e. the identification of genes 
encoding target antigens responsible for SSI. 
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2. Materials and Methods 
2.1) Mouse strains used in experiments 
Inbred female CBA mice, obtained from the University of Edinburgh, were used for 
experimental work and routine maintenance. Mice were housed in the same room in 
propylene cages with sawdust bedding and were fed on Harlan, SDS formula number 
I (Special Diet Services Ltd.) and drinking water supplemented with 0.05% 
paraminobenzoic acid (PABA) to aid parasite growth (Jacobs, 1964). Temperature 
was maintained between 22 and 25°C with a 12 hour light/12 hour dark cycle. 
2.2) 	Parasite lines 
Two cloned isolates of P .c. chabaudi parasites, AS and AJ, were used for the 
production of the genetic AFLP atlas. These are maintained in The WHO Strain 
Bank at the University of Edinburgh and were obtained from wild caught Thamnomy 
rutilans captured in the same locality in the vicinity of the town of Bangui in the 
Central African Republic in 1969. 
28 clones obtained from 2 different crosses between the parental strains AS and AJ 
of P. c. chabaudi were used (Table 2.1). 20 clones originated from a cross between 
AJ and AS 3CQ (a chloroquine-resistant clone derived from AS) (Canton et al., 
1998b), while 8 originated from a cross between AJ and AS 30CQ, another 
chioroquine resistant clone derived from AS 3CQ (Padua, 1981). AS 3CQ was 
derived from the chloroquine-sensitive AS PYR clone (derived in turn from the 
original AS clone) by selection with chioroquine (Rosario, 1976a). AS 30CQ was 
obtained after further selection for chloroquine resistance was applied on AS 3CQ 
(Padua, 1981). Fig. 2.1 illustrates the relationship among the various clones. Both 
clones are identical to the original, drug-sensitive AS clone, except for the presence 







Fig. 2.1. Origin of the chioroquine-resistant AS clones. AS PYR represents a clone selected for its 
resistance to the pyrimethamine drug. 
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Table 2.1. List of the recombinant cross-progeny clones from crosses between clone AJ and two 
different, drug-resistant sub-clones of AS, AS 3CQ and AS 30CQ used for the generation of the 
genetic linkage map. 
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2.3) Maintenance of parasites 
For routine maintenance of parasites, parasitised red blood cells collected from the 
tail veins of infected mice were passaged in citrate saline into uninfected mice. Thin 
blood smears, fixed in methanol and stained in 20% Giemsa, were taken 4-6 days 
after intra-peritoneal injection and examined under the microscope to verify presence 
of parasites. Cryopreservation of infected blood was performed by exanguination of 
mice anaesthetised with Halothane. Blood was collected in a tube containing 2-3 
times the volume of blood of citrate saline. The mixture was spun at 2000 rpm for 5 
mm, supernatant discarded and the red cell-pellet was mixed with 2 times the volume 
of deep-freeze solution (Appendix 1). The mixture was then aliquoted into several 
glass capillaries, which were sealed by flame and deep-frozen in liquid nitrogen. 
Cryopreserved blood was recovered by thawing the capillaries and diluting 1 ml of 
blood with 0.2m1 of 12% NaCl for 3-5 mins. Following that, 9 volumes of 1.6% 
NaCl were added dropwise and centrifuged at 2000 rpm for 3-5 mins. The 
supernatant was removed and 9 volumes of 0.9% NaC1! 0.2% dextrose solution were 
added dropwise. The mixture was centrifuged again, supernatant removed and red 
blood cells resuspended for injection. 
2.4) Parasitaemia count 
Parasitaemias were estimated by microscopic observation of thin blood smears taken 
4-6 days after parasite injection and stained with 20% Giemsa staining solution 
(BDH) for 15 minutes. Parasitaemia was estimated by calculating the number of 
iRBCs against the number of uninfected red blood cells in at least 5 microscopic 
fields and expressing the result as a percentage. 
2.5) Removal of host cell DNA 
Each parasite DNA preparation was obtained from 5 infected CBA female mice. It 
required extracting blood in the mid-afternoon, when parasites were at their 
trophozoite-stage, from infected mice having peak parasitaemias. The procedure was 
repeated for AS only, AJ only and cross-products infections. 
Blood was filtered in order to remove any lymphocyte or nucleated cells present in 
the blood, by placing onto a 5 ml column of powdered cellulose (Sigma) washed 
with citrate saline. This was repeated twice. Subsequently, blood was filtered through 
PlasmodipurTM filters (Euro-Diagnostica) twice. The filtrate was centrifuged for 5 
mins at 3000 rpm and supernatant discarded, leaving only packed cells. Twice the 
packed cells volume of 0.15% saponin in Phosphate Buffered Saline (PBS) was 
added to lyse cells. When the solution turned dark red, excess of PBS was added to 
prevent parasites being lysed. The solution was then centrifuged again at 4000 rpm 
for 5 minutes and washed twice in PBS. Supernatant was discarded and pellets kept 
at -70°C. Three thick smears of blood were taken prior to filtration, after cellulose 
filtration and after PlasmodipurTM filtration in order to determine the efficiency of 
host cell removal after each filtration. Thick blood smears were taken before and 
after filtration and stained with 20% Giemsa staining solution for 15 mm. The 
number of lymphocytes following filtration was determined by counting how many 
lymphocytes were present among 200,000-500,000 parasite nuclei in each smear. 
2.6) Extraction of parasite DNA 
The frozen pellet was re-suspended in 0.4 ml buffer A (Appendix 1). Then 10 jtl of 
10% SDS and 50 tg Proteinase K (Sigma) were added. The pellet was left at 37°C 
overnight. The following day, an equal volume of 1:1 phenol/chloroform mixture 
was added, mixed for 3 min and centrifuged at 5,000 g for 1-2 minutes. The upper 
aqueous layer was transferred to a fresh tube. The step was repeated 2-3 times. Then 
an equal volume of chloroform was added, tube was centrifuged as before for 1-2 
minutes. The upper aqueous layer was removed to a fresh tube. The procedure was 
repeated once. 
An equal volume of ether was added, the liquid centrifuged as before for 1-2 minutes 
and the upper layer removed. The remaining ether was left to dry in the air. 
Three volumes of ice-cold absolute ethanol and 11101h  volume of 3M sodium acetate 
(pH 5.2) were added. Tube was mixed and placed on ice 15-45 minutes to precipitate 
DNA. Subsequently the tube was centrifuged at 10,000 g for 10 minutes and ethanol 
mixture removed. The tube was centrifuged at 10,000 g in a Speed Vac (Savant) for 
5-10 minutes to remove final traces of ethanol and the pellet was resuspended in 100-
200 l TB buffer (pH 8.0) (see Appendix 1) and left at 37°C for 10 minutes. It was 
then stored at -20°C for future use. 
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2.7) Amplified Fragment Length Polymorphism (AFLP) technique 
0.5j.tg parasite genomic DNA were cut with two enzymes. Firstly, 10 U of EcoPJ 
(MBI Fermentas, recognition sequence: GAATTC) were added and DNA incubated 
at 37°C for 1 h, then 5 U of TruJJMseI (MBI Fermentas, recognition sequence: 
TTAA) were added and DNA incubated for further 3 h at 65°C. The digestion was 
in a 40 jil solution containing 2X Y/ Tango buffer (Promega). The fragments were 
then ligated with adapters matching the cut ends produced by the enzymes. All 
primers used were provided by MWG-Biotech UK Ltd. Adapters disrupted the 
cutting site recognised by the enzymes, to prevent cutting of the adapters from the 
DNA fragment. Adapters also provided a recognition site for primers. 
-MseI adapters: Mel-al and MeI.a2 
-MeI.al: 5'-GACGATGAGTCCTGAG-3' 
-MeI.a2: 	3 '-TACTCAGGACTCAT-5' 
-EcoRI adapters: EoI.al and EoI.a2 
-EoI.al: 5'-CTCGTAGACTGCGTACC-3' 
-EoI.a2: 	3' -CATCTGACGCATGGTTAA-5' 
Bold letters indicate base substitution to disrupt enzyme cutting site. 
Adapters were prepared by adding equimolar amounts of both strands and then 
performing the following procedure: 
Heat adapters at 94°C for 5 mins, then cool to 21°C for 5 mins 
Heat adapters at 72°C for 60 s., then cool to 21°C for 5 mins 
Heat adapters at 65°C for 60 s., then cool to 21°C for 5 mins. 
Adapters were diluted to 50 pmollpi. They were then utilised to prepare the ligation 
mixture. 10 .il of ligation mixture (Appendix 1) were added to 40 j.il of digested 
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DNA and incubated at 37°C for 3h, then overnight at 15°C. Ligated material was 
diluted 1:10 in TE buffer (pH 8.0) (Appendix 1) and stored at -20°C. 
A first PCR (polymerase chain reaction) amplification involved the use of "non-
selective" primers (i.e. primers with no extra nucleotides added at their 3' ends 
extending beyond the adapters sequence) matching the adapters. 
Non-selective EcoRI primer: 5'-GACTGCGTACCAATTC-3' 
Non-selective MseI primer: 5 '-GATGAGTCCTGAGTAA-3' 
A 20j.il PCR solution containing 0.32 M of each of the non-selective primers, 1 tl 
template DNA, 0.4 U Taq polymerase (Promega), 1X Mg-free PCR Buffer 
(Promega), 1.5 MM M902, and 0.2mM of all 4 dNTPs was set up. The following 
cycles were performed: 
- 94°C for 60 s., then 
- 94°C for 3Os. 
- 56°C for 60 s. 
- 65°C for óOs. 
- repeat the three steps for 20 cycles 
PCR material was diluted 50-fold in TE buffer (pH 8.0) and stored at -20°C. 
Selective amplification involved the use of a radiolabelled primer (usually the 
EcoRJ-primer) and of selective primers (i.e. primers with a selective extension at the 
3'-end, to reduce the number of fragments amplified). For radiolabeling, 2.5X Kinase 
buffer (Promega), 20U T4 polynucleotide Kinase (Promega), 100 p.Ci ['y- 33P] ATP / 
[7-32P] ATP (ICN) and 500 ng oligonucleotide primer were incubated in a 20 t1 
solution at 37°C for 60 mm. Reaction was stopped by adding 1 il of 0.1 M EDTA 
pH 8.0 and heating at 70°C for 10 mm. The mixture was made up to a volume of 50 
pi by adding sterile, distilled water. 
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Next, a primer purification was performed using TE Micro Select-D, G-25 
microcentrifuge spin columns produced by Eppendorf-5 Prime Inc. 
Hot PCR with the radiolabelled primer was performed as follows: 0.32 tM of the 
selective MseI primer, 0.05 jiM of the labelled selective EcoPJ primer, 1 p.1 template 
DNA, 0.4 U Taq polymerase (Promega), 1X Mg-free PCR Buffer (Promega), 2.5 
MM M902, and 0.2mM of all 4 dNTP's were added in 20p.l PCR solution. 
Additionally, a different PCR cycle was used: 
- 94°C for 60 s., then 
- 94°C for 3Os. 
- 65°C for 60 s., annealing temperature is reduced at each cycle by 
0.7°C for the next 12 cycles, then remained at 56°C for the 
remaining 23 cycles 
- 65°C for 60s. 
repeat the three steps for 35 cycles 
The AFLP procedure is summarised in Fig. 2.2. 
The PCR products were mixed with 20 p.1 of loading dye for sequencing gels 
(Anachem), then heated at 99°C for 3 min and quickly cooled on ice. 5p.l of each 
sample were loaded onto a 5% denaturing polyacrylamide gel (5% acrylamide, 
0.25% methylene bisacryl, 7.5 M urea in 50mM Tris/50mM Boric acidlln-iM 
EDTA). 500 p.1 of 10% APS (Ammonium Persulfate) and 1 00p.l of TEMED (Sigma) 
were added to 100 ml of gel solution and gel cast using a SequiGen 38x50 cm gel 
apparatus (BioRad). Electrophoresis was performed at 110 W for 2 h in lx TBE 
buffer. Gels were then dried in a vacuum gel drier (model 583, Bio Rad) and exposed 
overnight in phosphorimager screens (Fuji) at -70°C. Results were visualised on an 
autoradiography film (Kodak XAR-5). They were developed in an automatic 
autoradiographer developer (Exograph). 
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Hypothetical genome sequence with EcoRI and 
MseI recognition sites 
3 	 • •• • • • •• • •••••............ •• • •••••••••......  	 TikcJr4Ai I1i 5' 
MseI 
'I' 
G * .... 	....... 
5 ,4  CIG  Ligation 	E5]MlcAGGAcTcAT 
CAAIXIA1UG1Tth1 	 GAGIcCIGAGfAoA&5' 
EoI.al and EoI.a2 adapters 	 MeI.al and MeI.a2 adapters 
•....... losses . .•...... . ...u.0 .... 
	
.................................. 	if 
PCR amplification 	MseI primer + selective bases 
G'GAGCIUkGL&GCA&5' 
•uuie'i•.uuu..u••i• games n•uuuuuuu 5 9-1=EACIAC~'IIIOGFE~ACIIAA% ................................. 
5'- GACKXJ3T'AcCAA.TIC AcC —* 
EcoRI primer + selective bases 
5 _ 	 JJ3JY... .......   .. . .... . . ... c1&3 
cIt:i ()1VI](TIA(i 11113. en....  some .. .... somel GIC 
Fig. 2.2. Schematic representation of the AFLP procedure. Letters in bold style represent the base 
substitutions inserted to eliminate the enzyme digestion sites after ligation of the adapters. 
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2.8) Calculation of the genetic diversity between AS and AJ 
The Dice index (SD,) (Mougel et al., 2002) was used as a measure of the genetic 
similarity between AS and AT, where 
SD = nJ(n + (,/2) 	 (equation 1) 
in which nXY  is the number of fragments common to both strains (AS and AJ) and Axy  
is the number of fragments found only in AS or only in AT. 
This index may be used to estimate the sequence diversity. Polymorphic bands occur 
in two ways; firstly, by sequence differences in either a restriction enzyme site, 
EcoRI and MseI, or at positions represented by the selective bases or, secondly, by 
insertions or deletions in an amplified fragment. For the former, the probability of 
sequence difference at a given position between the two strains is given by 
d = 1 - (SD,)T 	 (equation 2) 
where r = the number of identical bases required for a common AFLP band (= 
6+4+4 =14, in this case, corresponding to the sequences recognised by the EcoPJ and 
MseI enzymes and the selective bases used in the experiments). 
For the latter (insertions and deletions), to a first approximation, the minimum 
probability of differences in sequence is given by 
d = (1 - SD, )/n 	 (equation 3) 
where n = the average size of a fragment in base pairs (200 bp in this case, see 
Chapter 3). 
2.9) Organisation of AFLP markers in a genetic linkage map 
For every marker, the parental alleles identified in each of the progeny clones were 
entered in an Excel spreadsheet (Appendix 2), with the absence of a band being 
considered as the presence of the other allele. Data were then prepared for analysis 
with the Map Manager QTX software (Manly et aL, 2001) according to the 
instruction manual. The dataset was designated as "Backcross" for the purpose of 
computer analysis. 
rN! x5 I 
Prior to linkage analysis, markers were tested for Mendelian segregation using a A?-
test. This was done in order to exclude markers segregating in a non-Mendelian 
fashion from the initial analysis with the Map Manager and thus prevent spurious 
linkage between such markers. Additionally, a Bonferroni correction was applied to 
the T-test. The Bonferroni correction is applied to increase the stringency of any 
statistical test. In this particular case it was added in order to take into account the 
"relatedness" of AFLP markers to each other (e.g. by being alleles of each other or 
belonging to the same linkage group). The Bonferroni correction was arbitrarily set 
at 24, after the estimated mean number of chromosome fragments produced during 
recombination at meiosis. This value was derived from studies conducted on P. 
falciparum (Walker-Jonah et al., 1992), which indicated an average of 10 
recombination events across the 14 chromosomes. Markers not following a 
Mendelian segregation were divided in two groups, i.e. those segregating in a non-
Mendelian fashion before and after Bonferroni's correction. These markers were 
added for software analysis after linkage groups had been determined and were 
allocated to linkage groups by using the "Distribute" command for pO.00l. Markers 
following a non-Mendelian segregation after T-test without Bonferroni correction 
were added first, and those still segregating in a non-Mendelian fashion after 
Bonferroni's correction were added last. 
Linkage groups were formed with an initial p-value of 0.0001 using the "Make 
Linkage Groups" command in Map Manager. p-values in Map Manager indicate the 
probability of a Type 1 error, that is, the probability of a false positive linkage. 
Linkage at 0.001 (i.e. a probability of a false positive linkage of 1:1,000) or lower 
values is considered significant. Following formation of linkage groups, the p-value 
was raised to 0.001. Using the command "Distribute", linkage groups were brought 
together. Subsequently, any remaining unlinked markers were also assigned to 
linkage groups using the "Distribute" command. Finally, markers from the two 
groups of AFLP markers not segregating in a Mendelian fashion were assigned 
similarly. The program also estimated genetic distance between markers in 
centiMorgans (cM). This was done using the "Kosambi" function in the software. 
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The presence of 44 previously characterised RFLP (Restriction Fragment Length 
Polymorphism) markers (Carlton et al., 1998b), which had been physically mapped 
onto P. c. chabaudi chromosomes, served as anchors for the placement of AFLP 
linkage groups onto chromosomes. 
2.10) Sequencing of AFLP markers 
2.10.1) Extraction and amplification of AFLP fragments 
AFLP fragments were excised from an acrylamide gel using a sterile scalpel. The gel 
fragments were then soaked in an Eppendorf tube in 50 p.1 of autoclaved, distilled 
water (sdH 20) overnight. Gel slices were centrifuged at 12000 g prior to removal of 
the liquid phase containing the DNA. DNA was precipitated using 1/10 volume of 
3M sodium acetate (pH 5.2) and 3 volumes of ice-cold absolute ethanol. The solution 
was placed at -20°C for at least 1 h. Thereafter the tubes were spun for 30 mins at 
high speed. The liquid phase was removed and the DNA pellet washed twice in 70% 
ethanol, before air drying. The pellet was then dissolved in 50 iI TB buffer (8.0 pH). 
The extracted DNA fragment was amplified by PCR, using the selective AFLP 
primers and PCR conditions. 
2.10.2) Cloning AFLP fragments into plasmids and transformation into E. co/i 
Following the manufacturer's instructions, the TOPO® TA Cloning kit (Invitrogen) 
was used, for cloning of PCR product and transformation of E. co/i (TOP 1OF'). The 
extracted fragments were amplified with a PCR reaction using non-selective EcoPJ 
and MseI primers. The product was analysed with a 1.5% agarose gel in 1XTBB 
buffer and subsequently used for cloning into pCR® 2.1-TOPO® plasmid vectors 
(Fig. 2.3). Transformed bacteria were spread onto a selective LB-Agar plate, 
containing 100p.g/ml ampicillin and 40 mg/ml X-gal and incubated at 37°C 
overnight. 
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2.10.3) Analysis of cloned AFLP fragments 
Successful insertion of the DNA fragment into the vector resulted in disruption of the 
lacZ gene (Fig 2.3) and of its ability to convert the X-gal contained in the LB-Agar 
plate into a blue product. This resulted in the presence of white E. coli colonies. 
Individual white colonies were picked and used to inoculate 10 ml overnight cultures 
of LB medium containing 100 .tg/ml of ampicillin. Following the manufacturer's 
instructions, 2 ml of the culture were used for the isolation of recombinant plasmids 
using the QIAGEN QlAprep® kit. Isolated plasmids were analysed by restriction 
endonuclease digestion for 1 hour at 37°C using EcoRI, run out on a 1.5% agarose 
gel in 1XTBE buffer to confirm the insert size. A PCR with non-selective EcoRI and 
MseI primers, with the conditions described previously, was also performed. In both 
cases the products were compared with the original size of the PCR product. In the 
case of the digestion control, the extra nucleotides from the plasmid were taken into 
account (Fig. 2.3). 
2.10.4) Sequencing of the cloned AFLP fragments 
Sequencing was performed using the M13 primers provided by the TOPO® TA kit. 
Reactions and gel analysis were performed at the ICAPB and CGR (Centre for 
Genomic Research) facilities of the University of Edinburgh. 
2.10.5) Analysis of sequences 
Sequences obtained for the various fragments were analysed using the GCG program 
for general analysis of sequences available on the HUMP site 
(www.hgmp.mrc.ac.uk). A comparison with known sequences from P. c. chabaudi, 
P. falciparum and other non-related organisms was performed using the BLAST 
search engine available on the Sanger centre site (http://www.sanger.ac.uk ). In order 
to match the sequences to the database, the primer sequences were removed and the 
original enzyme cutting sites reconstituted. 
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lacZooATG 
Ml3 Reverse Prrmer 	I Hind , 111 	 Ken 	Sect Batrtl I 	Scot 
CAG CAA ACA GC1 AC$C ATG ArF ACG CCA AGC T1'G GTA CCG AGC TCG OAT CCA CTA 
GTC. crr TOT CCA TAC TGP TAC TAA TGC COT TCG AAC CAT CCC TCG AGC CTA GOT OAT 
BXI EccrR 1 ___ 
I 	 HI 
0Th ACO 0CC 0CC AGT GTO CTO GAA VC 0CC C1F 	p pAG CCC GAA 'I'TC TOC 
CAT TGC CCC COG TCA CAC GAC crr AAG CCC CAf CrC CCC C11' AAG ACO 
EcoR V 	 &tX I 	Not I 	Xho I 	 Nail Xba I 	 Ape I 
ACA TAT CCA TCA CAC TOG. CCC CCC :CTC GAG CAT CCA TOT AGA GGC CCC AAT TCC IcCC TAT 
TCT ATA OCT AGT GTO ACC GCC GGC GAG CTC CTA COT AGA TOT CCC CCC TCA AOC GG ATA 
Ti Promoter 	 M13 Forward (20) Primer 	 M13 Forward (-40) Primer 
ACT GAO TCG TAT T* AAT TCA CTG CCC GTC GTr CrA 4r.A CPT COT GAC. TOG CAA AAC 
TCA CTC AGC ATA_AI TCA AGT GAC COG CAG CAA AAT_1I A_GCA CTG ACC CCC T1'G 
pCR®2.1-TOPO 
3 9 kb 	The eequénce above repesètds the pCRe2.1TOPO vector With a POR product 
inserted by TA OonIn. 
I 	 TOO armw4) Inthoafes the start ofrIpOoo for the Ti RNA polymerese. 
A-170403 
Fig. 2.3. Map of vector pCR® 2.1-TOPO®. Position where the PCR product is inserted, M13 primer 
sites, as well as the EcoRI digestion sites are indicated (adapted from the Invitrogen instruction 
manual). 
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2.11) Hybridisation experiments 
2.11. 1) Southern blotting of AFLP PCR reactions 
Ten AFLP PCR reactions were performed with non-labelled AFLP primers (Table 
2.2). The reactions were split into two groups of five, as indicated in Table 2.2, so 
that two separate blots for hybridisation could be prepared. The AFLP PCR reactions 
were run on two large 1.5% agarose gels in 1XTBE buffer at 100V for 40 minutes. 
The agarose gels were depurinated for 15 minutes in 0.25M HC1 and blotted onto a 
Hybond N+ nitrocellulose membranes (Amersham) using a Tyler vacuum pump 
using 0.4M NaOH buffer for 1 hour. The membranes were washed in 5XSSC for 10 
minutes prior to hybridisation. 
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AFLP combination 












E.O/M.O none none 1 
E.AG/M.O AG none 2 
E.AG/M.A AG A 1,2 
E.AG/M.T AG T 1,2 
E.AG/M.0 AG C 1,2 
E.AG/M.G AG G 1,2 
Table 2.2. Combinations of EcoRI and MseI primers used to amplify DNA by AFLP, which was 
subsequently used as target DNA for probe hybridisation. The combinations were blotted onto two 
different nitrocellulose membranes (1 and 2), as indicated in the table. 
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2.11.2) Preparation of radiolabeled probes 
The transformed and sequenced AFLP fragments were amplified by PCR using non-
selective AFLP primers, using the PCR program described in section 2.7. The 
concentration of the PCR product was estimated by spectrophotometry. For each 
hybridisation experiment, 25 ng of an amplified AIFLP fragment (which would be 
used as a DNA probe) and sterile distilled water (sdH 20) were added to a final 
volume of 20 .tl in an Eppendorf tube. The DNA probe was denatured by boiling at 
98°C for 10 mins and quickly chilling on ice. Then a mixture containing 20 p.1 of the 
denatured DNA probe, 4 p.1 of High Prime reaction mixture (Roche Diagnostic), 3 p.1 
dCTP, dGTP, dTTP mixture (Roche Diagnostic) and 50mCi of [a- 32P] dATP 
(Amersham), was prepared on ice. The solution was incubated for at least 60 mins at 
37°C. The reaction was stopped by adding 2p.l 0.2 M EDTA (pH 8.0) and by heating 
to 65°C for 10 mins. 
2.11.3) Pre-hybridisation and hybridisation of radiolabeled probes 
The nitrocellulose membrane with the blotted DNA was washed in 5XSSC and pre-
hybridised in pre-hybridisation solution (Appendix 1) at 45°C for at least 1 hour. In 
the meantime, a 1 ml blocking agent containing 0.1 mg of herring sperm DNA 
diluted in sdH20 was prepared, to block non-specific attachment of the probe to the 
target DNA. The radiolabeled probe was then added to the blocking agent solution. 
The mixture was boiled for 5 mins and then quickly chilled on ice for 5 mins. The 
labelled probe solution was added to a glass tube containing the membrane/s and 
hybridised overnight at 60°C in a Maxioven (Hybaid) hybridisation oven. 
2.11.4) Washing of membranes and signal detection 
The following day, the membrane was washed at 60°C as follows: 2 X 20 mm 
washes in 2XSSC/0.1%SDS, followed by 2 X 20 min washes in 0.5XSSC/0.1%SDS, 
followed by 2 X 20 min washes in 0.1XSSC/0.1%SDS. Subsequently the wet 
membrane was wrapped in Saran wrap and exposed at -70°C overnight onto an 
autoradiograph film (Kodak XAR-5) and the film was developed using an automatic 
autoradiographer developer (Exograph). 
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2.12) PCR and inverse PCR reactions for determination of AFLP marker 
alleles 
In order to identify alleles, primers for inverse PCR reactions were designed based 
on the sequences of the extracted AFLP fragments (Table 5.2). All primers were 
provided by MWG-Biotech UK Ltd. 
The inverse PCR principle is described in Fig. 2.4. 0.1 p.g of AS or AJ genomic DNA 
were digested in a mix containing 10 U of MseI enzyme and 2j.xl lox Y+/Tango 
buffer (both MBI Fermentas) in a total volume of 20il for lh at 65°C. Thereafter, the 
digestion mix was ligated using 20 U T4 DNA Ligase (Promega), 0.5mM ATP and 
lOpi of iox Y+/Tango buffer in a total solution volume of lOOpi, in order to dilute 
the DNA and promote ligation of the fragments onto themselves. The ligation mix 
was incubated at room temperature overnight. 
For all PCR reactions, conditions were maintained as described previously, but the 
following PCR cycles were used: 
For Pc-am02.Ox and Pc-am36.0x: 
- 94°C for 30 5. 
- 50°C for 60s. 
- 65°C for 60s. 
repeat the three steps for 30 cycles. 
- 65°C for 600s 
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Fig. 2.4 Diagrammatic representation of the inverse PCR principle. Inverse PCR was performed by 
digesting genomic DNA using the MseI enzyme. The cut fragments were circularised by ligation and 
specific primers were used to amplify the template upstream of the known DNA sequence. Inverse 






2.13) Proportional AFLP 
2.13. 1) Artificial mixtures of AS and AJ DNA 
Experiments for the proportional AFLP were set up by mixing AS and AJ pre-
amplified DNA at various concentrations, ranging from 100% AS to 0% AS relative 
to AJ. The mixtures were generated by mixing equal amounts of AS and AJ DNA in 
order to obtain a 50:50 mixture. This was then diluted in either pure AS or pure AJ 
DNA, thereby obtaining different proportions of AS to AJ DNA. Mixtures ranging 
from 0.8% to 99.2% AS DNA were thus produced and 1 p.1 of each added to a 
standard AFLP PCR reaction. 
2.13.2) Analysis of DNA proportion 
The resulting gels were exposed to a General Purpose Phosphor screen overnight and 
processed using a Storm 860 Phosphorimager (Molecular Dynamics) and the 
resulting image analysed using the ImageQuant 1.2 software (Molecular Dynamics), 
which allowed the quantification of band intensities. 
Band intensity was measured by drawing squares of equal perimeters around the 
bands, using a Local Median background correction. In order to obtain an accurate 
measure of the relative intensity of marker bands from different mixtures, a ratio of 
the marker's intensity over a non-polymorphic band intensity was calculated. This 
was done in order to compensate for the varying degrees of PCR reaction efficiency 
across the different individual reactions. 
For the second experiment, 7 mixtures of DNA (100%, 87.5%, 75%, 50%, 25%, 
12.5% and 0%) were chosen and PCR reactions for each sample were repeated 5 to 
10 times in order to obtain sufficient data for statistical analysis with the Minitab© 
software package. Data were transformed accordingly and T-tests and General Linear 
Model analysis was performed. 
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2.14) Analysis of AJ-immune-selected material by proportional AFLP 
2.14. 1) Origin of DNA templates 
For the experiments, the following samples were analysed: 
• Mixture of parental clones (AS +AJ) grown in naïve mice: DNA 74 
• Mixture of parental clones (AS+AJ) grown in mice immunised against AJ: DNA 
70 
• Cross-progeny (AS X AJ) grown in naïve mice: DNA 73 
• Cross-progeny (AS X AJ) grown in mice immunised against AJ: DNA 69 
The experimental protocol for the generation of template DNA is illustrated in Fig. 
2.5. This work was carried out by K. Grech. The cross-progeny material was 
obtained by mixing three individual genetic crosses between AS and AJ produced at 
the University of Edinburgh (Canton et al., 1998b; Rosario, 1976a; Walliker et al., 
1975). 
Mice were immunised as follows: a first infection with the AJ parental clone was 
induced with lx 106  parasitised red blood cell per mouse (prbc/pm) in 10 female CBA 
mice and treated at day 5, 6 and 7 post-infection with mefloquine (15mg/kg by oral 
gavage). A second challenge infection was given to each mouse with lx 106  prbc/pm 
of AJ-infected blood 98 days post infection. Mice were treated with mefloquine as 
indicated above. 148 days after the initial infection, the 10 mice were split into 2 
groups of five. One group was challenged with a mixture consisting of 50% AS and 
50% AJ parental clones leading to DNA 70, while another was challenged with the 
combined progeny from 3 different genetic crosses between AS and AJ leading to 
DNA prep 69. Both mixture and cross progeny were also grown in naïve mice (Fig. 
2.5). Each mouse received 1x107 prbc. DNA was extracted from five mice, with the 
exception of DNA 73, which was extracted from two mice (Fig. 2.5). This material 
was subsequently prepared for AFLP analysis, as described in Section 2.7. 
62 
AS + AJ mixture 




5x Naive Mice 	Naive Mouse 
DNA 74 	Naïve Mouse 
1 
5x Naïve Mice 
DNA 70 
AS X AJ cross progeny (0) 
5 x  2 x naive mice 	AJ-immunised  
mice 
DNA 73 	 Naïve Mouse 
5x Naïve Mice 
DNA 69 
Fig. 2.5. Flow chart depicting the origin of the naïve and AJ-immune-selected material used in the 
analysis of immune-selected material by proportional AFLP as described in Chapter 7. 
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2.14.2) AFLP reactions 
For the experiments, two combinations of AFLP primers were used. The first 
consisted of an EcoRI primer with AG as selective nucleotides at the 3' end and a 
MseI primer with the selective nucleotides AG. The second combination consisted of 
an EcoRI primer with selective nucleotides AG and an MseI primer with selective 
nucleotides AT. AFLP reactions were performed as described previously in Section 
2.7 with 5 to 10 repeats for each sample and each combination used. For pure AS and 
AJ DNA, only 2 to 4 repeats were done. 
2.14.3) Measurement of band intensities 
An intensity index for each AFLP marker was obtained by dividing the intensity 
values obtained for the different markers, by the intensity values of non-polymorphic 
bands located nearby. This was done in order to prevent the effect of local intensity 
variations due to factors unlinked with immune selection pressure. It was in contrast 
to the previous experiment, where a single non-polymorphic band was used as a 
reference band. Intensities were analysed with the ImageQuant software. Intensity 
indexes were transformed to obtain a normal distribution of the data for analysis by 
two-sample T-tests using the Minitab software in order to detect any statistical 
differences between parasites grown in naïve or AJ-immune mice. 
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3. Results: Generation of an Atlas of AFLP Markers for 
Two Cloned Isolates of Plasmodium chabaudi chabaudi 
3.1) Introduction 
The first part of the project was dedicated to the generation of genetic markers 
between two cloned isolates of P. c. chabaudi (AS and AJ), which could be used in 
order to generate a genetic linkage map of the rodent parasite. In order to obtain a 
sufficient number of genetic markers to cover the whole genome, the AFLP 
technique was chosen. The AFLP technique is based on the digestion of whole 
genomic DNA with two different restriction endonucleases (in this case EcoRI and 
MseI) and the subsequent ligation of the obtained fragments with specifically 
designed adapters that function as templates for the primers required in the AFLP 
PCR reaction (Fig. 2.2). To simplify analysis, AFLP reactions are performed using 
primers with extra nucleotides added at their 3' ends (called selective nucleotides). 
Mutations at either restriction endonuclease recognition sites or at the nucleotides 
recognised by AFLP primers with selective nucleotides and indel mutation in any 
AFLP fragment result in a genetic AFLP marker. AFLP markers can then be used to 
distinguish two P. c. chabaudi strains from each other. 
Prior to starting with the generation of AFLP markers, some important issues needed 
to be addressed. The first was the problem of host DNA contamination. Unlike free 
living organisms, where DNA can be extracted from cells with the certainty of no 
contamination, P. c. chabaudi, parasites must be extracted from the blood of the 
parasitised host. As host blood contains nucleated cells, their DNA will be extracted 
together with the parasite's DNA. This problem has the potential of causing 
confusing results in the interpretation of AFLP band patterns. Host DNA will be 
randomly present, thus generating AFLP bands of host origin that may interfere with 
the correct interpretation of the results. In particular, although mouse DNA was 
derived from female mice from the same inbred strain, it is known that low levels of 
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genetic differences are present even among individuals from the same inbred strain 
(Groen, 1977). It was thus essential to remove host DNA in the DNA preparations 
obtained from parasites. Furthermore it was essential to confirm that the elimination 
of host DNA had been successful at the levels required for AFLP analysis. Secondly, 
the repeatability and reliability of the technique needed to be tested. Only when this 
had been established, would it be possible to proceed with the generation of a reliable 
genetic atlas of AFLP markers. 
3.2) 	Results 
3.2.1) Removal of host DNA 
Blood obtained from mice was filtered through cellulose powder columns and 
PlasmodipurTM filters, as described in the Methods. Thick smears of blood were 
taken and examined under light microscope for the presence of lymphocytes and 
other nucleated cells of host origin. The procedure was repeated for all the parental 
strain preparations and all the progeny clones used in the experiments. 
On average, presence of white blood cells after filtration was determined to be below 
1 white blood cell per 100,000 parasite nuclei. This level was considered acceptable 
for AFLP analysis, as it resulted is a dilution of mouse genomic DNA to parasite 
DNA of less than 1:100. Due to competition of DNA fragments for the same primers, 
it is unlikely that mouse DNA at such low levels might yield more than weak 
background bands. This point is also further stressed by work on proportional AFLP 
(Chapter 5). 
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3.2.2) Reliability of the AFLP technique 
AFLP is known to be a reliable and repeatable technique (Vos et al., 1995). 
However, due to the nature of the DNA obtained in these experiments (i.e. the 
possibility of mouse DNA contamination, as well as possible variation of results 
between PCR reactions of the same material), it was imperative to test the reliability 
and repeatability of the AFLP results. The reliability of the AFLP technique was 
tested by comparing three different preparations from the same genotype (AJ) of P. 
c. chabaudi. However two of them, namely AJ 88 and AJ 82 had undergone an 
additional round of cloning by dilution, while the remaining preparation was taken 
from material that had been cloned by dilution only once. The three preparations 
were grown in three separate sets of five CBA female mice and extracted as 
described in the Materials and Methods section. In this experiment, four different 
primer combinations were used; the same EcoRI primer (E.AA) was used in 
conjunction with the following MseI primers: M.AT, M.CT, M.TA and M.AA. In 
Fig. 3.1 it can be seen that same sample, AJ 88, was tested twice. This represents two 
PCR reactions made in different occasions, to show the effect on band intensity that 
can occur between PCR reactions, as shown by combinations E.AA\M.AT and 
E.AA\M.CT. 
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AJAJAJAJ 	AJAJMAJAJAJAJAJ AJAJAJAJ 
82 81 88 88 82 81 88 88 82 81 88 88 	82 81 88 88 










Fig. 3.1. Four different AFLP combinations performed using primer combinations E.AA with M.AT, 
M.CT, M.TA and M.AA. 3 different DNA preparations of parental strain AJ were used (AJ 81. 82 and 
88). AJ 81 originated from material that underwent only one round of cloning, unlike AJ 82 and 88 
that underwent two. AJ 88 is present as two separate repeats of the same PCR reactions performed at 
different times. It can be noticed that band patterns are consistent between DNA preps, with minor 
differences due to faint bands (indicated by an ' or '#'), whose origin might be due to mouse DNA 
contamination or PCR reaction efficiency (see text for a more detailed account). 
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From Fig. 3.1 it can be seen that band patterns stayed the same across the different 
samples. Especially the strong AFLP bands proved highly consistent. However, 
minor variations could be observed as represented by the presence of unique faint 
bands between the DNA preparations. These faint bands can be divided in two 
categories: some faint bands appear in the more intense reactions and are absent in 
the fainter PCR's for the same combination of primers, most likely because they are 
too faint to leave a trace. Other faint bands appear to be unique to one or more DNA 
preparations. 
It is worth noticing that preparation AJ 81 is the one that varied most in this respect, 
possibly reflecting the effect of subsequent cloning by dilution on the other DNA 
preparations. While bands indicated by an '*' distinguish AJ 81 from the other DNA 
preparations, bands indicated by an '#' do appear in both AJ 81 and either AJ 82 or 
AJ 88 in combination E.AA'M.CT (where one AJ 88 PCR is less intense than the 
other, thus offering a likely explanation for the absence of the band there), while 
clearly being absent in the remaining DNA preparation. It is possible that those 
bands represent mouse DNA contamination. The fact that these bands are rather faint 
may well be a consequence of the filtration of blood to remove host nucleated cells, 
thus reducing the concentration of host DNA over parasite DNA, which is shown to 
affect the intensity of AFLP bands, as discussed in the chapter on proportional 
AFLP. It has also been observed that some faint bands do occasionally appear in a 
PCR reaction of a single parasite DNA, but are absent when the same reaction is 
repeated (data not shown). Thus they could reflect a different efficiency of PCR 
reactions for the different DNA preparations, which result in the appearance of faint 
bands. Faint polymorphic bands were ignored in making the atlas, unless they were 
present in a particularly faint PCR reaction, in which case they were placed in the 
"B" marker category described below, to be later confirmed during analysis of the 
progeny clones. 
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3.2.3) AFLP genetic atlas 
A sufficient number of genetic markers was required for the generation of a genetic 
linkage map of P. c. chabaudi covering the whole genome. These were generated 
using the AFLP technique and organised in a genetic atlas. In order to generate the 
AFLP genetic atlas it was decided to use the restriction endonucleases EcoRI and 
MseI, as previously done in the original AFLP paper (Vos et al., 1995). The enzyme 
combination also suited an A+T-rich genome, such as that of P. c. chabaudi, due to 
the predominance of A+T nucleotides in the recognition sites of the two restriction 
endonucleases. 
PCR amplification was performed using specifically designed EcoRI and MseI 
primers, as described in the Materials and Methods. EcoRI and MseI primers with 
two selective nucleotides each at their ends were chosen for the radioactive PCR 
reactions to maximise the number of markers obtained per combination. For AFLP 
reactions it is important to choose the right number of selective nucleotides. While 
choosing a low number of selective bases reduces the total number of reactions that 
need to be performed, it will also result in the loss of markers, due to the greater 
probability of non-polymorphic bands overlapping with AFLP markers. On the other 
hand, increasing the number of selective nucleotides over a certain limit will reduce 
the likelihood of overlapping bands, but the yield of a few extra markers is 
counterbalanced by the huge increase in PCR reactions that need to be performed. 
For the P. c. chabaudi genome it was concluded that two selective nucleotides were a 
reasonable compromise between genetic markers yield and amount of work needed 
to generate them. Such a combination yielded between 0 and 15 markers from 















(AS + AJ) 
Mean Mean % of 
number of number of amplified 
amplified clone-specific bands which 
bands per markers are clone 
primer (AFLP's) specific 
combination per primer (AFLP's) 
combination 
First A 14 
selective T 10 
base in C 8 
EcoRl G 10 
primer Total 42 
Second A 10 
selective T 12 
base in C 10 
EcoRl G 10 
Total 42 
Overall Total 42 
346 65 24.7 4.6 18.8 
304 51 30.4 5.1 16.8 
167 37 20.9 4.6 22.2 
229 50 22.9 4.5 21.8 
1,046 203 
265 54 26.5 5.4 20.4 
445 82 37.1 6.8 18.4 
180 36 18.0 3.6 20.0 
156 31 15.6 2.8 19.9 
1,046 203 
1,046 203 19.4 
Table 3.1. Estimations of the proportions of amplified bands, which are clone-specific (AFLP's) in 
Plasmodium c. chabaudi clones AS and AJ for different combinations of selective bases in the PCR 
primers used in the AFLP amplification reactions. 
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Fig. 3.2 shows a typical AFLP gel used to produce the atlas. In this case, the EcoRI 
primer has the AT selective bases at the 3' end. The nine other MseI primers used are 
described in the Figure. The genetic markers identified in this way were then 
designated as follows. The first two letters indicate the clone (i.e. AS or AJ) 
involved. The second two letters identify the selective bases used in the EcoRI 
primer. The three numbers identify the markers in decreasing size. The last two 
letters identify the selective bases of the MseI primer. A sample is shown in Table 
3.2. Some clone-specific bands were rejected as markers because of low or variable 
intensity between different AFLP reactions or of other difficulties in use (e.g. 
because of smearing). Furthermore, some clear markers were included, which needed 
particular caution during the analysis (e.g. due to close proximity to another band) 
and were thus labelled with a 'B' in the final table (Table 3.2). However, these 
observations were constantly re-assessed during the production of the genetic linkage 
map (see Chapter 4). 
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Fig. 3.2 Example of a section of the AFLP genetic atlas for P. c. chabaudi cloned isolates AS and AJ. 
All combinations were performed using EcoRI primer with selective 3' nucleotides AT. Nine 
combinations of MseI primers with different selective nucleotides at their 3'-ends are shown, as 
indicated in the Figure. 
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ASATOO1AA1 B ASACOO1AA1 ASTCOO1AA1 B 
ASATOO2AA1 ASACOO2AA1 ASTCOO2AA1 B 
ASAT003AA]. ASACOQ3AA1 ASTC003AA1 B 
ASATOO4AA]. ASACOO4AA1 
ASATOO5AA1 AJACOO1AA1 ASTCOO1AC]. 
AJATOO1AA1 B AJACOO2AA1 ASTCOO2AC1 B 
AJATOO2AA1 AJAC003AA1 AJTCOO1AC1 
AJAT 003 AA  B 
AJATOO4AA1 B ASACOO1AT1 B AJTCOO1AG1 B 
ASACOO2AT1 B AJTCOO2AG1 
ASATOO1AT1 ASAC003AT1 AJTC003AG1 B 
ASATOO2AT1 AJACOO1AT1 AJTCOO4AG1 B 
ASAT003AT1 AAJACOO2ATI B 
AJATOO1AT1 B AJAC003AT1 ASTCOO1TA1 B 
AJATOO2AT1 AJACOO4ATI AJTCOO1TA1 B 
AJAT003AT1 AJACOO5ATI AJTCOO2TA1 B 
AJATOO4AT1 AJTC003TA1 B 
AJ AT 005 AT 1 AJ AC 001 AC 1 	B 
AJ AT 006 AT 1 AJ AC 002 AC 1 AS TC 001 TT 1 	B 
AJATOO7AT1 B ASTCOO2TT1 
ASACOO1AG1 ASTC003TT1 
AS AT 001 AC 1 AS AC 002 AG 1 
ASATOO2AC1 AJACOO1AG1 ASTCOO1TC]. B 
ASAT003AC1 AJACOO2AG1 ASTCOO2TC1 
ASATOO4AC1 AJAC003AG1 ASTC003TC1 
AJ AT 001 AC 1 AJ TC 001 TC 1 	B 
AJ AT 002 AC 1 AS AC 001 TA 1 	B AJ TC 002 TC 1 	B 
AJAT003AC1 ASACOO2TA1 B 
AJACOO1TA1 B AJTCOO1TG1 B 
ASATOO1TA1 AJACOO2TAI B AJTCOO2TG1 
ASATOO2TA1 AJAC003TA1 
AJATOO1TA1 B AJACOO4TA1 B ASTCOO1CT1 
AJATOO2TA1 B AJTCOO1CT1 
AJAT003TA1 B ASACOO1TG1 B AJTCOO2CT1 B 
AJATOO4TA1 B AJ ACOO1TG1 B 
Table 3.2. Example of the classification of AFLP markers in the genetic atlas. The first two letters 
indicate in which cloned isolate the identified marker band is visible (i.e. AS or AJ). The second two 
letters correspond to the selective bases used in the EcoRJ primer. The three numbers identify the 
markers in decreasing size. The last two letters correspond to the selective bases of the MseI primer. 
The "B" appearing next to some markers indicates caution in interpretation during the creation of the 
genetic linkage map was needed, due to closeness to another band on the gel or other to factors which 
could affect a correct interpretation. 
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Using the P.c. chabaudi strains AS and AJ an AFLP atlas consisting of 819 markers 
was generated. There were 416 markers unique to strain AJ and 403 markers unique 
to strain AS (Table 3.3). The atlas was obtained using 181 combinations of EcoRl 
and MseI primers, which varied according to the selective bases at their 3 '-end. 
However, the number of markers that were eventually included altered with the 
development of the genetic linkage map, as some dubious markers were removed, 
while others previously discarded appeared as solid markers. 
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1G. 
Table 3.3. The number of AFLP markers identified in Plasmodium c. chabaudi 
cloned isolates AS and AJ using EcoRI and MseI site-specific PCR primer 
combinations having two selective bases each. The Table shows the number of 
clone-specific bands (AFLP markers) identified for each PCR primer combination 
for clone AS and clone AJ (next page). Subtotals of the numbers of AFLP markers 
identified with each of the EcoRI and Msel site-specific PCR primers are shown 
together with the grand total number of AFLP markers for each parasite clone. The 
total number of AFLP markers for both clones together is 819. 
-1 
Cloned Isolate AS 
Selective bases at MseI primer 
AA AC AG AT CA CT GA GT TA TC TG U CC CG GC GG 	I Total 
Selective bases 
at EcoRI primer 
AA 5 7335522333 ND 5 ND ND 47 
AC 4 02 3 0 ND 1 20 1 3 NDNDNDND 18 
AG 2 1 233 ND 0 1 01 1 0 1 02 19 
AT 5 4 6 3 4 2 4 ND 4 4 NDNDNDNDND 38 
CA 1 1 34 1 ND 24024 NDNDNDND 24 
CC 233 ND 03222 1 1 NDNDNDND 21 
CG 0 0 1 3 0 3 0 2 3 1 1 1 NDNDNDND 15 
CT 5 2 02 2 ND! 04 1 4 5 NDNDNDND 26 
GA 9 5 2 4 4 ND  0 2 1 0 1 NDNDNDND 30 
GC 6 2 03 0 6 ND 3 1 2 1 NDNDNDND 26 
GG 3 2 1 3 2 1 ND 1 0 0 0 NDNDNDND 13 
GT 5 2 7 2 ND 1 05 04 3 NDNDNDND 32 
TA 4 2 ND 2 3 2 ND 3 6 1 0 4 ND ND ND ND 27 
IC 320 1 2 1 1 1 1 303 NDNDNDND 18 
TG 6 04 2 3 2 2 1 2 2 1 5 NDNDNDND 30 
U 3 4 2 4 4 0 ND 0 ND 1 1 ND ND ND ND ND 19 
Total 63 37 36 42 35 25 22 16 41 20 25 32 1 6 0 2 403 
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Table 3.3 The number of AFLP markers identified in Plasmodium c. chabaudi 
cloned isolates AS and AJ using EcoRI and MseI site-specific PCR primer 
combinations having two selective bases each. This part of the Table shows the 
number of AFLP markers obtained for clone AJ using various AFLP primer 
combinations. 
Cloned Isolate AJ 
Selective bases at MseI primer 
AA AC AG AT CA CT GA GT TA TC TG TF CC CG GC GG 	I Total 
Selective bases at 
EcoRI primer 
AA 2 4 1 44 1 1 1 3 3 3 ND 1 ND ND 28 
AC 3 2 3 5 1 ND! 1 4 0 1 3 NDNDNDND 24 
AG 1 3 532 ND 42 1 222 1 02 30 
AT 4 3 1 7 2 6 2 ND 4 2 5 ND ND ND ND ND 36 
CA 4 0 2 4 3 ND 3 2 1 2 2 NDNDNDND 24 
CC 5 3 2 ND  1 1 3 2 0 6 5 NDNDNDND 34 
CG 2003 12024 13 1 NDNDNDND 19 
CT 3 5 1 5 5 ND 3 1 6 5 0 5 ND ND ND ND 39 
GA 4 5 3 5 4 ND! 1 3 0 2 2 NDNDNDND 30 
GC 2 1 1 4 0 2 ND 5 1 2 1 NDNDNDND 21 
GG 1 2 1 2 2 1 ND 0 0 1 0 0 ND ND ND ND 10 
GT 7 2 6 4 ND 1 1 0 3 4 3 2 NDNDNDND 33 
TA 1 3 ND 4 2 1 ND 2 3 1 0 1 ND ND ND ND 18 
TC 0 1 4 1 0 2 1 2 3 2 2 0 NDNDNDND 18 
TG 3 0 5 5 0 2 1 1 0 1 3 1 NDNDND ND 22 
U 4 5 4 5 3 3 ND 2 ND 1 3 ND ND ND ND ND 30 
Total 46 39 39 61 35 22 13 25 44 24 37 25 2 2 0 2 416 
3.2.4) Analysis of genetic atlas 
The AFLP markers obtained revealed information on the nature of the parasite DNA, 
which were analysed to establish if they were in accordance with previous 
observations on the P. c. chabaudi genome. By counting the total number of AFLP 
bands generated in each of 42 randomly chosen combinations of A1FLP primers (all 
16 combinations of EcoRI primer first and second position selective bases, and a 
subset of MseI primer selective bases from among the 181 combinations used) (Table 
3. 1), the proportion of all AFLP bands which were unique either to AS or to AJ was 
estimated. The total number of amplified bands counted during this exercise was 
1,046, of which 203 (19.4%) were unique to (polymorphic in) AS or AJ, i.e. they 
were clone-specific AFLP's (Table 3.1). 
The absolute number of amplified bands generated with the different primer 
combinations was greatest for AT-rich selective PCR primers (Table 3. 1), which was 
as expected, as the P. chabaudi genome consists of approximately 80% A or T 
nucleotides (McCutchan et al., 1984). The proportion of clone-specific bands 
(AFLPs) was not significantly affected by the selective base composition of the 
EcoRl primers. This proportion remained at around 20%, range 16.8% to 22.2% 
(Table 3.1). Thus polymorphisms between P. c. chabaudi clones appeared to be as 
likely to occur at A and T as at G and C sites, indicating that mutation rate is 
independent of the nucleotide present. In addition a small sample of representative 
amplified bands was sequenced (see Chapter 5), and from these the average length of 
the AFLP bands was estimated to be about 200 base pairs. 
3.3) 	Discussion 
Although AFLP is a tested technique in its reliability, due to the nature of the DNA 
used in these experiments, several issues needed to be addressed in order to proceed 
with the characterisation of the markers for the genetic linkage map. Firstly, the 
possibility of host DNA contamination needed to be addressed. Secondly, the 
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reliability of the AFLP band patterns was tested. Finally, a genetic atlas with all the 
identified AFLP markers was set up. 
Removal of DNA of host origin and establishment of the robustness of the AFLP 
technique were essential preparatory experiments. Host DNA was successfully 
removed by a series of filtrations through celluolose powder columns and 
PlasmodipurTM filters , as shown in the results. Parasite DNA from the same parasite 
strain obtained from different infected mice was then compared at the AFLP level to 
show robustness of the technique, as well as a further proof of host DNA removal. 
The results were positive and showed repeatability among the different DNA 
preparations. However, minor variations could be observed in the presence of faint 
bands across the DNA preparations. These could be explained as either mouse DNA 
contamination or variation in the efficiency of the PCR reactions. In the former 
scenario, the fact that those unique bands appear to be faint would be consistent with 
the removal of most of host cell nucleated cells, thus leaving only very few nucleated 
cells, whose DNA would have to compete with the preponderant P. c. chabaudi 
DNA. As PCR amplification in the AFLP technique is proportional (see Chapter 6), 
fainter bands for mouse DNA would be expected. 
For the second scenario, it has been previously observed that occasional faint bands 
might appear on repeated PCR of the same template, possibly reflecting different 
efficiency of the PCR reaction. In any case, those faint bands were ignored during 
the generation of the genetic atlas. This allowed the conclusion that the AFLP 
technique was reliable and that the effect of mouse DNA contamination was 
negligible. 
A total of 819 markers were generated by a first round of AFLP reactions performed 
using the AS and AJ P. chabaudi strains and the EcoRI and MseI enzymes, thus 
showing the efficiency of the AFLP technique when applied to the P. chabaudi 
genome. Those markers were classified according to their reliability and their 
validity was confirmed or rejected during the generation of the genetic linkage map. 
In general, fainter bands and those of unreliable intensity were excluded. However, 
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markers rejected during the generation of the atlas were also reinstated in the atlas if 
they proved usable during the generation of the linkage map. 
From a calculation on the presence of bands for AFLP primer combinations, it 
appeared that those primer combinations that contained two A or T selective 
nucleotides yielded the greatest number of bands, in accordance with the AT-rich 
nature of the P . c.  chabaudi genome. However, polymorphic bands were as likely to 
appear independently from the selective nucleotides present on the chosen primers. 
These data suggest that the mutation rate is independent from the nucleotide present 
at any given position. 
An estimate of the probability that there may be a sequence difference at any given 
base position between AS and AJ was based on the use of the Dice index (Sc) 
(Mougel et al., 2002) on the observed polymorphic rate of 19.4% and assuming an 
average band size of 200 bp, as suggested from sequencing. The genetic similarity 
between the two clones AS and AJ was calculated to be 0.893 as given by the Dice 
index in equation 1 (Section 2.8). From this value, the probability of sequence 
difference arising at a given base position was calculated. Two scenarios were 
considered. Firstly, that all AFLP bands originated from a nucleotide substitution at 
positions in the restriction sites or at the selective nucleotide positions. This 
eventuality was accounted for by equation 2 (Section 2.8). Secondly, that all AFLP 
bands arose by insertion or deletion events, calculated using equation 3 (Section 2.8). 
Were AFLP's to arise only by base substitution, the mean base substitution rate per 
single site between AS and AJ would be 8 x 10, i.e. approximately 1 in 125 
nucleotide positions at which polymorphism could arise. However, AFLP's could 
also arise from deletions or insertions in the sequence of an amplified fragment. This 
would give a rate of 5 x 10, i.e. about 1 in 2,000 nucleotide positions, at which 
insertion/deletion polymorphisms could arise. 
From these calculations it was possible to estimate the rate of polymorphism between 
two cloned isolates as lying between about 1 in 125 and 1 in 2,000, the exact value 
depending upon the relative proportions of point substitutions and insertion/deletions 
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across the genome. Sequence determination of a sufficient number of AFLP marker 
alleles in AS and AJ would enable these predictions to be tested. 
To conclude, it was shown that reliable AFLP polymorphic markers could be 
obtained in a comparison of two cloned isolates of P. c. chabaudi and that mouse 
DNA contamination could be reduced to a level too low to be detected by the AFLP 
technique. Approximately 800 markers between AS and AJ were generated using a 
combination of the EcoRJ and MseI restriction endonucleases. Furthermore, analysis 
of the markers obtained from various combinations of AFLP primers reflected the 
nature of the P. c. chabaudi genome, by showing a greater number of bands 
appearing for AT-rich combinations. Polymorphisms were nevertheless as likely to 
appear in A and T as well as C and G sites, thus indicating that mutation rate is 
independent from the nucleotide present at a given position. The polymorphism rate 
across the whole genome between the two strains was estimated to be in the range of 
1/125 to 1/2000 sites from a calculation performed on a random selection of primer 
combinations, where the percentage of polymorphic bands was estimated to be at 
around 20%. 
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4. Results: A Genetic Linkage May of Plasmodium chabaudi 
chabaudi AFLP Markers 
4.1) Introduction 
This chapter describes how the AFLP markers identified in Chapter 3 can be 
organised into a genetic linkage map, which will facilitate the identification of the 
target loci. The approach in this study benefits from a genetic linkage map generated 
from the pattern of inheritance of AS and AJ parental markers in independent 
recombinant clones derived from a genetic cross, more so than the more classical 
approaches used to identify genes encoding specific phenotypes. 
Classical approaches for the identification of genes linked to specific phenotypes are 
based on the generation of several recombinant progeny clones from a genetic cross 
between two parental clones, one of which displays the desired phenotype. Progeny 
clones can be classified according to the phenotype exhibited by their parents (e.g. 
drug-resistant vs. drug-susceptible). The inheritance of genetic markers from the 
parental clones can also be characterised for all the available recombinant clones. 
Markers close to a locus of interest (e.g. a gene conferring drug resistance) will be 
linked to the phenotype in progeny clones. According to whether a particular 
progeny clone exhibits the desired phenotype or not, markers can be classified 
accordingly and those sufficiently linked to the phenotype identified. When looking 
at a potentially highly multigenic factor such as strain-specific immunity, this might 
result in rather complicated phenotypes (as there is no clear-cut resistance or 
susceptibility) and would require a large number of clones. Local maps around the 
linked loci might be generated as. required without a genome wide linkage map. 
Quantitative trait locus (QTL) analysis is then usually required to identify the genes 
of interest. 
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In contrast, the approach that this study aims to develop does not require any cloning 
nor genotyping and phenotyping of the recombinant progeny. This is particularly 
advantageous when working with Plasmodium, where the isolation of recombinant 
clones is a notoriously laborious procedure. Instead, uncloned progeny material is 
taken and subjected to a selective pressure that eliminates or greatly reduces in 
number any progeny clones carrying particular target genes. Markers linked to 
potential susceptible target genes are identified by their complete removal, or more 
likely proportional reduction (see Chapter 6) in the parasite population under 
selection. Alternatively, markers linked to a resistant phenotype will appear more 
strongly. However, this method identifies anonymous markers whose relationship 
(i.e. linkage) to each other is unknown. Therefore it would be helpful to arrange 
markers in a genetic linkage map. 
Strictly speaking, markers identified during selection may be mapped on P. 
falciparum chromosomes using genome databases, and also therefore tested for 
linkage in P. c. chabaudi on the assumption of conserved gene synteny. This means 
that genes closely linked with each other in a species are also linked in another and 
that there is good conservation of gene order (Carlton et al., 1998b: Carlton et al., 
2002). However, conserved gene synteny between Plasmodium species has its 
limitations. Genes do not always appear on the same chromosomes and, furthermore, 
synteny breaks after a certain genetic distance, though the extent of synteny can vary 
from few kb up to several hundreds kb (Carlton et al., 2002). Furthermore, the 
number of genes linked to strain-specific immunity is not known and a greater 
coverage of the genome with markers might be needed, so that having a genetic 
linkage map on which novel markers of interest can be placed would be very useful 
as a guide to estimate the number of loci involved. Finally, as discussed in Chapter 6, 
the limits and possible inaccuracies of the proportional AFLP technique, as well as 
potential difficulties in interpreting data from cross-progeny parasites (Chapter 7) 
must also be taken into account. Thus, confirming eventual findings with markers 
closely linked to a marker of interest could provide essential evidence for further 
analysis. 
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The linkage map also provided other useful information beside the linkage of various 
markers, their assignment to chromosomes and their relative order within them. It 
provided an estimate of the genetic distance in map units between markers, the 
number of recombination events occurring per chromosome, as well as the 
conversion of genetic map units into physical units for P. c. chabaudi chromosomes. 
It also allowed the identification of AFLP marker alleles, as described in greater 
detail in Chapter 5. 
4.2) Results 
The inheritance of 672 AFLP markers was characterised in 28 progeny clones 
derived from two crosses between P. c. chabaudi AJ and clones AS3CQ and 
AS30CQ derived from AS (see Appendix 2 for raw data). Markers were assigned to 
linkage groups using the Map Manager program and groups assigned to 
chromosomes using previously physically mapped RFLP markers as anchors. 
Estimated number of recombination events, size of chromosomes and recombination 
frequencies were also determined for the identified chromosomes using Map 
Manager. The linkage map also provided some information on the amount of 
polymorphism due to indel mutations. 
4.2. 1) Reliability of the AFLP markers in the progeny clones 
In spite of the almost complete identity of the chloroquine-resistant clones with the 
drug-sensitive AS, minor differences did appear during AFLP analysis. Firstly, there 
were a few AFLP markers present in the original parents that did not segregate in the 
progeny clones. Secondly, a few markers appeared in the progeny clones that were 
absent in the parents. These markers were ignored during the generation of the 
linkage map. However, it is recognised that such markers could indicate genetic re-
arrangement in the drug-resistant clones, which might need to be taken into account 
during the generation of the genetic linkage map. Finally, some markers proved 
robust but were difficult to work with, due, for example to their proximity to other 
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bands or being located at the bottom end of the gel, where bands tend to be fuzzier 
and thus more difficult to interpret. 
4.2.2 Effect of typing mistakes in the markers 
The incorrect typing of both RFLP and AFLP markers in individual progeny clones 
and the consequences of such a mistake was an issue that was examined. Questions 
regarding the reliability of some of the RFLP anchors were raised during work on 
chloroquine resistance (P. Hunt, personal communication). Ongoing work on linkage 
between chloroquine resistance and markers on chromosome 11 suggested that some 
RFLP markers might have been incorrectly characterised in some of the clones. In 
particular for clones 62/3 and 266/6, the RFLP markers TBP, Topo I, p.22, H2A, 
CRK2, PCNA and EF-la might have been incorrectly typed as an AS, rather than AJ 
allele. This was noticed after sequencing of AFLP and RFLP markers and their 
subsequent identification on the genome of P. falciparum (P. Hunt, personal 
communication). 
To test the effect of incorrect typing in AFLP markers, some deliberate mistakes 
were inserted in markers. The effect of such incorrect typing ranged from the 
presence of double-crossover events involving one or few more markers and 
consequent over-estimation of genetic distance, change in the order of markers in the 
linkage group and finally incorrect assignment of markers and whole linkage groups. 
This was an important issue that will need further consideration before a final version 
of the genetic linkage map is produced. It cannot be excluded that the deviations of 
some chromosomes from predicted sizes and number of recombination events 
observed below might be due to incorrect characterisation of markers. This could 
also explain some of the large gaps between some markers observed in the 
chromosomes. For example, there is a large gap separating RFLP marker "ran" on 
chromosome 9 from the main linkage groups (Fig. 4.10. The same also applies to 
RFLP markers cDNA121 and dSSrRNA on chromosome 10 (Fig. 4.1g). These gaps 
from the main linkage groups could have arisen due to incorrect characterisation of 
those RFLP markers. 
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A significant number of double crossover events involving a single AFLP marker 
were observed throughout the linkage groups. Any such occurrence was re-checked 
on the original X-ray film to detect any possible errors of evaluation or ambiguous 
bands. Even after such control, many double crossover events were present. The 
same phenomenon was also observed by Su et al. (1999) in their linkage map of P. 
falciparum, and was a fairly common event, and may be due to non-reciprocal 
conversion events. 
4.2.3) Assignment of markers to linkage groups 
A total of 23 linkage groups were obtained after analysis of all markers (including 
those segregating in a non-Mendelian fashion) with a final p-value of 0.001. 11 
linkage groups could be assigned to P. c. chabaudi chromosomes by virtue of their 
linkage to RFLP markers previously assigned to specific chromosomes by physical 
mapping (Fig. 4.1 a-k). In total, 401 AFLP markers were placed on the identified 
chromosomes. No attempt was made to further allocate the remaining linkage groups 
to chromosomes by physical mapping. RFLP markers on chromosomes 2, 4 and 14 
were poorly characterised with only a handful of fully genotyped clones. As a 
consequence, no linkage groups could be established around those anchors. 
A significant number of AFLP markers could not be assigned to chromosomes. 214 
AFLP markers out of 672 were placed on 12 unassigned linkage groups each 
comprising 2-51 AFLP markers. Their lack of assignment to chromosomes was 
probably due to the lack of characterisation of several clones for some RFLP markers 
(most notably the RFLP anchors of chromosomes 2, 4 and 14, as discussed above) 
and the lack of physical mapping of crucial AFLP markers. At least three of these 
linkage groups are likely to belong on the "missing" chromosomes 2, 4 and 14. 
57 AFLP markers, 21 of which were segregating in a non-Mendelian fashion, could 
not be assigned to any linkage groups. Some of these markers may contain errors. 












ASTA02GT, AJTA03AT, AJAC03TA, ASTAOITT, 	 23.9 
AGCCO2TG, ASTA02AT, AJAG02TC, ASAAO1TC, 
9.2 	AJTA02TT, ASAA02CA, AJCG02TT 
AJAGO1GT 
9.6 	 Ag3003A 
ASTGOIAA, AJTGO1AA 
4.2 
ASCA02AT 	 16.3 
AJCAO2AT 
Fig. 4. la. Genetic linkage map for chromosomes 1 and 3. Numbers indicate distance between markers 
expressed in cM. 
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Chromosome 5 



















ASAC03AT, ASAA04AC, ASTA05TA, AJAA04AC, AJAT07AT 
4.8 
ASCC01AA, ASACOIAG, AJAT01AT, ASTAO1AC, AJTA01AC 
8.1 









Fig. 4. lb (continued). Genetic linkage map for chromosome 5. 
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Chromosome 6 
Total size: 67.2 cM 
DNApoIa, P.12 
11.3 
RESA, AJAG02AG, ASATOIAA, ASACO2AT, ASTGO1AT, ASTCOITC, 
AJTCO1TC, ASCCO1TC, AJAT02TA, AJAC01 GT, AJAG02CT, 














AJCTOIAA, ASTC01AA, AJTA02AC, AJGT03AA, ASCA01AC, ASAG01TG 
4.6 
ASCTO2TT 
Fig. 4. 1  (continued). Genetic linkage map for chromosome 6. 
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Chromosome 7 
Total size: 126.7 cM 
ASCTO3TT 
12.0 






AJCCO2CA, ASAT04AG, AJAA02GC 
5.6 
ASGA01CT, ASACOIGT, ASAA02GT 
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ASAT02AT, AJCTOICA, ASAC05AA 
7.8 	AJTG02AT, AJGA02GT, AJAT02AC, ASTG01TC, AJTA02TA, 
3.7 	AJTG01TC, AJGA03AC, ASAT02TC, AJAT02TC 
9.6 	










4.0 	ASAR05AT, ASAC01TA 
7.5 
AJAA03AT, AJTCOIAG 
Fig. 4.1 d (continued). Genetic linkage map for chromosome 7. 
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Chromosome 8 
Total size: 75.8 cM 
AJAG03AG, ASAGO lAG, ASAA07AC 
10.9 
AJAT01TA, AJCC03TT, ASAT03TA 
4.2 
ASAA06AA, AJAA07AA, AJTA03TA, ASTCO1 CT, 
AJTT02AT, AJTC01 TG 
9.6 
ASTG02AA, MSP-1, ASGT08AT, AJTT07AT 
8.4 
AJCA03AG, ASCA02AA, AJGT02AT, AJACO2AG, 












Fig. 4.1e (continued). Genetic linkage map for chromosome 8. 
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Chromosome 9 











AJAG01TC, ASCT01AC, AJAT04TA, AJAA04AA, AJCA01GT, AJCG01GT, ASCGO1GT 
AJAC01AA, AJCCO4CA 
ASGTO5AA 
AJTA01GT, ASAA04CA, AJAT01TC, ASAT04TC, ASTA01GT, AJAT05TG 
AJAC03AA, ASAC03CT, AJACOICT, ASTf05CA, ASCCO2AC 
AMA-1, ASTF02Tr 
Ag3027 
Fig. 4.lf(continued). Genetic linkage map for chromosome 9. 
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Chromosome 10 
Total size: 160 cM 
T VAPB 
7.2 	4 
ASTG01CA, AJGA01TT, ASGA01TC 
3.7 
AJACO2AC, AJCGO].CA, AJAG03AC, ASTTO1TT 
7.5 
ASAT05AG, AJGA02CA, AJGA01CA, ASGA01CA, 






Fig. 4.1g (continued). Genetic linkage map for chromosome 10. 
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Chromosome 11 
Total size: 87 cM 
OPL-04, CRK2, EF-la, PCNA 
5.3 
ASAG02CA, ASATOITA, AJAT03CT, ASCAOICT, ASCAOIGA, ASCT03TG, ASCA03AT, ASTCO2AC, ASAT03AA 
4.4 




AJCG02AT, ASCGOITA, AJCCO2AA, AJCT03TC, AJCC04TT, ASGTOIAA, AJGT03AA, ASAAOITC, AJAT03AA 
4.0 
ASAT03GA, ASTCOICA, AJATOIAA 
9.6 
ASCA03TT, AJTFO4TA, AJCTOITC, AJGA02TF, AJCA02GT 
8.1 















Fig. 4.1h (continued). Genetic linkage map for chromosome 11. 
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Chromosome 12 









3.9 	AJTTO1CT, Ag3040, OPR14 
11.3 









AJGT02AA, AJCG03AA, ASGTOITT 
ASATO1CT, AJCAOIGA, ASCGOITC, AJCGOITC, 












Fig. 4. lj (continued). Genetic linkage map for chromosome 12. 
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Chromosome 13 
Total size: 261.4 cM 
3.9 	
ASAAO5AT 
T ASTG02TF, AS170ITA, AJGAOIGT, ASCCO2AG 
AJGT02AG, AJCCOIAG, ASTAOIAA, ASCCO2TC, AST1702AG, AJTFOIAG 
AJAAO6AA 
AS1FOIGA, AJCCOICA, AJCTOIGT, ASCCOITA, AJAC04AT, ASAA02GC, AJCAOIAA 
AJCGOIAT, ASAAOITA, ASAA04TA, ASTA02CA, AJTAO1GA, AJAA03TG, ASCA04TT, ASAT04TG 
AJ1FO4AA 
AJTTO2AC 



















AJGTOIAT, ASAAOIAA, ASGTOIAT, AJGA02CT, ASGA03CA, ASATOIAG, 
ASTG03AA, AJAAO ITT, ASCA04AT AJGA02AG, ASCAO1GT, AJTG02AG, AJ1102CA, AJTF02TG, ASTA03TA, 
AJTAOITC ASATOIAC, AJrr02rr, AST1`02CA, ASGA02TA, ASTCO1GA, AJTCOIGA 
AS11'O4AT, AJGTOSAA AJGTOIAG, ASGTO3TA, ASTAOICT, AJCCO3TG, ASGTO3AT, 
ASATOIAT 	 AJAA03CA, AJAC03TT, AJCA03AA, ASAT03AT, AJAT02AT 
AJAAOIAG, ASAA05AA 
































Fig. 4.1k (continued). Genetic linkage map for chromosome 13. 
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Table 4.1 summarises the total number of markers assigned to each chromosome, 
including the RFLP anchors. Overall, the number of markers assigned tended to 
increase with the size of the chromosome. However, discrepancies were observed 
from the expected values. In chromosomes 3, 9 and 10 there were fewer markers 
than otherwise expected (Table 4.1). In the light of the relatively large number of 
unassigned markers, this was not surprising. It is also possible that the small number 
of markers might reflect the fact that those chromosomes were less likely to generate 
AFLP markers. The opposite was observed for chromosome 7, which contained more 
markers than expected (Table 4.1). Incorrect characterisation of RFLP and AFLP 
markers (mentioned in Section 4.3.2) could have been the cause of incorrect 
assignment of markers in these chromosomes. Alternatively, it could be that some 
chromosomes were more likely to produce markers than others. 
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1 18 22 
2 NA NA 
3 3 23 
4 NA NA 
5 36 28 
6 36 29 
7 57 33 
8 36 39 
9 26 39 
10 20 44 
11 56 52 
12 44 52 
13 108 79 
14 NA NA 
Total 440 440 
Table 4.1. Analysis of the genetic linkage groups assigned to chromosomes (1). The table indicates 
the total number of markers (both AFLP and RFLP) allocated per chromosome. The predicted number 
of markers per chromosome is also given. Those were calculated based on the number of markers 
allocated to the 11 identified chromosomes and the physical sizes of individual chromosomes, as 
indicated in Table 4.2. 
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4.2.4) Order of markers in the linkage groups 
AFLP markers were initially ordered on the linkage groups by the Map Manager 
software. Using the "Ripple" command, which optimises locus order by testing local 
permutations of the order to maximise the total LOD score for linkage, allowed a 
further refinement of the order. Finally, the order of the markers was controlled and 
further manipulated manually in order to deal with factors not considered by Map 
Manager, like the possible incorrect typing of markers. Some RFLP markers also had 
to be entered manually in the chromosomes, as Map Manager could not assign them 
to linkage groups. Their position in the map was established by previous knowledge 
about their physical location. The final order of the markers on the 11 linkage groups 
assigned to chromosomes is shown in Fig. 4. la-k. The remaining linkage groups with 
more than 8 markers each are shown in Appendix 3. 
4.2.5) Number of recombination events per chromosome 
The number of recombination events calculated for each chromosome was compared 
with the number expected from the size of that chromosome (Table 4.2). Again, 
several chromosomes deviated from the expected values. In particular chromosomes 
3, 10 and 11 showed fewer recombination events than expected, while chromosomes 
5 and 7 showed more. The number of recombination events reflected the number of 
markers assigned to chromosomes. Thus, while 3 and 10 had fewer markers than 
expected assigned to them (and thus fewer recombination events), chromosome 7 
had more. To a lesser extent, chromosomes 5 and 11 also showed some discrepancy 
from the expected values. Such discrepancies are likely to be caused by the same 
factors discussed in Sections 4.3.2 and 4.3.3. These results reflect again the need for 
more accurate mapping. 
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Chromosome No. of 
recombination 
events determined 





1 8 12 
2 NA NA 
3 5 13 
4 NA NA 
5 25 15 . 
6 15 16 
7 41 18 
8 18 21 
9 20 21 
10 12 24 
11 18 28 
12 29 28 
13 51 43 
14 NA NA 
Table 4.2. Analysis of the genetic linkage groups assigned to chromosomes (2). The table indicates 
the number of recombination events per chromosome. The predicted number of recombination events 
per chromosome is also given. Those were calculated based on the physical sizes of individual 
chromosomes, as indicated in Table 4.3. 
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4.2.6) Genetic size of identified chromosomes 
The genetic size of each identified chromosome was calculated by Map Manager 
based on the number of recombination events and expressed in centiMorgans (cM) 
(Table 4.3). Due to the relatively limited number of clones available (i.e. 28), the 
smallest genetic distance that could be measured between two markers was of 
approximately 3.6 cM, corresponding to the presence of a single recombination event 
in 28 clones between two markers. This would inevitably lead to some 
underestimation of size. It should also be pointed out that these sizes are likely to be 
underestimated because of the missing linkage groups and markers, and also because 
of possible lack of markers at the telomeric ends of chromosomes, which contain 
large numbers of repeat sequences (Canton etal., 2002). 
A Pearson correlation test confirmed that chromosomal size in cM tended to increase 
with physical size of the chromosome with a correlation value of 0.813 (p= 0.002). 
The correlation was not perfect, as some chromosomes displayed a greater genetic 
size than chromosomes expected to be larger based on their physical size (e.g. 
chromosomes 5 compared to 6, chromosome 7 compared to 8 or chromosome 10 
compared to 11). It is likely that some chromosomes might have been overestimated 
while others were underestimated. Possible incorrect typing of some RFLP or AFLP 
markers, as described in Section 4.3.2, might have contributed to such an 
overestimation, either by creating double cross-over events or false linkages, while 
the incomplete assignment of many markers to chromosomes (including some major 
linkage groups), as described in Section 4.3.3, definitely contributed to 
underestimation. 
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size(#) in kb 
Physical size of 
one cM 
(kb/cM) 
1 39.2 900 22.9 
3 40.2 940 23.4 
5 128.2 1140 8.9 
6 67.2 1200 17.9 
7 126.7 1320 10.4 
8 75.8 1580 20.8 
9 146.3 1580 10.8 
10 160 1800 11.3 
11 87 2100 24.1 
12 125.5 2100 16.7 
13 261.4 3200 12.2 
Total 1257.5 17860 14.2 
Table 4.3. Analysis of the genetic linkage groups assigned to chromosomes (3). The table gives the 
approximate physical size of individual chromosomes and the total genetic size of single 
chromosomes expressed in cM, as calculated by Map Manager. It also gives an estimate of the 
physical size of one cM for each chromosome and the average for all the 11 chromosomes. 
(#) Determined from chromosome separations of P. c. chabaudi clone AS 
(Carlton, 1995; hqp://www.ncbi.nlm.nih.gov/Malaria/Rodent/chabaudi.htnil)  
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4.2.7) Conversion of genetic map units into physical units 
Given the estimated physical size of the chromosomes in P. c. chabaudi (Canton, 
1995) and the genetic distances calculated by Map Manager for each chromosome, it 
was possible to estimate the physical size (expressed in kb) for one cM for each of 
the 11 identified chromosomes (Table 4.2). The values obtained lie between 8.9 
kb/cM (chromosome 5) and 24.1 kb/cM (Chromosome 11), with a mean of 14.2 
kb/cM for the 11 chromosomes (Table 4.2). These values are in remarkable 
agreement with the estimate of 17 kb/cM calculated by Su et al. (1999) and the 
estimate of 15-30 kb/cM calculated by Walker-Jonah etal. (1992) for P. falciparum. 
Chromosome 5 showed a considerably higher physical size for one cM than the 
average for all 11 chromosomes, while chromosomes 1, 3 and 11 showed a 
considerably lower size than the average. The variation observed in the single 
chromosomes was not surprising, due to the incomplete nature of the genetic linkage 
map, as discussed in Section 4.3.3. Many markers and linkage groups have not yet 
been assigned to chromosomes, which can result in an underestimation of the 
physical size of one cM. Possible errors in the typing of clones in RFLP or AFLP 
markers can result in an increase of recombination events and thus the physical size 
of one cM. Furthermore, other details must be taken into consideration, such as the 
statistical limits imposed by the relatively low number of recombinant clones used 
(so that the definition of the map is limited and thus genetic distances generally 
underestimated), the inevitable loss of genetic size when adding genetic distances to 
determine the size of a linkage group and the possible lack of markers at the 
telomeric ends of the chromosomes resulting in an underestimation of genetic size, 
which, in turn, would lead to an overestimation of the physical size of a cM in the 
chromosomes. 
The factors described above could explain the variation in the physical size of one 
cM observed among the chromosomes. However, there is evidence from different 
species that recombination rate varies in different genomic regions (Nachman, 2002). 
It is thus possible that chromosomes in P. c. chabaudi might naturally differ among 
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each other in the physical size of their map units, even in a tight, complete and error-
free genetic linkage map. 
4.2.8) Estimate of potential alleles due to indel mutations 
Of the 401 AFLP markers placed on known chromosomes, 37 pairs shared the same 
selective bases at both primer ends and segregated independently in the cross-
progeny clones (Fig. 5.6 and 5.7). Such markers were also separated only by few 
base pairs in size. They are likely to be alleles of each other. This was confirmed in 
two examples, where a couple of fragments representing such a pair, were sequenced 
(see Chapter 5). Meanwhile, from the data available from the linkage groups which 
have been allocated to chromosomes thus far (Fig. 4.la-k), this suggests that a 
significant proportion of the polymorphism observed between AS and AJ might be 
due to small insertions or deletions giving rise to these marker pairs separated by a 
few base-pairs on the acrylamide gels. 
4.3) Discussion 
The generation of a complete AFLP genetic linkage map was originally conceived as 
an essential step towards the identification of markers linked to genes under immune 
selection. Advances in the characterisation of the genomes of both P. c. chabaudi 
and P. falciparum have provided new tools that partially superseded the importance 
of a complete genetic linkage map. However, the limits of the proportional nature of 
AFLP for detecting markers under selection and the unknown extent of the number 
of genes under selection mean that there is still value to the generation of a linkage 
map based on the AFLP markers, particularly if multiple loci are expected. 
Of the 672 AFLP markers analysed, 401 could be assigned to eleven of the fourteen 
chromosomes, while 214 were placed on 12 linkage groups of yet unknown 
chromosomal allocation, but presumably including groups located on chromosomes 
2, 4 and 14. The remaining 57 AFLP markers could not be assigned to any linkage 
group. 
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The number of markers assigned to each of the identified chromosomes was 
calculated, as well as approximate genetic size of chromosomes and the number of 
recombination events in each chromosome. These numbers were expected to increase 
with the size of chromosomes. This was not always be observed, but there was some 
indication of it being the case. Considering the incomplete state of the map presented 
here, as well as the problems relating to the RFLP markers, this was an encouraging 
result. 
After ordering of markers within linkage groups, Map Manager provided a size of 
each chromosome in genetic units. The resulting sizes showed a general correlation 
with physical sizes of chromosomes. Any disparity observed might be explained by 
the relatively large number of unassigned markers and linkage groups, physical 
structure of the chromosomes (especially the telomeric ends), as well as possible 
errors in the characterisation of both RFLP anchors and AFLP markers. 
Similarly, in general, the number of recombination events on a chromosome was also 
correlated to physical size, as expected. Some exceptions were observed, probably 
due to the same problems discussed above. 
Based on the genetic size obtained by Map Manager and the approximated physical 
size of P. c. chabaudi chromosomes, the genetic map unit (expressed as one cM) of 
each chromosome, as well as the average map unit for the 11 chromosomes mapped 
thus far, was converted in kb. Although some chromosomes were outside the 
expected range (most notably chromosomes 1, 3, 5 and 11), values tended to be 
within the expected limits. These values are expected to become more reliable with 
the refinement and completion of the genetic linkage map. However, it cannot be 
excluded that differences among individual chromosomes will remain, indicating the 
increased tendency of some chromosomes compared to other to recombine. 
The map presented in this chapter is still incomplete. There are some AFLP primer 
combinations still missing, but most importantly, no actual sequencing and physical 
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mapping of crucial AFLP markers has been yet performed. Furthermore there were 
issues regarding the reliability of some of the RFLP markers used as chromosomal 
anchors. A first step towards obtaining a more reliable map and in solving 
ambiguities regarding the allocation of markers will be the completion of the 
characterisation of the AFLP markers available. RFLP markers will be rechecked 
and, when needed, retyped in order to provide more reliable anchors for the linkage 
map. Furthermore, individual AFLP markers will be sequenced and matched against 
the genome data available for P. yoelii and P. falciparum (Carlton et al., 2002; 
Gardner et al., 2002). 
This chapter presents a preliminary genetic linkage map based on AFLP markers, 
which will become more precise and will be confirmed by physical mapping. The 
final map will be used during the analysis of immune selected parasites and will be 
useful in the identification of loci linked to strain-specific immunity. 
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5. Results: Identification of Alleles of AFLP Markers 
5.1) Introduction 
The identification of alleles of AS or AJ markers was originally undertaken to 
facilitate cloning of genetic cross material of P. c. chabaudi by limited dilution 
(Walliker et al., 1975), using such markers to type individual clones. Increasing the 
number of parental clone-specific markers would make the genetic identification of 
recombinant clones an easier and more reliable process. This approach, however, lost 
its immediate relevance when clones from the progeny of two previous genetic 
crosses between AS and AJ were made available for use in this project. Nonetheless, 
the development of allelic markers will be of relevance for the identification of 
recombinant clones in the future. However, a further application for the identification 
of alleles, especially if they are previously known AFLP markers, has been found 
with the development of the proportional AFLP technique (Chapters 6 and 7). Due to 
the current limits of the technique, alleles of AFLP markers might provide useful 
confirmation of observations relating to markers showing evidence of selection 
pressure. 
AFLP markers are visible on an autoradiograph as the presence of a band in one 
strain and its absence in the other. The identity of the corresponding allele of any 
given AFLP marker is not obvious, however. In the following section, the 
approaches utilised to identify alleles of AFLP markers are described. Two broad 
approaches were used: a molecular approach and a genetic approach. The molecular 
approach was the first to be applied. The process was unexpectedly problematic due 
to the difficulties involved with some of the techniques used (notably inverse PCR). 
Although these difficulties could have been eventually overcome, the subsequent 
availability of the genetic linkage map and of the P. c. chabaudi genome sequencing 
project data simplified the task enormously and allowed the successful identification 
of alleles of AFLP markers. In the results, the molecular approach, involving the use 
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of various molecular techniques to identify alleles, will be presented first. It will be 
followed by the genetic approach, through which several alleles could be identified. 
5.2) 	Results 
5.2.1) Molecular approach to the identification of AFLP marker alleles 
The first approach that was used for identification of AFLP marker alleles involved 
the use of various molecular techniques. This work was done before coverage of the 
P. c. chabaudi genome was sufficiently advanced to be of use for this purpose. The 
analysis was based on the assumption that genetic polymorphisms can be generated 
by either removal of enzyme recognition sites, mutation in the selective bases of the 
primers used to generate a specific AFLP marker, indel mutation or combinations of 
the three. 
The molecular approach involved the isolation of specific AFLP markers, the 
sequencing of those markers and their eventual re-amplification and use as 
radiolabeled probes on P. c. chabaudi DNA cut, ligated and amplified using a variety 
of primers as for AFLP. It was hoped that in most cases, this approach would yield a 
clear signal corresponding to the other allele. The hybridised probe would then give a 
first indication on the nature of the other allele, such as its size and the type of 
mutation that generated it. Only two AFLP markers could be successfully hybridised 
to the parasite DNA. To further characterise the two alleles and to obtain their 
sequences, two inverse PCR reactions were designed. However, several problems 
were encountered during this step, which prevented the identification of the sequence 
of the alleles. 
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5.2.1.1) Extraction and preparation of AFLP fragments 
An acrylamide gel containing AFLP products of the AS and AJ P. chabaudi strains 
for four different combinations of primers (i.e. E.AG with M.A, T, C or G) was 
electrophoresed for 3 h, in order to obtain better resolution of the bands (Fig. 5.1). A 
total of 14 amplified fragments were extracted, 10 were AFLP markers for AS and 
AJ, while 4 were non-polymorphic bands, i.e. conserved between AS and AJ. The 
bands were left to soak in distilled water overnight before the DNA was extracted 
and used as a template for a PCR reaction using non-selective EcoRI and MseI 
primers. 
5.2.1.2) Transformation of fragments into plasmids and analysis 
PCR products were used for cloning into plasmids and subsequent transformation 
into E. coli using the TOPO TA cloning Kit provided by Invitrogen. Single colonies 
obtained from the transformation plates were selected for plasmid isolation using the 
Miniprep kit from Qiagen. Presence of an insert was determined by digestion of the 
vectors with EcoRJ. Only those plasmids containing an insert were used for further 
analysis. A PCR reaction using non-selective EcoRI and MseI primers was set up for 
each plasmid. Only plasmids containing the specific AFLP fragment were amplified 
by these primers. The PCR product obtained by this procedure was compared with 
the original PCR product, in order to confirm the presence of a fragment of the 
expected size on an agarose gel. 
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E.AG+M.A 	E,AG+M.T 	E.AG+ M.0 	E.AG+M.G 








Fig. 5.1. AFLP fragments of P. c. chabaudi AS and AJ DNA for which the corresponding allele was 
sought. The figure shows the original acrylamide gel from which the fragments were obtained. Four 
AFLP primer combinations for the AS and AJ strains were used. The EcoRI primer remained constant 
(i.e. with the AG selective bases, represented as E.AG in the Figure), while 4 different MseI primers 
with A, T, C and G selective bases were chosen (M.A, M.T, M.C, M.G as indicated in the Figure). 
Fragments were cut out from the gel and theDNA amplified using all combinations, but only those 
fragments whose identity could be confirmed by sequencing are indicated on the gel. Markers were 
initially named according to the selective base present on the MseI primer. 
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5.2.1.3) Sequence analysis of cloned AFLP fragments 
The cloned candidate AFLP fragments were sequenced using the vector specific 
forward (M13F) and reverse (M13R) primers flanking the insert, to provide double-
stranded sequence. Two markers could not be sequenced. Markers were then 
renamed after their genomic size and selective bases present in the two primers 
(Table 5.1) 
Sequencing revealed the presence of MseI recognition sites in 5 of the 10 fragments 
analysed. These fragments were the products of the ligation of two unrelated AFLP 
fragments produced during enzyme digestion. Such contaminating fragments were 
frequently extracted from the polyacrylamide gel together with actual AFLP markers 
and were not used for further analysis. 
Amplified fragments whose sequences did not contain any obvious anomalies, e.g. 
unexpected restriction sites, were used to conduct blast searches on the P. c. 
chabaudi genome database. This analysis was performed after the experiments took 
place, as the database was not available at the time. All fragments corresponded to P. 
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Ti AJ AG/T 171 yes AJAG171T 
C7 AJ AG/C 265 yes AJAG265C 
T2 AJ AG/T 139 yes AJAGI39T 
C3 AS AG/C 129 yes ASAG129C 
Al AJ AG/A 222 yes AJAG222A 
A2 AS and AJ AG/A 184 yes AG184A 
Table 5.1. Classification of sequenced AFLP fragments. AFLP fragments were sequenced and 
renamed according to their genomic size. The first two letters correspond to the strain of origin, the 
second two to the selective bases at the EcoRl primer, the last letter to the selective base at the MseI 
primer. The markers were subsequently used in the hybridisation experiments described below. The 
origin (AS or AJ) of the markers is also indicated. A2 (AG 1 84A) is a non-polymorphic band used as a 
control. 
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5.2.1.4) Hybridisation of sequenced fragments to AFLP products 
Standard AFLP reactions were set up as described in Section 2.6. The two sets of 
AFLP PCR combinations and selective primers were chosen with two aims in mind. 
The combination performed with non-selective primers served to identify the 
corresponding allele of a given AFLP marker, while the combinations with the 
selective primers had the purpose of providing more information on the nature of the 
allele. 
15 jti of each product were electrophoresed on a 1.5% agarose gel to achieve good 
separation of the individual PCR products. The agarose gel was blotted to 
nitrocellulose and pre-hybridised to block sites on the membrane where probe might 
bind non-specifically on an agarose gel (Section 2.8) AFLP markers were 
radiolabeled and were hybridised with the membrane overnight, washed and exposed 
to film at -70°C overnight (Sections 2.8 and 2.9). 
Analysis of the autoradiographs obtained from three of these experiments produced 
multiple signals, which were difficult to interpret. A possible explanation for such 
results could be related to the presence of cross-hybridising non-specific bands that 
could have arisen when, for example, non-target cut and ligated AFLP products 
cross-reacted with the probe. 
5.2.1.5) Analysis of Southern Blot probed with AJAG265C and AJAG171T 
Two of the AFLP markers used to probe the blots (AJAG265C and AJAG171T) 
produced unambiguous results. Fig. 5.2 shows the results obtained when the probe 
AJAG265C was used to hybridise to a blot comprising AFLP products amplified 
with non-selective or selective primers that produced the fragment used as a probe 
(AJAG265C). Examination of the autoradiograph (Fig. 5.2) shows a strong signal in 
lane 8, corresponding in size to the probe itself (Table 5.1). Fainter signals were also 
detected and were initially ignored. However, no signal was observed that could be 
attributed to the AS allele using non-selective primers. This result was at first sight 
unexpected because all possible AFLP's should be amplified by the non-selective 
primers. It is possible, however, that the PCR where non-selective primers were used 
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may have failed or produced very little product. The non-selective primers are 
expected to amplify a very large number of sites within the genome with the result 
that very little or no-specific product corresponding to the AS allele might have been 
made. The possibility also exists that amplified products may not have transferred or 
bound efficiently to the membrane. 
The AJAG171T probe produced two strong signals in lanes 2 and 6 (Fig. 5.3). Both 
originated from AJ DNA and corresponded in size to the probe itself. Again, no 
signal for the AS allele was detected. 
Only the EcoRI primer remained constant throughout the combinations (excluding 
the non-selective primer combination, which, however, never worked). As no signal 
was observed in the AS DNA for all the AFLP combinations run, it was suspected 
that a mutation occurring within the EcoRI enzyme recognition or the nucleotides 
immediately following it (corresponding to the selective nucleotides of the EcoRJ 
primer) might have been the cause of the results observed. 
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1 	2 	3 	4 	5 	6 	7 	8 	9 	10 
E.O/M.O 	E.AG/M.A 	E.AG/M.T 	E.AGTM.0 	E.AG!M.G 
AS 	AJ AS 	AJ AS 	AJ AS AJ 
—250 bp 	- 	
. $ 
Fig. 5.2. Hybridisation results for fragment AJAG265C. Note prominent band for the combination 
E.AG/M.0 for the AJ strain, corresponding in size to the original marker. No band for the AS allele 
was detected. The fainter bands are non-specific. 
1 	2 	3 	4 	5 	6 	7 	8 	9 	10 
Fig. 5.3. Hybridisation results for fragment AJAGI71T. The fragment appears as a band in the 
E.AG/M.T combination, as well as in the E.AG/M.0 combination both at the right size. Note the 
absence of the AS allele. 
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5.2.1.6) Attempted identification of alleles by inverse PCR 
In order to identify a possible mutation at the EcoRI site of the AS alleles of either 
AFLP markers, it was necessary to sequence that position in the AS alleles. 
Furthermore, sequencing upstream the enzyme recognition sites might have been 
required to reveal any further enzyme cutting sites and thus the whole sequence of 
the AS alleles. 
Based on the sequence of the AJ markers, primers were made for an inverse PCR 
reaction designed to amplify the sequence around the EcoRI cutting site, as well as 
the sequence upstream of it, in the AS allele of AJAG256C and AJAG171T (Table 
5.2). Whole genomic AS DNA was digested with MseI and subsequently diluted in 
distilled water. The diluted DNA fragments were then ligated in order to create an 
inverse DNA library (Section 2.10). The library was the used as a template for the 
inverse PCR primers. 
Inverse PCR reactions using the primers based on the AJAG171T sequence 
constantly failed to yield a product. No further attempts were made subsequently. 
Inverse PCR was successful in amplifying a band based on the primers designed for 
fragment AJAG265C. The putative allele, however, presented some problems. 
Sequencing revealed several repetitions of the sequence of one of the primers used 
for the inverse PCR reaction (pc-am02.03) suggesting some complications with the 
PCR reaction or the template (data not shown). Subsequent blasting of the original 
marker sequence on the P. c. chabaudi database produced multiple hits. This 
revealed that the marker was part of a sequence with multiple repeats across the 
genome. This observation might also explain why fainter signals were detected 
across the AFLP combinations when probing with AJAG265C (Fig. 5.2). It is 
possible that there was partial recognition of repeated sequences from the probe 
across the different AFLP combinations. Due to this complication, the allele of 
AFLP marker AJAG265C could not be identified. 
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Primer sequence 
pc-am02.03 5'-TGT CIT TTG TTT TTC ATC CC-3' 
pc-am02.04 5'-CGA AAA AAC ATA CAA AAT CCG-3' 
pc-am36.05 5'-TTT TCT CIT TGC ACC CAC ACC-3' 
pc-am36.06 5'-AAT GCA TGG CU TAT TCC ACG -3' 
Table 5.2. Primers designed for the inverse PCR reactions needed to identify the alleles of fragments 
AJAG265C and AJAGI71T. Primers based on the sequence of AJAG265C are named pc-am02.03, 
pc-am02.04 and pc-am02.05, those based on the sequence of AJAG171T are pc-am36.05 and pc-
am3 6. 06. 
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5.2.2 Genetic atrnroach to the identification of AFLP marker alleles 
An approach to identify alleles of AFLP markers was developed after the generation 
of a first version of the genetic linkage map and the advancements in the 
development of the P. c. chabaudi AS database. Contrasting to the more laborious 
molecular approach, this was relatively quick and yielded reliable results. The actual 
or predicted sequences of alleles were readily identified by this method. 
5.2.2.1) Identification of alleles through the genetic linkage map 
This approach was applied after the completion of a first draft of the AFLP genetic 
linkage map of P. c. chabaudi presented in chapter 4. During the generation of the 
genetic data, the presence of several independently segregating markers, separated by 
several bp in size was noticed among the recombinant progeny clones of the AS X 
AJ P. c. chabaudi crosses (Fig. 5.4 and Fig. 5.5). 
Two such pairs were extracted from the gel and cloned for sequencing, as described 
in Sections 5.2.1 and 5.2.2. The pairs were: ASTAO1AC and AJTAO1AC (Fig. 5.4), 
and ASTT02CA and AJTT02CA (Fig. 5.5). Sequencing was repeated on four 
different clones from the transformation for each AS and AJ marker in order to 
ensure identification of the correct fragment. Sequences were also blasted on the P. 
c. chabaudi database for further confirmation. 
Comparing two putative alleles with each other using the GCG software confirmed 
the expectations. In both cases, the sequence data confirmed that the markers were 
alleles of each other. ASTAO1AC and AJTAO1AC had a size difference of 12 bp 
(Fig. 5.6). This size difference was due to deletions in both alleles, with 15 bp 
deleted in AS and 3 bp deleted in AJ (Fig. 5.6) In ASTT02CA 7 bp were deleted 
compared to AJTT02CA (Fig. 5.7). Additionally several point mutations between the 
AS and AJ alleles were present in both marker pairs. 
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Fig. 5.4. Autoradiograph showing marker pair ASTAO1AC and AJTAO1AC (highlighted by the box 
and arrows, top right). The gel shows parental strains AS and AJ, and the 28 cross-progeny clones 
(indicated by the numbers on top of the figure). Note that the markers in question are mutually 
exclusive in the progeny clones. 
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Fig. 5.5. Autoradiograph showing marker pair ASTTO1CA and AJTTO1CA ( highlighted by the box 
and arrows). The gel shows parental strains AS and AJ, and the 28 cross-progeny clones (indicated by 
the numbers on top of the figure). Note that the markers in question are mutually exclusive in the 
progeny clones. 
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ASTAO 1AC 	 TACAACGGAGGAGGGCGAAGAGGTGGG 
II 	11111 	1111111111 	11111 	1111111 	111111 
AJTAO1AC 	 TJACAACGGAGGAGGGCGAAGAGGTGGG 
AS TAO 1AC AAATGAC G...............ATGTAGAAAAAGAAGAAATAACGAATG 
1111111 
AJTAO 1AC AAATGATGAPGTAGGGAGTGTCA1GTAGAAAAAGAAAP.AATAACGAATG 
AS TAO 1AC AACAAGAAGAAACGACGAAGTGAAAGTAAATCAAPTAAGAGATGATGAT 
HIM 	IIII 	111111 	II 	111111 	II 	I 	II 	1111111 
AZTTAO 1AC AACAAGCGGAA... ACGAAGTGAAAGTAAATCAAATAAGAGATGATGAT 
AS TAO 1AC GAAAAAAAGGTGTACATTCCACTAATGCAAAGTAAAAAAAAGAAAGCAAG 
I 	111111 	111111 	I 	III 	liii 	II 	111111 	111111 	1111 
AJTAO 1AC GA\AAAAAGGTGTACATTCCACTAATGCPAAGTAAAAAAAAGAAAGCAAG 
ASTA01AC AATTTCCAAATGGCT-T 	 212 
III 	III 	I I 	11111 	11111111 	I 
AJTA01AC AATTTCCAAATGGTTGT 	 224 
Fig. 5.6 Sequences of ASTAOIAC (top) and AJTAOLAC (bottom) compared with each other. In 
the EcoR! and MseI primer sequences, in blue the selective bases of the primers. The numbers at the 
end of each fragment indicate total fragment size in bp. Lines between letters indicate a match in the 
sequence of the two alleles. Dots indicate deletions or insertions in the alleles. 15 nucleotide deletions 
are present in AS. 3 in AJ. 
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ASTT02CA 	 ;TTACCATATCCTCTTCATCTATTC .A 
III 	H 	1111111 	II 	I 	1111111 	11111111 	I 
AJTT02CA CATTACCATATCCTCTTCATCTATTCAA 
ASTT02CA 	AAAAGGGTAGATATATAA ...... TATTATTATTATGTTTTACGCATTTT 
II 	III 	I 	I 	I 	I III 	I 	II 	11111 	I 	11111 
AJTT02CA 	AAAAGGGTAGATACATAATATTATTATTATTATTATGTTTTACGCATTTT 
ASTTO 2 CA 	ATTATGTTATAAAAGGGTCTTTCAAGGGGTTACCCGGAAGC:,: 
111111111111111 	11 	11111111111 	1111111111111111111 
AJ'TT02CA 	ATTATGTTATAAAAAAGGCCTTTCAAAGGGATTACCCGGAAGC/ 
ASTT02CA 	ACGCJ-: 148 
liii 	1111 
A..7TT02CA 	 155 
Fig. 5.7 Sequences of ASTT02CA (top) and AJTI'02CA (bottom) compared with each other. in rd 
the EcoRl and MseI primer sequences, in blue the selective bases of the primers. The numbers at the 
end of each fragment indicate total fragment size in bp. Lines between letters indicate a match in the 
sequence of the two alleles. Dots indicate deletions or insertions. A total of 7 nucleotides have been 
deleted in AS or inserted in AJ. 
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5.2.2.2) Identification of alleles through the P. c. chabaudi database 
The approach and work described in this section were developed and performed by 
P. Hunt. It is included because it completes the approach for the identification of 
alleles of AFLP markers explored in this work. Through the availability of a P. c. 
chabaudi genome database based on the AS strain, another approach was developed 
based on the identification of alleles of AJ markers. By sequencing AJ markers, it 
was possible to find their corresponding alleles from the data available on the AS 
genome and thus to identify any polymorphisms present. Furthermore, with the 
availability of sequenced data outside the limit of the markers themselves, it was 
possible to predict the sequence of the allele of any AJ marker. In at least one case, 
i.e. marker AJACO1CA, the corresponding allele could be confirmed on an X-ray 
film (Fig. 5.9). However, identification of alleles could be rendered more difficult by 
juxtaposition of non-polymorphic bands. 
In order to reduce the possibility of an unrelated non-specific sequence being 
characterised, 6 to 12 different plasmids per marker isolated from single-colonies on 
transformation plates were sequenced. The sequences thus obtained were compared 
with the P. c. chabaudi database to confirm correct identification. In order to match 
the sequence to the database, the primer sequences were removed and the enzyme 
cutting sites reconstituted. 
Two examples are given here. The first example represents a mutation abolishing an 
enzyme restriction site to create a novel allele. The second involves a mutation at the 
selective bases of the primers used to amplify the AFLP marker. 
5.2.2.2.1) Marker AJACO1CA: an example of an enzyme restriction site mutation 
AJ marker AJACO1CA was isolated and sequenced and its sequence was used to 
perform a Blast search on the P. c. chabaudi AS database to identify potential "hits". 
"Hits" corresponded to DNA inserts from different vectors of the P. c. chabaudi AS 
DNA library. The primer sequences were removed from the sequence and the 
enzyme recognition sites reconstituted so that only correct sequences were used for 
Blast searches. In this case, several "hits" appeared, mostly corresponding to the 
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same sequence. The candidate AS allele showed several point mutations, one in 
particular created a novel MseI recognition site in the AS allele (Fig. 5.8). The 
predicted AS allele was 61 bp in size (compared to 129 bp for the original AJ 
marker) and had two thymine nucleotides at the 3'-end of the MseI primer. A faint 
AS marker of similar size was identified in the X-ray film of the appropriate primer 
combination in the genetic atlas (Fig. 5.9) and corresponded to marker ASAC04TT 
of the genetic atlas. Furthermore, analysis during the generation of the linkage map 
revealed that both markers were segregating independently, supporting that 
ASAC04TT was indeed the allele in question. 
5.2.2.2.2) Marker AJTT03CA: an example of a point mutation in the primer 
selective bases 
The predicted allele of AJ marker AJTT03CA was identified on the database. Only 
one "hit" was identified. Again several point mutations were detected. The most 
relevant of these changed a cytosine nucleotide into a thymine nucleotide (shown as 
their complementary bases in Fig. 5.10). The AS allele could not be identified on an 
X-ray film of the atlas. However, the marker provided a good example of a point 
mutation involving the primer selective bases. 
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AJACO1CA 	ri. I:rACAGAACTACCTTAGAATAGTACCGAAATGTCGTATTTTGW 
III! 	liii 	I 	I III 	I 	11111 	II 	I 	liii 	II 	III 	1111 
AS allele 	ATTCCAGAACTACCTTAGAATAGTACCGAAAATGTCGTATTTTGAAA 
AJACO 1CA AGGTAAAT AATWTATAAAPAGGAATGCATATACAAATATATAGCATA 
I 	I 	III 	11 
AS allele 	AGGTAAPL ... .......................................61 
AJAC01CA TATATTAGGAkCGCACATAACTTTGiH:. 129 
AS allele 
Fig. 5.8. Sequence of AJACO I CA (top) and match found on database (bottom). Note that primers 
have been removed and enzyme recognition sites (blue) reconstituted. Highlighted in red the crucial 
base substitution in the predicted AS fragment and the new AfseI recognition site. Numbers at the end 






Fig. 5.9. Identification of the allele of AJCAO1AC on the AFLP autoradiograph using selective 
primers E.TT and M.AC. The AS allele (i.e. ASAC04TT) is highlighted by an arrow and a box and 
corresponds in size to the fragment predicted from the P. c. chabaudi database. 
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AJTT03CA 	 I:TTATTAGGGGTATCAGACCAATTTTTCGAGTTCATACTATT I 	52 
I 	till 	lIlt 	II 	ill 	ii 	I 111111 	I 	Iii 	11111 	liii 
AS allele 	I.TT'TTTATTACGGGTATCAGACCAATTTTTCCAGTTCATACTATT TTAA 52 
Fig. 5.10. Sequence of AJT03CA (top) and match found on database (bottom). Highlighted in red 
the crucial base substitution in the predicted AS fragment. Note that primers have been removed and 
enzyme recognition sites (blue) reconstituted, Numbers at the end indicate the size in base pairs. 
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5.1) 	Discussion 
Attempts were made to identify alleles using three different approaches; the original 
approach used molecular techniques, the second was developed later and was based 
on the analysis of the genetic linkage map. The third approach consisted in the 
identification of alleles through the P. c. chabaudi genomic database. 
Molecular techniques proved to be laborious and time consuming. Following 
hybridisation experiments with probes obtained from AFLP markers, two probes 
yielded interpretable results. An approach based on inverse PCR was used to identify 
the alleles and sequence them. However, difficulties in obtaining a product in one of 
the reactions and the location of the other allele in an area of the genome containing 
many repeats prevented the correct identification of the alleles. No further attempts 
were made due to lack of time, although eventually this approach should have proved 
successful. 
The approaches based on genetic and genomic data, on the other hand, proved to be 
quicker and more reliable, alleles for all the analysed markers were successfully 
identified, either directly, as in the case of marker pairs involving indel mutations, or 
indirectly through searches of the database of the AS strain by using the AJ allele 
sequence as probes. This approach successfully identified the three types of 
mutations responsible for the generation of AFLP markers: indels, single nucleotide 
mutations removing (or generating) restriction endonuclease cutting sites and single 
nucleotide mutations altering the structure of selective bases present in the AFLP 
primers. These were shown to occur alone or in combination to produce AFLP 
markers. This technique is likely to be implemented in the future to provide 
additional novel markers for cloning experiments, as well as to provide confirmation 
of relevant observations by proportional AFLP during immune-selection 
experiments. 
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6. Results: Developin2 Proportional AFLP as a Technique to 
Identify Markers under Selection 
6.1) Introduction 
The main aim of the project was to identify AS and AJ markers linked with P. c. 
chabaudi genes involved in strain specific immunity in the host. The experimental 
approach involved obtaining progeny from a genetic cross of the parental isolates AS 
and AJ. Progeny clones represent different combinations of AS and AJ DNA, which 
would then be subjected to strain-specific immune pressure against either AS or AJ 
parental antigens. Those progeny clones carrying the strain-specific antigens are 
expected to be removed or greatly reduced in the cross-progeny population under the 
immune selection. Consequently, such a disappearance should be reflected in the 
absence or intensity reduction of any AFLP markers linked to the genes in question. 
Markers are unlikely to disappear completely from a pool under selection, unless 
they are closely linked to the gene under selection and the selective pressure is 
absolute (i.e. all the clones carrying the gene under selection are removed from the 
pool). It is more likely that the selective pressure might not be absolute and/or that 
the markers are located at varying genetic distances from the gene of interest (Fig. 
6.1). The question that needed to be addressed here was whether such an effect could 
be detected through the AFLP technique by measuring the relative intensity of 
marker bands. 
The main problem with using PCR-based techniques in situations where the quantity 
of starting material needs to be determined is that amplification occurs in a non-
linear manner in relation to the amount of starting template DNA. Additionally, 
impurities affect the reproducibility of the reactions. Thus, when two different DNA 
samples are amplified separately, the quantitative relationship between two templates 
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Fig. 6.1. Effect of selective pressure on markers with various degrees of linkage to the target allele. 
The percentage values indicate the likelihood of a marker to stay with the allele under selection during 
genetic recombination at meiosis. The further a marker is located from the allele, the more likely it is 
to recombine away from it. Thus, markers closely linked with the allele under selection are also more 
likely to be removed from a population under selection. The further away a marker is located, the less 
likely it is to be removed with the allele, giving a range of degrees of apparent "selection" on the 
markers themselves. Thus, a marker located at 30cM distance from the allele will appear to be reduced 
in the population under selection by 70% of its original level because 70% of the time it will be linked 
to the allele under selection, i.e. present in the same progeny clone which is removed by selective 
pressure. 
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(Lucito et al., 1998). However, techniques have been devised to circumvent this 
problem. In a technique called "balanced PCR" (Makrigiorgos et al., 2002), two 
distinct genomic DNA's are digested and ligated to specially-designed adapters to 
function as templates for the same PCR primers, as well as primers able to 
distinguish between the two populations. The two genomes are then mixed and 
amplified in a single PCR reaction. This technique allows the retention of the 
original quantitative difference between the amplified DNA samples. This is 
achieved by mixing several template DNA fragments sharing the same primer-
binding sites. All the fragments use the same primers and the effect of different PCR 
reaction efficiencies caused by factors such as PCR inhibitors is removed. Therefore 
the quantity of the amplified product is correlated with the amount of template 
present in the original reaction. Thus proportions of DNA fragments present in the 
original template are maintained after amplification. This technique is strikingly 
similar in principle to the AFLP digestion, ligation and amplification steps and it 
comes as no surprise therefore, that AFLP has been reported to be a quantitative 
technique able to distinguish heterozygous from homozygous levels of DNA for a 
marker (Peleman, 1999). Furthermore, as in balanced PCR, in the experiments to 
identify AFLP markers under selection, a "mixture" of two distinct DNA populations 
will be used, albeit in the form of mixed recombinant progenies. 
AFLP has not been designed primarily as a quantitative technique. As an additional 
complication, in our experiments we will be comparing separate PCR reactions, 
where impurities and different reaction efficiencies affect the final outcome. 
However, we would expect it to be able to detect relative quantity levels of different 
template DNA within a certain limit, based on the principle used for balanced PCR. 
It was thus important to establish how sensitive and reliable AFLP could be as a 
proportional technique. 
To address this question, artificial mixtures of P. c. chabaudi AS and AJ DNA were 
set up to observe the behaviour of genetic markers specific to either clones. The 
results obtained in these experiments showed that band intensity behaved 
proportionally to the quantities of DNA representing each P. c. chabaudi clone in the 
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starting material quantity and set the limits of sensitivity of the AFLP technique in 
measuring these proportions. 
6.2) Results 
A crucial aspect for the success of the immune selection experiments to identify 
markers linked with potential candidate genes for strain-specific immunity, was to 
determine how sensitive AFLP could be in measuring the intensity of a band. As it is 
unlikely that a marker will be so close to the gene under selection as to be removed 
completely, there will be some parasites left that carry the marker and whose DNA 
will be amplified during the AFLP PCR reaction. Thus, rather than observing a 
complete disappearance of the marker band, one is more likely to notice a more or 
less marked reduction in the relative intensity of the polymorphic band. 
The first experiment consisted of comparing the intensity of AS and AJ markers 
across a series of DNA mixtures ranging from pure AS down to pure AJ. This was 
done in order to establish if intensity was indeed affected by the quantity of DNA 
present. 
The second experiment focused on looking more closely at the various levels of 
intensity and establishing the levels of DNA quantity differences that were detectable 
by AFLP and the general limits of the technique. 
6.2. 1) Testing the effect of DNA mixtures on AFLP markers intensity 
The first test that needed to be done, was to examine whether AFLP band intensity 
reflected the proportion of DNA present in a mixture. In order to do this, a series of 
DNA mixtures of AS and AJ were prepared, ranging from 99.2% to 0.8% AS over 
AJ DNA (Fig. 6.2). An AFLP PCR reaction was set up using an EcoRI primer with 
AA selective nucleotides and an MseI primer with CA selective nucleotides. Gels 
were exposed to a Phosphor screen overnight and scanned with a Phosphorimager 
machine (Molecular Dynamics). By analysing band intensity for AS and AJ markers 
by eye, decline in intensity of specific AS or AJ markers could be observed in the gel 
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along the gradient of the various DNA mixtures from 100% to 0% AS. The decline 
in AS marker intensities became pronounced when the proportion of AS fell below 
50%; likewise for AJ markers when AJ DNA fell below 50% (Fig. 6.2). 
The intensities of each polymorphic band analysed in the experiment were expressed 
as ratios of their intensity relative to that of an arbitrarily chosen stable non-
polymorphic band (NP 1) for each of the different DNA mixtures (intensity index). 
Hence: 
Intensity of AS/AJ marker in "x" 
Intensity index for mixture "x" 	
Intensity ofNPl in "x" 
The intensity index was normalised before being plotted on a graph (Fig. 6.3) as 
expressed in the following formulas: 
For AS markers: 
Intensity index of AS marker for mixture "x" 
normalised intensity index in "x" = Intensity index of AS marker at 100% AS 
For AJ markers: 
Ratio of AJ marker for mixture x 
normalised ratio in "x" =  
Ratio of AJ marker at 0% AS 
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For the non-polymorphic band (NP2): 
Intensity index of NP2 band for mixture "x" 
normalised intensity index in "x" = Average of NP2 band intensity indexes for each 
mixture 
The results for these measurements and normalisations showed a linear decline of the 
band intensity of any given AS or AJ marker, as their DNA proportion decreased 
(Fig. 6.3). Non-polymorphic bands remained more or less constant compared with 
each other in all the mixtures of AS and AJ DNA. 
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Fig. 6.2. AFLP film showing a series of dilutions obtained by mixing AS and AJ DNA. The bands 
used for analysis are indicated by the arrows. Dilutions range from 99.2% to 0.8% AS over AJ DNA. 
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Fig. 6.3. Relative intensities of NP2 (a non-polymorphic band, blue diamonds). ASAAO1CA (AS 
marker. . triangles) and AJAAOICA (AJ marker, squares) over a constant, non-polymorphic 
band (NP 1). Values are measured along the gradient of AS material present in the mixture used in the 
PCR reactions. While NP2 appears relatively constant, the AS and AJ marker decline or increase 
almost gradually according to the DNA gradient. 
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The experiment was repeated using a 1:100 dilution of AS and AJ DNA for all the 
mixtures to determine whether proportionality was maintained even when 
considerably reducing the amount of starting material. The relative intensities of AS 
and AJ markers were very close to those from the experiment with the undiluted 
material (Fig. 6.4 and Fig. 6.5). This showed the robustness of the proportional 
AFLP PCR reaction independently of the starting template quantity, at least within 
the levels tested here. 
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Fig. 6.4. AFLP film with mixtures of AS and AJ DNA (1:100). All the samples have been diluted 
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Fig. 6.5 Normalised values for the relative intensities of NP2 (diamonds, blue). ASAAO1CA 
(triangles, ) and AJAAO1CA (squares, ........ ) over NFl using 1:100 diluted PCR templates. A 
similar pattern to the values generated with undiluted templates is observed, thus confirming that 
proportionality is maintained in diluted material. 
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6.2.2) Measuring the proportionality of the AFLP technique 
An experiment was designed in order to determine the reliability of AFLP marker 
intensities to measure the proportion in a mixture of template DNA that generated 
each AFLP marker. 
Proportions of AS to AJ DNA ranging from 100% AS, 87.5%, 75% 50%, 25%, 
12.5% and 0% (i.e. pure AJ) were prepared and PCR reactions performed 5-10 times 
and run on acrylamide gels. The gels were then exposed to a general-purpose 
phosphor screen and developed using a Phosphorimager machine. 
The same bands as were used in the previous experiments were also used to produce 
the ratios needed for statistical analysis. The intensity values were determined as 
before by drawing same-sized rectangles around the bands. The sizes of these 
rectangles varied from gel to gel, to take into account possible distortions that may 
require an increase in size. Additionally, a background correction was applied in the 
form of the "Local Median" option available on ImageQuant software (Molecular 
Dynamics). 
Ratios of the analysed bands (NP2, ASAAO1CA and AJAAO1CA) to the band used 
as a standard (NP!) were calculated. These were subsequently transformed by 
calculating the Arcsine of the square root of each ratio (standard transformation for 
ratios below 1) for analysis with Minitab software. 
To test whether a general trend of intensity increase or decrease was present across 
all the mixtures analysed, a Pearson correlation test was performed for each of the 
bands (Table 6.1). This statistic gives an indication of any possible positive or 
negative correlation between the observed values and the amount of AS DNA 
present in the template. A value of 1 or —1 indicates a perfect correlation. For both 
the AS and AJ markers, the correlation approaches 1 very closely with a high 
statistical significance, as indicated by their respective P-values. The AJ marker 
displays a negative correlation, since intensity is measured in relation to the 
proportion of AS material. For the non-polymorphic band (NP2), a slight negative 
correlation is measured. However, in sharp contrast with the results for the AS and 
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AJ markers (Table 6.2 and Table 6.3), the results from the T-Tests analysis for NP2 
(Table 6.4) indicate a lack of statistical significance in the differences between all the 
DNA mixtures. 
Next, values obtained from individual proportions were compared with each other 
with the help of Two-Sample T-tests. Two groups of values obtained from two 
different DNA mixtures were chosen for each band and compared with each other to 
determine whether any difference was statistically significant. 
For the AS and AJ polymorphic bands (Table 6.2 and Table 6.3 respectively), most 
comparisons indicated a statistical difference in intensity between different DNA 
mixtures. AFLP band intensity was highly reliable in detecting decreases of 
proportions of strain-specific DNA generating markers. Template DNA level 
decreases of 50% or more could be easily detected and the technique was still 
reliable for decreases of 25%. Below this value, reliability seemed less certain, with a 
decrease of 12.5% from either pure AS or pure AJ DNA (i.e. 100% down to 87.5% 
AS DNA or 12.5% down to 0% AS DNA) statistically indistinguishable from the 
intensity for the band obtained with the pure material. However, intensity difference 
measured for similar decreases between mixtures of 87.5% and 75% AS DNA and 
12.5% to 25% AS DNA (i.e. 87.5% to 75% AJ DNA) were highly significant, as 
indicated in the tables. When DNA was decreased by approximately 90% or more, 
band intensity became too faint to be distinguished effectively from background 
radiation by the ImageQuant software (Fig. 6.2 and Fig. 6.3). This was considered to 
be the lower limit of band intensity difference detection. 
For the non-polymorphic band (NP2), none of the comparisons showed statistical 
significance (Table 6.4) (with P-values ranging from 0.101 to 0.936), indicating that 
none of the differences observed were relevant and thus that the intensity remained 
effectively constant throughout the different DNA mixtures. 
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Marker Pearson Correlation P-value 
ASAAO1CAINP1 0.953 <0.0001 
AJAA01CA/NP1 -0.949 <0.0001 
NP2INP1 -0.384 0.002 
Table 6.1. Pearson correlation test results for the ratios obtained for ASAAO 1 CA, AJAAO 1 CA and 
NP2. Both AS and AJ markers display a strong positive and negative correlation respectively, as 
expected. NP2 displays a slightly negative correlation. 
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AFLP marker Proportion of AS Mean value of p-value for significance 
tested and AJ compared transformed of the difference 
intensity index between the two AS 
(S.D.) proportions in each 
comparison 
ASAAO1CA 100% AS 1.0050 	(0.0211) 
VS. 0.152 
87.5% AS 0.9530 	(0.0653) 
100% AS 1.0050 	(0.0211) 
VS. <0.0001 
75% AS 0.8103 	(0.0725) 
100% AS 1.0050 	(0.0211) 
VS. <0.0001 
50% AS 0.7087 	(0.0812) 
87.5% AS 0.95 30 	(0.0653) 
VS. <0.0001 
75% AS 0.8103 	(0.0725) 
75% AS 0.8103 	(0.0725) 
VS. 0.006 
50% AS 0.7087 	(0.0812) 
50% AS 0.7087 	(0.0812) 
VS. <0.0001 
25% AS 0.5151 	(0.0652) 
25% AS 0.5151 	(0.0652) 
vs. 0.001 
12.5% AS 0.3948 	(0.0733) 
Table 6.2. Two-Sample T-Tests for the AFLP marker ASAA01CA for different proportions of AS to 
AJ DNA. Percentage refers to the amount of AS DNA present in the mixture. Apart from the highest 
percentage values, all comparisons made yielded statistically significant differences, as indicated by 
the P-values. 
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AFLP marker Proportion of AS Mean value of p-value for significance 
tested and AJ compared transformed of the difference 
intensity index between the two AS 
(S.D.) proportions in each 
comparison 
AJAAO1CA 0% 	AS 0.7954 	(0.0549) 
vs. 0.793 
12.5% AS 0.7834 	(0.0748) 
0% 	AS 0.7954 	(0.0549) 
vs. <0.0001 
50% AS 0.5127 	(0.0797) 
0% 	AS 0.7954 	(0.0549) 
vs. 0.004 
25% AS 0.6471 	(0.0771) 
12.5% AS 0.7834 	(0.0748) 
VS. 0.001 
25% AS 0.6471 	(0.0771) 
25% AS 0.6471 	(0.0771) 
VS. 0.001 
50% AS 0.5127 	(0.0797) 
50% AS 0.5127 	(0.0797) 
VS. 0.001 
75% AS 0.4013 	(0.0487) 
75% AS 0.4013 	(0.0487) 
VS. <0.0001 
87.5% AS 0.2577 	(0.0362) 
Table 6.3. Two-Sample T-Tests for the AFLP marker AJAAO 1 CA for different proportions of AS to 
AJ DNA. Percentage refers to the amount of AS DNA present in the mixture. Apart from the lowest 
percentage values, all comparison made yielded statistically significant differences. 
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Non-polymorphic Proportion of AS Mean value of p-value for 
band tested and AJ compared transformed significance of the 
intensity index difference between the 
(S.D.) two AS proportions in 
each comparison 
NP2 100% AS 0.5925 	(0.0486) 
VS. 0.254 
75% AS 0.6321 	(0.0580) 
100% AS 0.5925 	(0.0486) 
vs. 0.936 
50% AS 0.5886 	(0.0875) 
75% AS 0.6321 	(0.0580) 
VS. 0.200 
50% AS 0.5886 	(0.0875) 
50% AS 0.5886 	(0.0875) 
VS. 0.155 
25% AS 0.6359 	(0.0600) 
25% AS 0.6359 	(0.0600) 
VS. 0.360 
12.5% AS 0.6628 	(0.0718) 
50% AS 0.5886 	(0.0875) 
VS. 0.101 
0% 	AS 0.6692 	0.0320 
Table 6.4. Two-Sample T-Tests for NP2 for different proportions of AS to AJ DNA. Percentage refers 
to the amount of AS DNA present in the mixture. None of the comparison yielded statistically 
relevant differences, with P-value well above 0.05 in most cases. 
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6.3) Discussion 
One question that arose during the analysis of potential outcomes of this project, was 
whether markers linked to the genes under selection would disappear completely 
under selective pressure or rather decline in intensity in relation to the strength of the 
selection and/or proximity to the gene under selective pressure. This scenario could 
be due to two possible situations. The first was that genes would not be under 
complete selection, i.e. the strain-specific immunity elicited by antigens of interest 
would only have a partial effect, still leaving surviving parasites carrying the targeted 
antigens and therefore the markers linked to them. The other situation was that there 
was a varying degree of proximity of genetic markers under selections to the genes 
of interest, with markers located closer to the gene being under greater apparent 
pressure. It was assumed that the indirect effect of immune selection on the intensity 
of the markers would decrease the further a marker was located from the gene under 
selection, due to the greater probability of genetic recombination occurring between 
the marker and the gene. In such scenarios, most markers would not disappear 
completely. It was thus necessary to establish whether partial reduction in parasites 
carrying specific markers could still be picked up by a decrease in the intensity of the 
AFLP markers. 
In order to determine the behaviour of AFLP polymorphic bands in response to 
reduced proportions of template, a pilot experiment was set up. It considered a 
gradient of artificial mixtures of AS and AJ DNA, in order to analyse the behaviour 
of AFLP polymorphic bands in preparations with different proportions of AS and AJ 
DNA. The intensity of polymorphic bands was measured against the intensity of a 
stable, non-polymorphic band to take into account different PCR reaction efficiencies 
among the different samples. 
The results showed an almost linear decline in band intensity for both AS and AJ 
markers relative to the decline of either AS or AJ proportions in the template used for 
the PCR reaction. The changes of intensity in polymorphic bands became visible 
when the proportion of DNA of one strain was reduced by at least 25%. Once the 
148 
DNA proportion was reduced below approximately 10%, the bands marking the 
strain became too faint to be distinguished from the background. 
The next step consisted in choosing several mixtures of AS and AJ DNA and 
repeating the PCR reactions between 5 to 10 times, in order to get enough repeats for 
statistical analysis. This experiment was performed to test the reliability of the 
previous observations, as well as to determine the limits of detection by the AFLP 
technique at lower proportions of DNA of a particular strain in a mixture of DNA of 
two different strains. Both the Pearson correlation test and the individual 2-Samples 
T-Tests indicated that there was a decline in band intensity for AS and AJ 
polymorphic bands as each was respectively diluted against the other, but not for the 
non-polymorphic band analysed. Furthermore, the intensity level accurately reflected 
the proportion of template DNA present in the mixture. 
A decrease or increase in the strain-specific DNA proportion generating the AFLP 
polymorphic band of approximately 25% yielded a difference in intensity detectable 
by the ImageQuant software. Below that difference, results were less clear (Table 6.2 
and Table 6.3). While a difference was detectable when DNA mixtures containing 
87.5% AS (or AJ) DNA and 75% AS (or AJ) DNA were compared, proportionality 
broke down when comparing mixtures consisting of 100% AS (or AJ) DNA with 
mixtures consisting of 87.5% AS (or AJ) DNA. Thus at DNA proportion differences 
of 12.5% or less, the DNA proportions being compared seemed to influence the 
outcome of the analysis. 
From the data collected, therefore, AFLP polymorphic band intensity was able to 
reliably detect differences in DNA template quantity as small as 25% and possibly 
less. The implication of these results for the project is that it will be possible to use 
AFLP to determine, within a reasonable range, the effect of strain specific immune 
selective pressure on AFLP markers linked to the alleles under selection. 
From the data analysed, reductions in proportion of a strain-specific AFLP marker 
ranging from 25% up to 100% (i.e. complete disappearance of the band) are readily 
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detected. Once the proportion of DNA generating the band is reduced to a threshold 
below approximately 10%, the band becomes too faint for detection and differences 
below this level cannot be compared. However, for the purpose of this project, this 
aspect is not relevant, as disappearance of the band is a clear indication of strong 
immune selection pressure, thus indicating a marker of interest. Differences of DNA 
proportion below 25% might not be distinguishable in all cases, although a more 
extensive analysis would be needed to define the precise limits. From the data 
collected, a reduction of 12.5% seems to be at the limit of detectability. However, 
such minor reductions of proportions are unlikely to be of importance for the scope 
of this project, as the focus will be on reductions affecting intensity by 50% or more. 
Such reductions are readily detected by AFLP. 
To conclude, AFLP measures linearly proportional differences of DNA from two 
different strains of P. c. chabaudi in mixtures of the two strains based on the 
intensity of the polymorphic strain-specific bands relative to non-polymorphic bands. 
Thus, it i& expected that when immune selected material from a genetic cross 
between two strains is analysed, any AFLP marker whose DNA template proportion 
is sufficiently reduced compared to the non-selected material, will be detected by its 
relative intensity reduction. The limits of the detection will depend upon the strength 
of the immune selection pressure on the allele under selection as well as the genetic 
distance of the marker from the allele in question. From the results obtained in the 
experiments presented in this section, if the combination of these two effects results 
in a 25% or greater reduction in the relative proportion of the AFLP marker's DNA, 
then it will be detectable. 
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7. Results: Proportional AFLP analysis of Immune Selected 
Material 
7.1) Introduction 
During strain-specific immunity, parasites of the immunising strain are preferentially 
removed by the immune system while the heterologous parasites are able to grow, 
albeit at a reduced parasitaemia, as discussed in Section 1.4 of the Introduction. 
Chapter 6 showed that it was possible to measure AFLP marker intensity and to 
relate it to the relative proportions of the clone. Thus, it is expected that in a mixture 
of AS and AJ parasites grown, for example, in an AJ immune mouse, AJ markers 
would decrease in intensity, while AS markers would show an increase. In contrast, 
in a genetic cross grown in a mouse immunised against the AJ clone, only those AJ 
markers linked to targets of strain-specific immunity are likely to show a decrease in 
band intensity, while AS markers linked to the AS allele should show an increase. 
The aim of this chapter was to evaluate how proportional AFLP might be used to 
identify markers linked to genes encoding targets of strain-specific immunity. 
The experimental approach employed here was based upon two parasites 
populations: i) a 50:50 mixture of AS + AJ clones ii) the uncloned progeny of a 
genetic cross between AS and AJ (AS X AJ). Both the mixture and the cross-progeny 
were grown in naïve and AJ immune mice. The DNA was extracted from the mice 
and analysed by AFLP. The work presented here is based upon only 8 AFLP 
markers: 3 AS markers and 5 AJ markers. Furthermore, the same template DNA 
samples had also been analysed using Real Time PCR (based on the MSP-1 gene) 
and proportional sequencing (based on the Multi-Drug Resistance (MDR)-1 gene). 
This provided data for a comparison with the results obtained here by proportional 
AFLP. 
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One of the problems encountered while evaluating marker intensities was the higher 
growth rate of AJ compared to AS (R. Carter, personal communication, J. de Roode, 
personal communication). This may result in a selection pressure favouring at least 
some AJ markers and needs to be taken in consideration when analysing and 
evaluating the results. 
7.2) 	Results 
7.2. 1) Passage history of the AJ-immune-selected material 
Following exposure of both the AS + AJ mixture and the AS X AJ cross-progeny to 
AJ-specific immune selection, parasites were allowed to recover in naïve mice to 
allow parasitaemia to reach levels suitable for DNA extraction. The parasitaemia 
from both experiments was followed in the naïve mice (Fig. 7.1). The parasites from 
the cross-progeny appeared to recover more quickly and required 2 sub-inoculations, 
while the parasites from the mixture recovered only after an extra sub-inoculation. 
Although it was tempting to attribute this to the different composition of the parasite 
populations in the mixture and cross-progeny, it is also possible that the difference 
was due a different parasite inoculum size at sub-inoculation, when the parasitaemia 
was too low to be measured accurately. 
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Fig. 7.1. Parasitaemias during and after AJ-immune challenge for the AS + AJ parasite mixture 
(diamond& bhic) and AS X AJ cross-progeny (squares. ). Arrows () indicate sub-inoculations. 
Parasites were sub-inoculated into naïve mice to allow recovery of parasite population for DNA 
extraction. 
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7.2.2) Quality control and choice of AFLP markers 
11 AFLP markers were present in the chosen combinations. Of these, 3 were 
discarded. Reasons for removal were: a) the faintness of the AFLP marker intensity 
(ASAGOIAT, Fig. 7.2), b) the high presence of background bands around the AFLP 
marker (AJAGO1AT, Fig. 7.2) and c) the presence of an area of decreased intensity 
for bands with higher molecular weights for cross-progeny parasites grown in naïve 
mice in which the marker under question seemed to be more affected than the others 
(AJAGO lAG, Fig. 7.3). 
Three AJ and five AS AFLP markers were identified for analysis. The markers used 
are listed in Table 7. 1, together with their assignment to linkage groups of the genetic 
linkage map produced in Chapter 5. Markers ASAGOIAG and AJAG03AG were 
both located on chromosome 8. Furthermore, they were closely linked to each other, 
possibly forming an allele pair. They also appeared to be weakly linked to MSP-1 
(Fig. 4.1). 
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Fig. 7.2. AFLP analysis of DNA from parasites grown in naïve mice or following selection in AJ-
immune mice (1). Each lane represents a separate PCR reaction, lanes are grouped according to the 
template used. Results for the primer combination EcoRI.AG and MwI.AT are shown. The templates 
used for the various combinations are indicated on top by letters or numbers. AS: parental clone AS: 
AJ: parental clone AJ; 69: immune selected AS X AJ cross progeny: 70: immune selected AS + AJ 
parasite mixture; 73: AS X AJ cross progeny grown in naive mice: 74: AS + AJ parasite mixture 
grown in naïve mice. 
Markers are indicated by arrows, removed markers in - " indicates area with high concentration 
of background bands. "C's indicate non-polymorphic bands used for calculation of ratios. 
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Fig. 7.3. AFLP analysis of DNA from parasites grown in naïve mice or following selection in AJ-
immune mice (2). Each lane represents a separate PCR reaction, lanes are grouped according to the 
template used. Results for the primer combination EcoRi.AG and Msel.AG are shown. The templates 
used for the various combinations are indicated on top by letters or numbers. AS: parental clone AS; 
AP parental clone AJ; 69: immune selected AS X AJ cross progeny; 70: immune selected AS + AJ 
parasite mixture; 73: AS X AJ cross progeny grown in naive mice; 74: AS + AJ parasite mixture 
grown in naïve mice. 
Markers are indicated by arrows. removed markers in . Box indicates area of general reduced band 
intensity. #'s indicate non-polymorphic bands used for calculation of ratios. 
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AS Markers Linkage Group 
ASAGO lAG Chromosome 8 
ASAG02AG Unlinked 
ASAG02AT Group B 
AJ Markers Linkage Group 
AJAG02AG Chromosome 6 
AJAG03AG Chromosome 8 
AJAG04AG Chromosome 13 
AJAG02AT Group A 
AJAG03AT Group G 
Table 7.1. List of AFLP markers used for analysis and their assignment to linkage groups. Linkage 
groups are listed in Fig. 4.1 and in Appendix 2 for groups not yet assigned to chromosomes. 
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7.2.3) AS + AJ parasite mixtures 
For this experiment, two templates of DNA obtained from a mixture of AS and AJ 
parasites were used. One template was obtained from the mixture grown in naïve 
mice (DNA 74), the other from the same mixture grown in mice immunised with the 
AJ strain (DNA 70). The data are summarised in Table 7.2. 
In naïve mice, the three AS AFLP markers from the parasite mixture of AS and AJ 
indicated proportions of AS parasites to be between 10.3% and 11% (Table 7.2). 
Conversely, the five AJ markers indicated the proportion of AJ parasites to be 
between 89.7-119% (Table 7.2). These data clearly indicate that AJ parasites 
increased their proportion during the infection, as expected by their superior growth 
rate. The proportions observed for the AS and AJ AFLP markers were 
complementary, adding up to approximately 100%, as expected. 
When the AJ-immune selected mixture was analysed, all AS markers increased in 
intensity and all AJ markers decreased. AS markers showed proportions between 
44.6-60%, AJ markers between 39.9-66.1% (Table 7.2). Again, the proportions 
observed for the AS and AJ AFLP markers were mutually complementary, adding up 
to approximately 100%. This was expected to be the case in the mixture, where the 
sum of the proportions of the two clones constitutes the total of parasites present. 
The proportions obtained for each AFLP marker from parasites from both the naïve 
and the AJ-immunised mice were compared. With no exceptions, all showed an 
increase (AS markers) or decrease (AJ markers) in AJ-immune selected material 
relative to naïve mice, all of which were statistically significant (Table 7.2). In 
general it was observed that while AJ markers showed a decrease in the proportion of 
AJ parasites in AJ-immune selected parasites (approximately down from 90% to 
50%), AS markers showed an inverse trend for AS parasites in AJ-immune selected 
mice, when compared to naïve mice (approximately up from 10% to 50%). The 
observations for the parasite mixtures grown in naïve and AJ-immune selected mice 
are diagrammatically summarised in Fig. 7.4 (for the AS markers) and Fig. 7.5 (for 
AJ markers). The graphs show the marked increase in AS and decrease in AJ strain- 
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specific DNA proportion following AJ-immune selection. These data indicate that 
strain-specific immunity was acting on the mixture. This strain-specific immunity 
was at a level which seemed to balance out the growth rate advantage of AJ in favour 
of AS. 
Some factors affected the final outcome of the analysis. Some markers yielded 
proportions of AJ parasites over 100% (i.e. AJAG03AG and AJAG03AT). This was 
probably due to two factors: firstly, there is the natural fluctuation of band intensity, 
as observed in Chapter 6, which means that band intensity can vary between two 
repeats from the same DNA. This is especially true for samples above approximately 
90% and below approximately 10%. Most importantly, however, the number of 
repeat determinations performed for pure AS and AJ DNA were less (between 2-4) 
than the number performed for the mixture samples (between 5-10). Any natural 
fluctuation occurring among the pure clonal DNA was thus likely to affect the 
average intensity to a greater extent than in the mixture samples. Thus, one repeat 
with a particularly low intensity for an AFLP marker might have had a great effect in 
the average intensity for pure AJ DNA, resulting in proportions in the mixtures 
above 100%. 
The proportions obtained with proportional AFLP for the parasite mixture were 
compared with proportions obtained previously for the same material using two 
different techniques, i.e. Real Time PCR and proportional sequencing (Table 7.3). 
Both techniques indicated approximately 0-9% proportion of AS parasites in mixture 
in naïve mice, while a proportion of approximately 50% AS was determined for 
mixture grown in AJ-immune mice. These data were in agreement with the results 
obtained for the AFLP markers using proportional AFLP and gave an indication of 
the reliability of all methods of measuring parasite proportions. 
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Name of Intensity index Relative Intensity index Relative p-value for 
polymorphic (S.D.) of AFLP intensity of (S.D.) of AFLP intensity of the 
marker markers for naïve AFLP marker in markers for AJ- AFLP marker in difference 
mice test sample in immune mice test sample in between the 
naïve mice AJ-immune- intensity 
compared to selected mice index of 
pure AS or AJ compared to naïve and 
(%) pure AS or AJ AJ-immune 
(%) selected 
parasites 
ASAGOIAG 0.072 (0.03271) 11 0.292 (0.05613) 44.6 0.002 
ASAG02AG 0.256 (0.04979) 10.3 1.486 (0.14151) 60 <0.0001 
ASAG02AT 0.0636 (0.00397) 10.3 0.2829 (0.01028) 45.7 <0.0001 
AJAG02AG 0.54 (0.07937) 95 0.226 (0.02221) 39.9 <0.0001 
AJAG03AG 0.488 (0.06760) 119 0.193 (0.03591) 47.1 <0.0001 
AJAG04AG 1.246 (0.07234) 97.7 0.606 (0.07876) 47.5 <0.0001 
AJAG02AT 0.3632 (0.02237) 89.7 0.2285 (0.02041) 56.4 <0.0001 
AJAG03AT 0.8818 (0.04038) 113.2 0.5152 (0.01554) 66.1 <0.0001 
Table 7.2. Summary of results of proportional AFLP analysis of mixtures of the AS + AJ parasites 
grown in naïve or AJ-immune mice. p-values indicate statistical significance of differences between 
mixtures grown in naïve and AJ-immune mice. All markers show statistically significant difference 
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Fig. 7.4. Diagrammatic representation of the proportional AFLP results for AS and AJ mixtures grown 
in naïve or AJ-immune mice as obtained for the AS AFLP markers. In naive mice (DNA 74, 
squares,) AS proportions are approximately 10 1/o, while a considerable increase in AS proportion is 
observed in mixtures under AJ-immune selection (DNA 70. green diamonds,). Differences in 
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Fig. 7.5. Diagrammatic representation of the proportional AFLP results for AS and AJ mixtures grown 
in naïve or AJ immune mice as obtained for the AJ AFLP markers. In mixtures grown in naïve mice 
(DNA 74, squares,) AJ markers represented 90% to 100% (values over 100% are present due to 
overestimation by the AFLP technique). In AJ-immune selected mixtures (DNA 70, green diamonds) 
the proportions of AJ markers decrease to approximately 50%. All differences are statistically 
significant. 
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Origin of DNA Number of Proportion of AS Proportion of AS DNA 
Template Tested DNA DNA measured by measured by 
Template Real Time Proportional 
quantitative PCR for Sequencing 
MSP-1 (%) for MDR-1 (average %) 
Naïve Mixture 74 8.6 0 
AJ-Immune 70 52 49.8 
Selected Mixture 
Naïve Cross 73 0 0 
AJ-Immune 69 30 20 
Selected Cross 
Table 7.3. AS DNA proportions as measured on two different genes by Real Time quantitative PCR 
and proportional sequencing in the different DNA templates used in the experiments. Proportional 
sequencing analysed a neutral gene Multi-Drug Resistance-i (MDR-1) a gene linked with drug 
resistance) and unlikely to be under selection, while the gene analysed by Real Time-PCR was 
Merozoite Surface Protein-I (MSP-1), a likely candidate antigen for strain-specific immunity (Results 
of S. Cheesman and P. Hunt). 
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7.2.4) AS X AJ cross progeny 
The analysis of the data obtained from the cross-progeny was more complex. The 
behaviour of markers were more unpredictable, due to the presence of growth rate 
differences between AS and AJ, which meant that progeny clones were in effect 
subjected to growth-rate selection, as well as AJ-immune selection. Thus any AS or 
AJ alleles linked to growth rate factors (or target antigens) would show a higher or 
lower intensity compared to neutral markers. Other factors, such as the presence of 
parental clones (especially AJ) or the presence of a limited repertoire of recombinant 
progeny clones could complicate the outcomes. 
In naïve mice, cross-progeny clones gave proportions of 0-15.9% for AS AFLP 
markers and proportions of 88-117.9% for AJ markers (Table 7.4). Assuming that 
there is no significant proportion of parental clones in the cross-progeny and that a 
large number of genetic recombinant clones is present, then it could be proposed that 
all the AFLP markers are linked to growth rate genes, since they diverge from the 
expected 50% proportion. However, a priori, it is most unlikely that 8 randomly 
chosen markers are all linked to growth rate genes. Indeed these results are consistent 
with the presence of significant proportions of AJ parental clone in the cross-
progeny, thus invalidating at least one of the assumptions above. 
In AJ-immune selected mice, the proportions of AS markers in the cross-progeny 
were between 21-30.2%, while the proportions of AJ markers were between 75.6-
98.6% (Table 7.4). 
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Name of Intensity index Relative Intensity index Relative p-value for 
polymorphic (S.D.) of AFLP intensity of (S.D.) of AFLP intensity of the 
marker markers for naïve AFLP marker in markers for AJ- AFLP marker in difference 
mice test sample in immune mice test sample in between the 
naïve mice AJ-immune- intensity 
compared to selected mice index of 
pure AS or AJ compared to naïve and 
(%) pure AS or AJ AJ-immune 
( °/o) selected 
parasites 
ASAGOIAG 0.0450 (0.0129) 0(*) 0.1440 	(0.0227) 22 0.005 
ASAG02AG 0.2150 (0.0465) 9 0.7480 	(0.0391) 30.2 0.001 
ASAG02AT 0.09876 (0.00496) 15.9 0.1301 	(0.0194) 21 0.025 
AJAG02AG 0.4475 	(0.0737) 88 0.4350 	(0.0165) 76.8 0.839 
AJAG03AG 0.4103 	(0.0156) 100 0.3311 	(0.0355) 75.6 <0.001 
AJAG04AG 1.280 	(0.128) 100.5 1.1580 	(0.0709) 91 0.167 
AJAG02AT 0.4099 	(0.0118) 101.2 0.3710 	(0.0135) 91.6 0.002 
AJAG03AT 0.9186 	(0.0368) 117.9 0.7682 	(0.0576) 98.6 0.006 
Table 7.4. Summary of results for the DNA obtained from the progeny of a cross between AS and AJ 
parents grown in naïve and AJ immune mice. p-values indicate the statistical significance differences 
between mixtures grown in naïve and AJ immune mice. 
(*) No band was present. The intensity index refers to background residual activity, which is relatively 
high due to the faintness of the marker. Statistical analysis was performed using this ratio. 
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When comparing cross-progeny grown in naïve mice with the same material 
subjected to AJ-immune selection, statistical analysis revealed a significant 
(p<0.025) increase in the proportion of AS AFLP markers (Table 7.4, Fig. 7.6). The 
results also suggested that all the AJ markers showed decreased intensities in AJ-
immune selected material, of which three (i.e. AJAG03AG, AJAG02AT and 
AJAG03AT) showed a statistically significant decrease, with p<0.006 (Table 7.4, 
Fig. 7.7). Assuming again the presence of a large number of recombinant progeny 
clones and no significant proportion of parental clones in the cross-progeny, a 
possible explanation would be to attribute the observed increase and decrease in 
AFLP markers proportion to linkage of the six markers showing statistically 
significant difference between naïve and AJ-immune mice to genes encoding targets 
of strain-specific immunity. It seems unlikely, however, that out of eight randomly 
chosen markers, six were linked to genes under immune selection. 
The proportions obtained for the cross-progeny were compared with the 
measurements done previously with proportional sequencing and Real Time PCR 
(Table 7.3). The proportions obtained for material grown in naïve mice seemed to 
agree with the previous observations, although two AS AFLP markers (i.e. 
ASAG02AG and ASAG02AT) indicated the presence of AS DNA, which had not 
been detected in the two genes analysed by proportional sequencing and Real Time 
PCR. The proportions obtained for the AJ-immune selected parasites showed an 
agreement between proportional AFLP and the other techniques when the AS AFLP 
markers were considered. Proportions of AS lay between 20-30%, in the same range 
as detected by Real Time PCR and proportional sequencing (Table 7.3). However, 
AJ AFLP markers were more difficult to relate to previous results. While two 
(AJAG02AG and AJAG03AG) were within the range observed previously (i.e. a 
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Fig. 7.6. Diagrammatic representation of the proportional AFLP results for AS and AJ cross progeny 
grown in naïve and AJ immune mice as obtained for the AS AF'LP markers. In cross progeny grown 
in naïve mice (DNA 73, circles) proportions of AS markers varied between 0% and 
approximately 15%. In AJ-immune selected cross progeny (DNA 69, I triangles) the proportions 
of the AS markers increase to between 20-30%. All differences observed between naïve and AJ 
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Fig. 7.7. Diagrammatic representation of the proportional AFLP results for AS and AJ cross progeny 
grown in naïve and AJ immune mice as obtained for the AJ AFLP markers. In cross progeny grown in 
naïve mice (DNA 73, circles) proportions of AJ markers varied between 85% and 100 1/o. In AJ-
immune selected cross progeny (DNA 69, H triangles) there is a greater degree of variation, with 
proportions ranging from approximately 65% to above 100%. Not all differences were statistically 
significant. 
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7.2.5) Comparing mixture and cross-progeny AFLP markers proportions 
Interpreting these results requires the consideration of many factors. Obviously, there 
are the two selective pressures being exerted on the parasites, i.e. the growth rate 
selection and the AJ-specific immune selection. While the first favours parasites 
carrying AJ (and possibly some AS)-growth rate genes (as these grow faster), the 
latter favours those parasites carrying AS antigens of strain-specific immunity. This 
is clearly reflected in the parasite mixture, as seen in Section 7.3.3. In the cross-
progeny, however, genetic recombination means that markers are moved around 
from one genetic background to another and cannot be treated as a single entity. 
Variation in intensity between the markers is expected, as some will be linked to AS 
or AJ growth-rate factors, others to genes encoding targets of strain-specific 
immunity, while the majority may be neutral markers under no selection. Thus AJ 
markers (and possibly some AS markers) linked to growth rate factors should show 
an intensity greater than the neutral markers in naïve mice, while AJ and AS markers 
linked to target antigens should display weaker or stronger intensity respectively. 
Intensities from parasites grown in naïve mice do not show any obvious difference 
between mixture and cross-progeny. Unfortunately, no statistical test could be 
performed to confirm this observation, due to the different treatment undergone by 
the two DNA templates prior to AFLP analysis. 
In AJ-immune selected material, the proportion of intensity of AS markers in the AS 
X AJ cross appears lower than in the AS + AJ mixture, while no firm conclusion can 
be drawn from the AJ markers. A statistical test might help confirming these 
observations, but due to the different treatment, to which the two DNA's sets have 
been subjected prior to AFLP analysis, this is not possible. The results nevertheless 
suggest that AS markers are lower in proportion of intensity in the cross-progeny 
compared to the mixture. AJ markers in the cross-progeny also behaved differently 
compared to the mixture. AJ markers showed different ranges of proportions, but 
were clearly higher in intensity than in the mixture under AJ-immune selection. 
Again, no statistical analysis can be done to confirm this. 
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7.2.6) Three markers linked to genes encoding potential target antigens 
7.2.6.1) AFLP markers ASAGO1AG and AJAG03AG 
As indicated in Table 7.1, one AS AFLP marker (ASAGO lAG) and one AT AFLP 
marker (AJAG03AG) used in this experiment both appear on chromosome 8. Closer 
analysis revealed that they were closely linked, being identical for every clone 
analysed. It was suspected that they might be alleles of each other, possibly the 
product of an mdcl mutation. 
For two alleles, the proportions of AS and AJ measured for the markers should add 
up to 100%. But even very closely linked markers from different strains should 
display proportions adding up to values close to 100%. In cross-progeny parasites 
grown in naïve mice, ASAGO lAG gave a proportion of 0% AS, while AJAG03AG 
gave a proportion of 100%. Although there are doubts regarding the intensity 
measured for ASAGO1AG, as it is a faint marker, both markers appeared to 
complement each other in terms of intensity and proportions. When the cross-
progeny under AJ-immune selection was analysed, ASAGO lAG gave a proportion of 
22% AS, while AJAG03AG gave a proportion of 75.6% AJ. The proportions 
measured for the two markers added up to almost 100%. The proportions thus 
reflected the close linkage of the two markers. 
ASAGO lAG and AJAG03AG were also linked with the MSP-1 gene in the genetic 
linkage map (Fig. 4.1), although linkage was not strong, with a genetic distance from 
MSP-1 of about 25 cM. Nonetheless, the proportions of AS and AT matched well the 
proportions measured for MSP- 1 by Real Time PCR, especially when a certain 
degree of error for the AFLP measurements is considered. Interestingly, AJAG03AG 
showed a high statistical difference (p<z0.001) between AT-immune mice and naïve 
mice and the lowest proportion measured for all AT markers (Table 7.4). It would be 
tempting to speculate that this observation is consistent with the marker being linked 
to a gene encoding an antigen under strain-specific immune selection (i.e. MSP-1). It 
will be worth re-analysing these two markers in the future in a larger scale 
experiment with better conditions and a new cross-progeny. 
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7.2.6.2) AFLP marker AJAG02AG 
AJAG02AG was assigned to chromosome 6 and is closely linked to the gene 
encoding RESA (in fact identical to it for every clone analysed), another potential 
target of strain-specific immunity. It displayed a proportion of AJ in AJ-immune 
selected cross-progeny of 76.8%, similar to that of the MSP-1 linked AFLP marker 
pair presented above. It is interesting to observe that both AJ markers linked to 
potential targets had lower AJ proportions compared to unlinked AJ markers (Table 
7.4), although there is no statistical evidence to confirm this. It would be tempting to 
attribute this difference to strain-specific immune selection. However, no statistical 
difference was observed for AJAG02AG between naïve and AJ-immune selected 
mice (Table 7.4). It is not possible to make any speculations. There appears to be no 
real difference between the two measurements and thus no selective pressure acting, 
unless the measurement done in the naïve mice (which was lower compared to the 
measurements for the other AJ markers) is shown to have been underestimated. 
7.3) Discussion 
The experiments presented here were performed using DNA from a 50:50 mixture of 
AS + AJ parasites and DNA from the progeny of a genetic cross between AS and AJ. 
The DNA was obtained from parasites that had either been grown in naïve mice or 
mice immunised with the AJ strain. The original purpose of this study was to 
demonstrate that AFLP was able to measure differences in band intensity (and thus 
DNA proportion) for AS and AJ markers in material that had undergone immune 
selection pressure. The results obtained with the AFLP technique could be compared 
with the results from two other quantitative techniques: Real Time quantitative PCR 
and proportional sequencing. A total of 3 AS and 5 AJ markers obtained from two 
AFLP primer combinations were used in these experiments. 
The main observations in the AS + AJ mixture were that: i) AJ markers were more 
intense than AS markers in naïve mice, ii) AS markers increased in intensity, while 
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AJ markers decreased in intensity after passage through AJ immune mice. These data 
are entirely consistent with the growth rate advantage of the AJ clone over the AS 
clone in naïve mice and with the selection exerted by strain-specific immunity 
against AJ in AJ-immune mice. 
In naïve mice, AFLP markers did not behave differently in the cross-progeny 
compared to the mixture, with AJ markers having intensities close to 100% and AS 
markers close to 10%. In the AJ immune-selected cross-progeny, intensities of AS 
markers, increased after AJ-immune selection, as in the case of the AS + AJ mix. 
However, no clear change was observed with the AJ markers as a whole after AJ 
immune selection compared to AJ markers obtained from parasites grown in naïve 
mice. Nonetheless, proportions measured for AS and AJ markers appeared to differ 
between the mixture and the cross-progeny under AJ-immune selection. It is 
impossible to give a clear analysis of the data presented, as too many variables are 
present and no statistical analysis could be performed. However, these differences 
seemed to indicate that parasites in the AS + AJ mixture were behaving differently 
from parasites in the cross-progeny, when exposed to AJ-specific immune selection. 
A theoretical model explaining the results is represented here. This is based on 
biological evidence and on speculative interpretation of the AFLP data. 
7.3. 1) A theoretical model 
7.3.1.1) Biological evidence for the presence of recombinant clones in the cross-
progeny 
Previous analysis of the crosses used in this work (Rosario, 1976b; Carlton, 1995), 
showed that at least between 50% and 75% of the clones recovered from the crosses 
were genetically recombinant. This information clearly indicates that recombinant 
progeny clones were present in the original cross products. 
It was also noticed that the growth rate behaviour of the cross-progeny was different 
from that of the mixture when grown in naïve mice after AJ-immune selection (Fig. 
7.1). It was speculated that the difference might have been an indication that 
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parasites in the cross-progeny recovered more quickly than those in the mixture 
following immune-selection. This would be consistent with the suggestion that a 
phenotypically different population was present in the parasites from the cross, 
compared to those from the mixture. However, no evidence is available to prove this 
speculation. Indeed, the observed difference may be due to different inoculum sizes 
when parasites were passaged into naïve mice. 
7.3.1.2) Presence of pure parental AJ clone in the cross-progeny 
An important factor to be considered in the cross-progeny material, is the presence of 
the parental AJ clone. During the generation of recombinant progeny from a malaria 
cross involving equal numbers of parental parasites, about 50% of the recombinant 
clones are expected to be either pure AS or pure AJ, according to Mendelian 
genetics. That might not necessarily be the case as cross-fertilisation might be 
favoured over self-fertilisation. Still, data available from two of the crosses used in 
this study suggest that AJ parental clone might have constituted 45% of the 
recovered clones in one cross (Rosario, 1976b) and 25% in another (Carlton, 1995), 
while AS was considerably less in both cases. Even if these data were an 
overestimation of parental AJ, a high proportion of pure AJ parental clones was 
probably produced. Even if AJ parental clones constituted only 5% of the total 
parasite population, they would have certainly outnumbered any new individual 
recombinant clone between AS and AJ, especially in a large cross containing 
possibly thousands of progeny clones. 
As discussed previously, the AJ parental clone has a distinct growth advantage over 
the AS parent. In cross progeny grown in naïve mice, AJ will quickly outgrow AS, 
while the various recombinant progeny clones will show varying growth rates. Due 
to the several passages into naïve mice (parasites spent between 40-50 days being 
grown in naïve mice, data not shown) prior to the immunisation experiments, it is 
likely that AS and some of the recombinant progeny clones might have been 
outgrown by AJ and the faster-growing recombinant progeny clones, such that they 
may disappear or be reduced to negligible levels in proportions. Additionally, 
because AJ was present at a much higher initial proportion than any of the faster- 
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growing recombinant clones, it would have still dominated the infection, unless the 
new faster-growing recombinant clones had a remarkable growth rate advantage. As 
a consequence, AJ parental parasites had plenty of time to increase their relative 
proportions in the cross-progeny material, so that the final proportion of the AJ clone 
might have been very high, possibly close to 90%. Following selection of this 
material in AJ-immune mice the pure AJ parasites (and any susceptible recombinant 
progeny clones) would have however been greatly reduced, thus allowing some of 
the recombinant clones carrying AS target antigen genes (and thus "resistant" to 
strain-specific immunity) to increase their proportion relative to the AJ parental 
clone. 
Subsequent passages in naïve mice prior to DNA extraction generate a rather 
complex scenario. They would certainly have favoured any surviving AJ, which 
could grow back as a consequence of their fast growth rate. This would be true for 
some recombinant clones as well. Furthermore, some of the recombinant clones 
"resistant" to immunity but with faster growth rate would continue to prosper. The 
overall picture is too complicated to be predicted based on the scarce information 
available. But if AJ had survived well enough to maintain a certain advantage (either 
in growth rate, or by still being present in a greater proportion than other clones, or a 
combination of both), passages in naïve mice prior to DNA extraction are likely to 
have given any surviving parental AJ the opportunity to grow back. Although it is 
not possible to determine how much of the AJ DNA in the cross-progeny under AJ-
immune selection originated from pure AJ, this could have still constituted a 
considerable proportion of the total parasites prior to DNA extraction. A proportion 
of 50% is conceivable. Taking this high parental AJ proportion into consideration is 
important when interpreting the data observed, as it helps to explain the higher than 
expected proportion of AJ measured in the cross-progeny. Additionally, the 
surviving repertoire of recombinant progeny clones might have had an effect, as 
discussed below. 
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7.3.1.3) Number of recombinant clones present in the cross-progeny 
The next crucial question concerns the number of recombinant clones present in the 
cross-progeny. If a large number of recombinant clones were present we should 
expect both AS and AJ alleles of neutral markers (i.e. not under selection) to be 
equally represented in the recombinant material, whether of AS or AJ origin. 
However, in the presence of an excess of parental AJ clone, the overall proportion of 
AJ markers should be biased towards AJ (as seems to be the case). Hence all neutral 
AJ markers should be equally high in proportion and all neutral AS markers should 
be equally low in their proportions by AFLP. 
In the present experiment, the relative intensities of the 5 AJ markers varied between 
75-100% in the immune-selected cross-progeny. If the relative intensities measured 
for the three more constant AS markers (i.e. between 20-30%) are taken as the 
expected proportions in the immune-selected cross-progeny, then it could be 
concluded that three AJ markers (i.e. AJAG04AG, AJAG02AT and AJAG03AT, 
Table 7.4) have a higher than expected proportion of AJ. In this case, there are two 
possible explanations: (a) either those three AJ markers are linked to AJ growth rate 
factors (thus yielding higher than expected proportions), or (b) a very low number of 
recombinant clones is present, leading to random over- or under-representation of 
individual markers. The first explanation (i.e. linkage to growth rate genes) is the less 
probable, as it seems highly unlikely that from five randomly chosen, unlinked 
markers, three of them were linked to growth rate genes. The second explanation (i.e. 
that only a relatively low number of recombinant clones is present) is more likely. 
This could be due to the possibility of a relatively large presence of AJ parental clone 
in the original crosses and its superior growth rate. Thus, given the series of passages 
into naïve mice prior to the experiment, the AJ parental clone population is likely to 
have constituted a majority of the parasites in the crosses and to have overwhelmed 
the recombinant clones. In fact, only those with a sufficiently powerful growth rate 
might have been able to compete with AJ. Thus, before the cross-progeny was 
injected in AJ-immune mice, only a relatively small number of recombinant clones 
may have survived. This number of recombinants is likely to have been further 
reduced by AJ-immune selection, which eliminated those clones carrying AJ-derived 
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genes encoding target antigens of AJ-strain-specific immunity. Thus, it is likely that 
only those recombinant clones carrying superior growth rate factor genes (mostly 
inherited from the AJ parent) and AS alleles for genes encoding antigens target of 
strain-specific immunity directed against AJ might have survived post-challenge to 
contribute significantly to the parasite population composition measured by AFLP. 
This, by consequence, would imply that only a limited number of recombinant clones 
were present following the AJ-immune selection. 
7.3.2) Conclusion 
The preliminary analysis of proportions of parasites from a mixture and from a cross-
progeny exposed to strain-specific immunity using proportional AFLP led to several 
conclusions. Firstly, it was established that AFLP was reliable in analysing material 
in an experimental situation involving immune selection. Secondly, the material 
analysed revealed the extent of strain-specific immunity and also gave some insight 
into growth rate differences between AS and AJ. Thirdly, a complex picture 
emerged from the analysis of the cross-progeny material, not only due to the effect of 
genetic recombination, but also due to the effect of growth rate differences between 
the parental clones. It was suggested that the superior growth rate of AJ caused it to 
be present in a large proportion in the cross-progeny even after immune selection. 
Furthermore, growth rate differences between recombinant clones might have caused 
a loss of recombinant clones prior to the immunisation experiment. 
The results presented in this chapter are clearly limited and preliminary. In future 
studies, a more complete examination involving a much larger number of markers is 
planned, so that genes under selection can be more readily identified. A new 
immune-selection experiment is planned, aimed at mitigating the effects of the 
growth-rate advantage displayed by the AJ parental clone, for example by 
eliminating blood passage after production of a genetic cross prior to immune 
selection. Backcrossing of the immune-selected recombinant progeny with the 
immunising parental clone is being considered. Alternative parental clones more 
evenly matched in their growth rate will also be tested. Finally, analysis of AFLP 
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markers linked to potential targets of strain-specific immunity (such as MSP-1, 
AMA-1 or RESA) in the genetic linkage map will be given special consideration. 
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8. Discussion 
This study is concerned with the development of an approach for the identification of 
antigen targets of immune responses in malaria parasites. The approach is based on 
the effects of strain-specific immunity (SSI), which is a well-documented 
phenomenon in several malaria species, including P. falciparum and P. c. chabaudi 
(Ciuca et al., 1934; Jeffrey, 1966; Powell et al., 1972; Jarra and Brown, 1985). SSI 
can induce a highly protective immune response against the immunising strain, while 
the immune response to challenges with heterologous strains in immunised subjects 
is less effective and allows survival of parasites. Understanding the nature of SSI 
should be a priority in malaria research. The approach developed in this study could 
eventually result in the discovery of novel surface antigens that could be used in 
vaccine development. It would also provide a greater understanding in the 
development of immunity against malaria, which could lead to the development of a 
more effective strategy for the development of malaria vaccines that would protect 
people from the more deleterious effects of the disease. 
A study of the magnitude required for this aim would be unfeasible in human beings. 
Besides ethical issues involving infecting hundreds of naïve individuals with malaria, 
a constant host genetic background (i.e. the use of genetically identical individuals) 
is required to maintain experimental conditions unaltered. However, the availability 
of mouse models for malaria, allows such a study to be undertaken. Inbred strains of 
mouse offer a sufficiently uniform host genetic environment required to study the 
effects of SSI on malaria parasites. P. c. chabaudi was chosen as the model due to 
the availability of well-characterised strains of the parasite and the well-documented 
presence of strain-specific immunity against P. c. chabaudi in mice. Furthermore, the 
existence of conserved gene synteny in malaria parasites, whereby the gene order 
observed in one species tends to be well conserved across the other species enables 
genes identified in P. c. chabaudi to be moved to an equivalent genetic region in P. 
falciparum and other relevant human malaria parasites. 
178 
The approach to identify genes encoding targets of SSI is based on the filtration by 
selection of the progeny of a genetic cross between two clones of P. c. chabaudi in 
mice rendered immune to one of the parental strains. All progeny clones carrying 
alleles of the parental parasite against which the immunity was raised for genes for 
antigen targets of SSI will be removed or greatly reduced in number by immune 
selections. We aimed to track such a disappearance or reduction using a large 
number of genetic linkage markers covering the whole genome. Any markers linked 
to the alleles of genes against whose products SSI was induced are expected to be 
relatively reduced or to disappear from the S SI-selected cross-progeny. The study 
presented here was concerned with the development of the various steps required for 
the successful application of this approach. It was subdivided in five areas of work. 
The first concerned the development of genetic markers. The AFLP technique was 
chosen for this and was optimised to work in P. c. chabaudi. In the second area, the 
AFLP markers were ordered in a genetic linkage map. The third area dealt with the 
identification of alleles of AFLP markers which, although initially developed for the 
purpose of producing markers for cloning by dilution experiments, later became a 
useful tool for the confirmation of certain observations made during this study. The 
fourth area concerned the development of AFLP as a proportional technique, an 
essential step to allow the identification of those markers linked to genes of interest. 
The final area was a preliminary test of the approach with uncloned progeny of a P. 
c. chabaudi cross following exposure to SSI. 
8.1) Generation of the AFLP genetic atlas 
The first step in the study involved the generation of a genetic atlas with the AFLP 
markers generated from two strains of P. c. chabaudi, AS and AJ. During this work, 
the AFLP technique was optimised for use with P. c. chabaudi. Adequate removal of 
host DNA contamination from the parasite DNA preparations was achieved by 
filtration of the blood through a series of fine filters. The same AFLP reactions were 
performed on parasite DNA templates obtained from different mice. In all cases, 
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AFLP bands from the parasite DNA proved repeatable and robust. Mouse DNA 
contamination might have been present in the form of occasional faint bands, which 
were generally ignored during AFLP marker analysis. The repeatability of AFLP 
band patterns from AFLP reactions on the same DNA template at different times was 
also demonstrated. 
Using a single combination of two restriction endonucleases, EcoRI and MseI, a total 
of 819 AFLP markers between AS and AJ was identified for the generation of a 
genetic atlas. The AFLP markers appeared to be divided almost equally between the 
AS and AJ clones. Although the number of usable AFLP bands changed slightly 
during the generation of the genetic linkage map, with some markers being rejected 
and others added, most markers proved to be robust, i.e. reliable and reproducible. 
Reflecting the A+T-rich nature of the P. c. chabaudi genome, most amplified bands 
were generated using primer combinations that contained A or T nucleotides in their 
selective base positions. However, the probability that a given band was polymorphic 
was independent of the nucleotide present at any given position. 
The rate of polymorphic AFLP bands between the two cloned isolates of P. c. 
chabaudi, AS and AJ, was calculated at 19.4% using 42 randomly chosen AFLP 
primer combinations. Based on this value and the assumption that the average band 
size is 200 bp, an estimate of the probability that there may be a sequence difference 
at any given base position between AS and AJ was calculated with the help of the 
Dice index (Mougel et al., 2002). The rate of polymorphism between AS and AJ was 
thus estimated to be between about 1 in 125 and 1 in 2,000 nucleotide positions. The 
first value is based on the assumption that all mutations occur as a result of base 
substitutions at the enzyme restriction sites or the selective base positions, the second 
on the assumption that all AFLP band polymorphisms arise as a consequence of mdcl 
mutations. The exact rate of polymorphism lies between these two values and 
depends upon the proportions of point substitutions and insertions/deletions over the 
total number of AFLP band polymorphism observed across the genome of the two P. 
c. chabaudi clones. 
180 
8.2) The genetic linkage ma 
A genetic linkage map was generated with the AFLP markers generated for AS and 
AJ using 28 progeny clones derived from two crosses between AJ and two 
chioroquine-resistant clones derived from AS. Although the map is incomplete and 
has yet to be confirmed by physical mapping, it produced several linkage groups, 11 
of which could be assigned to specific chromosomes. In total, 401 AFLP markers 
(out of 672) were assigned to 11 chromosomes, while a further 214 appeared in 12 
separate linkage groups of, as yet, unknown chromosomal allocation. Map Manager 
software was used to generate the genetic linkage map and also provided some 
valuable data on the number of recombination events and the approximate genetic 
size of chromosomes. These values were expected to increase with the actual 
physical size of the chromosomes. Although this was not always the case, a 
reasonable correlation could still be observed between recombination events and 
chromosome size, in spite of the incomplete nature of the genetic linkage map. 
The sizes of chromosomes as determined genetically were then used to convert 
genetic map units into actual physical size for each of the 11 chromosomes to which 
linkage groups were assigned. This was done using the actual physical size of the 11 
chromosomes in question, as determined by Pulsed Field Gel Electrophoresis. 
Although discrepancies with expected data were found, most could be explained by 
either incorrect characterisation of AFLP markers or of the RFLP markers, which 
had been used as chromosomal anchors, or by the lack of complete data for the 
chromosomes (i.e. linkage groups as yet to be allocated to chromosomes). However, 
it cannot be excluded that some chromosomes might be more likely to recombine 
than others, thus explaining some of the variation observed between chromosomes. 
The linkage map obtained thus far will be improved in the future. Some issues will 
need to be addressed in order to do so. Firstly, the assignment of AFLP marker 
linkage groups to chromosomes by Map Manager was not confirmed by physical 
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mapping and will need to be done in the future. Physical mapping will also be used 
to assign unassigned AFLP linkage groups and individual markers. Secondly, the 
absence of reliable RFLP anchors for three chromosomes (namely chromosomes 2, 4 
and 14). This was due to the fact that those RFLP anchors had only been 
characterised for a restricted number of the 28 clones used in this study to generate 
the linkage map and were not thus sufficiently accurate to be used as anchors. A 
fuller characterisation of these anchors will improve the quality of the genetic 
linkage map. Finally, the presence of possible mistakes in the characterisation of 
some RFLP anchors, as suggested by the large gaps separating these RFLP anchors 
(such as "ran" or d5SrRNA) from the main linkage groups in their respective 
chromosomes. These RFLP anchors will be re-analysed to improve the quality of the 
genetic linkage map. The genetic linkage map also proved useful for another 
purpose, namely the identification of alleles of AFLP markers, discussed below. 
8.3) Identification of alleles for AFLP markers 
This part of the project was originally concerned with the generation of markers to 
distinguish recombinant clones in mixed infections. Three different approaches were 
employed to identify alleles. The first approach which was based on several 
molecular techniques (such as the creation of radioactive probes, hybridisation 
experiments and inverse PCR), proved laborious and ultimately unsuccessful. The 
second approach was based on the genomic data currently available for P. c. 
chabaudi. Several AJ AFLP markers were sequenced and matched onto the P. c. 
chabaudi database. Since the database has been derived from the AS strain, 
polymorphisms between AS and AJ AFLP markers could be detected directly from 
the database and the AFLP allele identified. The third approach was based on 
classical genetics. Several AFLP markers formed pairs of closely positioned bands 
on gels between the AS and AJ clones, usually separated by few base pairs in size. 
Furthermore, during analysis of progeny clones of a genetic cross between AS and 
AJ for the construction of the genetic linkage map, it was observed that such pairs 
almost always segregated independently from each other. They behaved therefore 
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like alleles of each other at a locus, probably generated by indel mutations. Two such 
marker pairs were isolated and sequenced, confirming that they were indeed alleles 
of each other, differing by indels. 
The ability to identify alleles of AFLP markers has uses relevant to the final aim of 
this study. Knowledge of AFLP marker alleles will be used to study their behaviour 
under SSI. Thus loss of intensity of an AFLP marker, which could reflect immune 
selection by its linkage to a gene of interest, could be confirmed if the allele of the 
marker in question showed an increase in intensity. 
8.4) Development of the proportional AFLP techniflue 
Depending on how closely linked markers are to genes under immune selection, and 
on how strong is the immune pressure is against the antigens encoded by such genes, 
different effects on the proportion of parasites carrying such markers present in the 
immune selected cross-progeny can be expected. This could result in the complete 
absence of a marker, or, more likely, in a reduction in band intensity in the cross-
progeny exposed to SSI compared to cross-progeny grown in a naïve mouse. It was 
thus essential to establish whether proportional reductions in marker intensity could 
be detected by the AFLP technique. 
Initial experiments were conducted based on a set of artificial mixtures of AS and AJ 
parasite DNA with the aim of identifying the ability of AFLP to measure proportions 
of parasites of different genotypes in a mixed infection based on AFLP marker band 
intensity and to determine the limits of proportionality detected by this method. 
Increase or decrease in marker band intensity reflected alterations in the proportion 
of template DNA and was statistically significant. This was a first indication that 
proportional AFLP could detect increases or decreases of parasite proportions, as 
opposed to simply detecting parasite presence or complete absence. More detailed 
experiments revealed that proportional AFLP was capable of detecting deviations 
from a baseline proportion of 50% (for example 50% AS and 50% AJ in the cross- 
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progeny) down to about 10% or up to about 90% of parasites carrying the allele in 
question. Below or above these values the proportion could not be distinguished from 
0% and 100% respectively. Proportional AFLP could also readily distinguish 
changes in the proportion as small as a decrease from 50% to 37.5% (or a 
corresponding increase). This provides a useful degree of resolution that makes 
proportional AFLP suitable for the detection of markers linked to genes under 
immune selection. It can also provide a first indication on the strength of the immune 
selection pressure "experienced" by an AFLP marker linked to a gene under 
selection. Since this depends on the strength of the immune selection on the gene and 
on the distance of the AFLP marker from the gene itself, it could be possible, within 
limits, to map markers linked to the gene under selection according to their decrease 
or increase in proportion in SSI selected cross-progeny. 
8.5) Analysis of immune selected material by proportional AFLP 
Once the various elements for the establishment of an approach to identify genes 
encoding antigens target of SSI through their linkage with AFLP genetic markers had 
been successfully developed, a preliminary study was performed to test the approach. 
A mixture of AS and AJ parasites and the uncloned cross-progeny of AS and AJ 
were subjected to AJ-specific immune selection pressure in previously immunised 
mice. It was expected that AJ-immune selection would have a negative effect on the 
intensity of AJ AFLP markers in the mixture, when compared to the same mixture 
obtained from naïve mice, while the results from the cross-progeny parasites were 
expected to be more variable. There was also the question of the effect of growth rate 
difference between AS and AJ, which was expected to skew proportions towards a 
greater presence of AJ over AS. The DNA extracted from these infections was 
analysed by using eight AFLP markers of AS and ALE. The analysis by proportional 
AFLP showed the effect of growth-rate difference between AS and AJ in the mixture 
grown in naïve mice. As expected, AJ outgrew AS. In the mixture of parasites 
recovered from AJ-immunised mice the effects of strain-specific immunity in 
reducing the proportion of AJ parasites in the mixture was demonstrated. 
Furthermore, the observed proportions of AS and ALE parasites in the mixture, as 
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determined by proportional AFLP, agreed with measurements on the same material 
obtained by Real Time PCR (S. Cheesman, personal communication) and 
proportional sequencing (P. Hunt, personal communication). 
The picture obtained from the cross-progeny material was more complicated and 
difficult to interpret. This was partly due to the limited number of AFLP markers that 
were used in this preliminary study. Proportions in the immune-selected cross-
progeny were also measured by proportional sequencing and Real Time PCR. 
However it was not possible to directly compare the values obtained with these 
techniques with the proportions measured by proportional AFLP for the eight AFLP 
markers used in this experiment, because each marker behaves independently from 
the others due to genetic recombination. Especially if the number of recombinant 
clones present in the immune-selected cross-progeny is low, it can result in a 
considerable degree of deviation in the proportion of markers in a cross-progeny 
from expected values, independently from the activity of SSI. All three AS markers 
were represented in similar proportions to each other. AJ markers, however, showed 
significant variation in intensity to each other, with two markers giving lower values 
and three giving greater values. It is statistically unlikely that the results are due to 
linkage of the AJ AFLP markers to genes under selection (either immune selection or 
growth rate selection). Because of the high growth rate of clone AJ compared to 
clone AS, the pure unrecombined parental AJ clone is likely to have been favoured 
by repeated passages of the cross-progeny in naïve mice prior to the immune 
selection experiment. This would have resulted in the presence of a high proportion 
of the parental AJ clone and conversely in a reduction of recombinant clones in the 
cross-progeny material prior to the immune selection experiment. If only a few 
recombinant clones (and thus few recombination events) are represented in the cross-
progeny, considerable "chaotic" variations in the proportions of markers are 
expected. However, these speculations must be regarded with reservation, due to the 
limited amount of data on which they are based. 
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8.6) Conclusions and future work 
The results presented above have laid the molecular and genetic basis for the 
application of the approach described in this project to identify genes of the malaria 
parasite P. c. chabaudi, which encode antigens which can be targets of strain-specific 
immune selection pressure in immunised mice. 
The completion of the P. falciparum genome project, as well as the availability of 
sequences on the P. c. chabaudi genome database (Hoffman et al., 2002) have 
provided a very powerful resource to allow the rapid identification of candidate 
genes within regions identified by the approach taken here. Data from the genome 
projects have already been used in this study in connection with the identification of 
AFLP marker alleles (see Chapter 5). However, the greatest value of the genome 
project data to this study will be for the identification of the target genes of interest in 
this study. 
There will be two approaches by which this will be achieved. The first will involve 
the sequencing of specific AFLP markers and their identification on the P. c. 
chabaudi database. Although the genome is not complete, a large number of contigs 
is available. This should be enough to allow the identification of sequences upstream 
and downstream of an AFLP marker. If a locus located between two AFLP markers 
is identified, primers can be designed based on the sequence of the region of interest 
to allow sequencing of regions within the locus in both parental strains and the 
identification of polymorphic areas for the creation of primers able to distinguish 
between the two strains used in this experiment. However, since the data of the P. c. 
chabaudi database are incomplete, another approach might be required to achieve 
this. Sequences of AFLP markers in P. c. chabaudi can also be transferred directly to 
the complete P. falciparum genome by virtue of conserved gene synteny (Carlton et 
al., 1998b; Carlton et al., 2002). Loci of interest can be thus identified directly on the 
P. falciparum genome. However, great care must be take when considering 
conserved gene synteny, as the areas of gene synteny can vary considerably in size, 
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as shown in the case of P. berghei and P. falciparum (Canton et al., 2002). Thus, 
ideally, AFLP markers should be chosen that are located very close to the locus of 
interest. Alternatively, a sufficient number of AFLP markers on either sides of the 
locus could allow the identification of two (or more) synteny groups on different 
chromosomes of the P. falciparum genome, which could then be analysed separately. 
Primers can be designed based on the locus of interest and then transferred to P. c. 
chabaudi, to allow sequencing and the identification of polymorphic regions between 
the two parental strains used in the experiment. 
Once novel highly polymorphic regions, have been identified, primers can be 
designed that are able to distinguish between the two strains. These primers can then 
be used to perform a Real Time PCR reaction that is able to quantitate the amount of 
both alleles present in the cross-progeny used for the immune selection experiment 
using the Lightcycler method (Williams et al., 1998). It is important that primers are 
based on highly polymorphic regions that distinguish the two clones being analysed, 
in order to avoid any possible non-specific amplification. This method is very 
powerful and can detect DNA proportions differences as low as 0.5%, as has been 
shown in experiments conducted with parasite mixtures in our lab (S. Cheesman, 
personal communication). Designing primers on both sides of AFLP markers linked 
to genes under immune selection should allow moving closer to the gene itself. If a 
locus enclosed between two AFLP markers were identified, this procedure would 
allow the reduction of the size of the locus and facilitate the identification of the gene 
encoding the target antigen. This would be achieved by transferring the locus to the 
P. falciparum genome, as established by conserved gene synteny between the two 
species of Plasmodium. In the P. falciparum genome database, a list of genes 
contained within the locus will be available. Thus, it would only be a question of 
identifying among those a gene encoding a protein with antigenic properties. 
Findings could then be confirmed by identifying the homologous gene in P. c. 
chabaudi and determining its involvement in SSI. 
Another quantitative method has recently been developed, which might be useful for 
the successful completion of our project. The proportional sequencing technique (P. 
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Hunt, unpublished) allows reliable quantification of DNA proportions based on 
single nucleotide polymorphisms and will be useful in confirming observations made 
with AFLP markers using proportional AFLP. It might also find some application in 
the case of lack of highly polymorphic regions within a locus of interest, where the 
Lightcycler-based approach cannot be applied. 
If successful, the approach, for which this study lays the basis, will provide a 
powerful method to investigate SSI in malaria and ultimately contribute to the 
development of malaria vaccines. Furthermore it has an enormous potential in the 
study of genes underlying other types of selectable phenotypes (such as drug-
resistance, growth-rates and virulence), not only within malaria, but also in other 
related pathogens, such as coccidians and Theileria species. Future studies in this 
laboratory are now taking the molecular tools developed in the course of work 
presented here to test the principle of gene identification by filtration under a specific 
selection pressure of recombinant progeny of crosses between clones of malaria 
parasites. The approach could eventually provide a streamlined experimental system 
for the identification of malaria genes underlying specific biological phenotypes of 
malaria parasites. 
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APPENDIX 1: Chemicals, Solutions and Buffers 
SOLUTIONS: 
1:1 FCS: Ringer Solution: 
- 50% (v/v) heat inactivated calf serum 
- 50% (vlv) mammalian Ringer solution 
- 20 units heparin/ml mouse blood 
20x SSC (Sodium Saline Citrate: 
- 3MNaC1 
- 0.3M of sodium 
- Adjust pH to 7 with ION solution of NaOH. 
- Sterilised by autoclaving 
Citrate Saline: 
- 0.9% w/v NaCl, 
- 1.5% w/v Sodium Citrate 
- Adjust pH to 7.2 
- Sterilised by autoclaving 
Deen Freeze Solution: 
- 28% (v/v) glycerol 
- 3% (v/v) sorbitol 
- 0.65% (v/v) NaCl 
- Sterilised by filtration 
Pre-hvbridisation Solution (for 250mfl: 
- 10% SDS (sodium dodecyl sulfate)- 2.5 ml 
- 50 % Dextran Sulphate- 25 ml 
- 20xSSC- 62.5 ml 
- sdH20- 156.25 ml 
- Mix at 65°C for 40 mins. 
- Autoclave and store at -20°C in 20m1 aliquots 
Ligation Mixture (lOu! 
- 5mMATP 
- 1U T4 DNA Ligase (MBI Fermentas) 
- 50 pmol MseI adapters 
- 5 pmol EcoRI adapters 
- Made up to 10 il with sdH20 





- Sterilised by autoclaving 
SSC (saline-sodium citrate 
- 3MNaC1 
- 0.3 M sodium citrate 
BUFFERS: 
1X TBE Buffer 
- lOOmMTris 
- 100 mM Boric Acid 
- 2 mM EDTA (Ethylenediaminetetraacetic Acid) 








APPENDIX 2: Raw data for May Manager analysis 
The next pages show raw AFLP marker data as typed from autoradiographs. The 
nomenclature of markers is generated using the strain of origin (AS or AJ), the 
selective bases used in the AFLP primers and a number , usually starting with "01" 
indicating the highest molecular weight marker. "+" indicates presence of a marker 
for a specific clone, "- "its absence and "N" indicates undetermined clones. 
Numbers at the top of the table, ranging from 39 to 84, indicate various recombinant 
progeny clones. 
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APPENDIX 2: Raw data for Map Manager analysis 
Recombinant progeny clones 
-.... 	I1 	0 r. 
name 	39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 62 63 64 65 83 84 
t'J 
AS AA 004 AA *ASAA04AA  
AS AA 001AA *AS01 
AS AA 005AA *AS05 
AS AA 006AA *AS06 
AS AA 002 AA *AS02 
AJAA 001AA *AJ01 
AJAA 005AA *AJAAOSAA  
AJAA 006AA *AJ06 
AJAA 007AA *AJ07 
AJAA 002AA *AJ02 
AJAA 003 AA *AJ03 
AJ AA 004 AA *AJO 4AA 
AS AA 001AT *AS01AT 
AS AA 002 AT *AS02AT 
AS AA 003AT *AS03AT 
AS AA 004AT *AS04AT 
AS AA 006AT *AS06AT 
AS AA 005AT *AS05AT 
AJAA 001AT *AJ01AT 
	
N + + - + - - N N + N + 	+ + + + + - + - - + 
- + - - - N + + + - + - + 	+ + + + + + 	 - - + - + 
- + + - - N + + + - + - + + - + 	+ + + + 	+ - + - + 
- - + - - - + + + - + + + + 	-N + 	+ + + + N N + - + 
+ + + + + N - - + - + + N N - N 	+ - - - - - + - + + - 
- - + + - N - - + - N + + + - 	 + 	 + + + - - - + 
+ + - + + + - - - + - - - 	+ N + 	+ 	 + + - + - 
- + + + - + + + + - - + + + + + 	 + 	+ 	+ - + + + + 
'0 
AJAAOO2AT*AJAAO2AT + + + + + + + + - + - + - - + + + + + + + - - + + - + 	+ 
AJAA003AT*AJAAO3AT - + + + - + + + + - - - + - + + + - - + + + + - + - + 	+ 
ASAAOO1AC*ASAAO1AC - + + + + + ----- + + + + + + 
ASAAOO4AC*ASAAO4AC - + + ------ + + + ------ + + + + + - 	+ 
ASAAOO5AC*ASAAO5AC N N + N N N N N N + + N N N + N + N N N N + N + N + N 	+ 
ASAAOO6AC*ASAAO6AC - + - - - - - - - - + + + + + + - - - - 	+ 
ASAAOO7AC*ASAAO7AC - + + + + + + + + + + + ----- + 
AJAAOO1AC*AJAAO1AC + + + + + + + + + + + + + + + + 	+ 
AJAAOO2AC*AJAAO2AC + + + + + + + + + + - - - + - 	- 
AJAA003AC*AJAAO3AC + + + + + + + + + + + + + + + 	- 
AJAAOO4AC*AJAAO4AC + + + + + + + + + + + + + + + + - - - - - + 	- 
AJAAOO5AC*AJAAO5AC + + + + + + + + + + + + + + + + - + + + + 	- 
ASAOO1AG*ASAAO].AG - + ------ + - + - + + - - + + + - - - + + - - + 	- 
ASAA003AG*ASAAO3AG ------ + + - + + - - - + + + + + + + + + - + - - 	+ 
AJAAOO1AG*AJAAO1AG + - N + + + N - - + - N - - + - N + - - - - + - + - + 	- 
ASAAOO1TA*ASAAO1TA + + + + + - + + + + - - + + + - - - + + + 	- 
ASAAOO2TA*ASAAO2TA ------ + + - + + + + + - + + + + + - + - - 	+ 
ASAAOO4TA*ASAAO4TA + + N + + + - + + + + - - + + + - - - + + + 	- 
ASAA003TA*ASAAO3TA + + - - - + + + - - + + - + - - + - + - 	- 
AJAA003TA*AJAAO3TA + + + + + + + + + + + + + + - + + - + - + - + 	- 
AJAAOO1TA*AJAAO1TA + + + + + + + - + ----- + + + - - + + 
AJAAOO2TA*AJAAO2TA + + + + + + + - + + + + + - - - + + 
AJAAOO1TT*AJAAO1TT N N + + + + - - - + - + - + - - - + - - - + + + + - + 	- 
AJAAOO1TT*AJAAO2TT + + + + + + - - + - - + + - + - - - - + - - + + - + + 	- 
ASAlOO1TC*ASAAO1TC + - + - + - - - + - + + + - + - - - - - - - - + + - - 	- 
ASAA003TC*ASAAO3TC - + + N - + + - - + + 
ASAAOO4TC*ASAAO4TC - + - - - - - - - - - + - + - - + + + - - - + + - - - 	+ 
AJAAOO2TC*AJAAO2TC + + + + + + + + - - - + + + 
AJAA003TC*AJAAO3TC - + + + + + + + - - + + - 
AJAAOO4TC*AJAAO4TC + + + + + + + + + N - - - + + + - - + + - - + - - - 	- 
ASAAOO1TG*ASAAO1TG N ----- + + + + + + + + - + ---------- + 	+ 
ASAAOO2TG*ASAAO2TG N + ------ + - + - + + - - + 
ASAA003TG*ASAAO3TG - + + ------ + + - - - + 
AJAAOO1TG*AJAAO1TG N + + + + + - + - + + - + N + - - + + + + + + 	- 
AJAAOO2TG*AJAAO2TG N + + + + + + + + - - + + + + + + + + + + + + + + + - 	+ 
AJAA003TG*AJAAO3TG N + + + + - - + + + - - + + 
ASAPOO1CA*ASAAO].CA + - - - + - - - + + + + + + + + + ----- 
ASAAOO2CA*ASAAO2CA + - + - + - - - + - + + + - + -------- + + - - 	- 
ASAAOO4CA*ASAAO4CA + - - - + - - - - + + - - + + + + + ------ 
ASAAOO5CA*ASAAO5CA + + - - + - - - + - + + + + + 
AJAAOO1CA*AJAAO1CA + - - - + - - - + + + + + + + + + ----- 
AJAAOO5CA*AJAAO5CA - - + + - + + + - + - N - N + + N + 
AJAA003CA*AJAAO3CA + - - + + + - - - + - + - - + + 
AJAAOO4CA*AJAAO4CA + + + + + + + + + + + + + + + + + + + + + + + + + + + 	+ 
ASAAOO1CT*ASAAO1CT - - + - - - + - - - + - N + - + + - + + + 
ASAA003CT*ASAAO3CT - N - - - - + + N + + - - - + + + - + + + + + - + - - 	+ 
AJAAOO1CT*AJAAO1CT + + + + + + - - - + - + - + + - + + + - - + + + + + + 	- 
ASA1OO1CC*ASAAO1CC -------- + - + + + + - - - + 
ASAAOO1CG*ASAAO1CG N - N + - N N - + + + - - + - - + + 
ASAAOO2CG*ASAAO2CG N + N - - + + + - + - + + - + + N + 
ASAP003CG*ASAAO3CG 	N 	 - + - + N + + - - + + + - - - + + - - + - + 
AJAAOO1CG*AJAAO1CG 	N + + + + - - + - - + + - + - - - - + - - + + - + + - - 
ASAAOO1GA*ASAAO1GA 	N + - - - - - - - - + + - + - - + + + - - - + + - - - + 
ASAAOO2GA*ASAAO2GA 	N - + - - - - - - + + - - - + N + ------+ + + - + 
AJAAOO1GA*AJAAO1GA + + + + + + + + - - - + - - + + + + - + + + - + + + + + 
ASAAOO1GT*ASAAO1GT 	+ + - - + - + + - + + - N + N + + - + + - - - N + + - - 
ASAAOO2GT*ASAAO2GT N - - - N - N - N + N - N + N - - - + - - - - N - N - N 
AJAAOO1GT*AJAAO1GT 	+ - + + + + + + + + - - + - N + - - - + + + - N + + + - 
ASAAOO1GC*ASAAO1GC 	+ ------+ - + - + + - - + + + - - - + + - - + - 
ASAAOO2GC*ASAAO2GC 	------+ + - + + - - - + + - - + + + - - - + + + - 
AJAAOO1GC*AJAAO1GC 	+ + 	+ + + + + + - - + + + - + - + + + + + + - - - + - 
AJAAOO2GC*AJAAO2GC + + + + + + + + + - - + + - + + + + + + + + + + + + N + 
AJAA 001GG *AJ01GG N + - + - N + + - + N + + + - + + + + + + + + - - + + + 
AS AT 006AA *ASAT06 
AS AT 001AA *ASAT01 
AS AT 007AA *ASAT07 
AS AT 002AA *ASAT02 
AS AT 003 AA *ASAT03 
AS AT 004 AA *ASAT04 
AS AT 005AA *ASAT05 
AS AT OO8AA *ASAT08AA  
AS AT 009AA *ASAT09 
AS AT 010AA *ASAT10 
AS AT 011AA *ASAT11AA  
AJAT 001AA *AJAT01 
N N + 	 N + 	+ 	+ + -----+ 	+ + N - - - + 
N N 	 + 	 + + N 	+ + 	+ N N 	+ 	N N + - + N 
N N 	+ -----+ + 	 + + 	+ 	+ 	+ + 	N + + + + 
N -----+ + 	+ + + + + + + + + + + - + - - + 
+ + 	+ + 	 + + 	 + 	 + + 	+ 	+ 	- N - - - 
N N 	 + 	+ N 	+ + 	 + 	+ + 	+ + 	+ 	N - + - - 
N N N N 	N + 	+ + + + + + + + N - - + - 
+ + + + + + ---------N + + + + + + + + + + N - 
'0 
AJATOO2AA*AJATO2AA + - + + + + + + + + - - + - + + - - - + + + - N + + + 	- 
AJAT003AA*AJATO3AA + + + + + + -- - - - - - - + - + + + + + + + + + + - 	- 
AJATOO4AA*AJATO4AA N - + + + + + + - + - + - - + + - - - + + + - + + + - 	- 
ASATOO4AT*ASATO4AT + + N + + + + + + + + + N + + + + + N + + N + N + N + 	+ 
ASATOO5AT*ASATO5AT + - N - + - - - + - + + + + - - - + + - - N - N - + - 	- 
ASATOO1AT*ASATO1AT + + N - - - + + + - + - + + - + + - + + + N - + - + - 	+ 
ASATOO2AT*ASATO2AT + + N - + - - - + - + + + + - - + + + - - N + + + - - 	- 
ASAT003AT*ASATO3AT - + N - - - + + + - + - + + - + + - + + + N - + - + - 	+ 
AJATOO1AT*AJATO1AT + - N + + + + + + - - + N + - + + + + + + N N N + - + 	- 
AJATOO2AT*AJATO2AT + - N + + + - - - + - + - - + - - + - - - N + - + - + 	- 
AJATOO4AT*AJATO4AT - - N + - + - - + - - + + - + - - + N - + N + + - - + 	+ 
AJATOO5AT*AJATO5AT + - N + + + + + - + N - - + - + + + N + N N - N - - - 	- 
AJATOO6AT*AJATO6AT - - N + N N N N N N N N N N N N N N N N + - + N + - - 	- 
AJATOO7AT*AJATO7AT + - N + + + + + + - N + + + - + + + + + + N - N - - + 	N 
ASATOO1AC*ASATO1AC - + + + + - + - + - + + + - + + + - - - - + - 	+ 
ASATOO2AC*ASATO2AC + - + + + + - - + - - + - + - - - + - - + + - - - 	+ 
ASAT003AC*ASATO3AC - - + - - - - - + + + + + + - - + + - + + + - - - - + 	+ 
ASATOO4AC*ASATO4AC + - + + + - + + + - - + + - + + - - - - + - + - 	- 
AJATOO1AC*AJATO1AC + - + + + + + + + + - - + - + + - - - + + + - - + + + 	- 
AJATOO2AC*AJATO2AC - - + + + + + - + - - - - + + - + + + + + - - - + N 	+ 
AJAT003AC*AJATO3AC - + + + + + - - - + + - - + - - + + + + - + - + 	+ 
ASATOO1AG*ASATO1AG + N + + - + - + + + + + + + - - - + - 	+ 
ASATOO2AG*ASATO2AG + + N N + + - - + + + + + + + - 	+ 
ASAT003AG*ASATO3AG + + N N + + + + + + + + + + + - + + 	+ 
ASATOO4AG*ASATO4AG - - - - - - - - - + + - - + - - - - - - - - - - - - + 	- 
ASATOO5AG*ASATO5AG + + + + N + + + + - + + + + + + + + - - - 	- 
AJATOO2AG*AJATO2AG + + + + + + N N + - - + + + + + + + + N - - + - - 	+ 
AJATOO1AG*AJATO].AG + + - + + + N + - + - - - - + + + - - + + 
ASATOO1TA*ASATO].TA + + + + + + + + + + - + ---------- + 	- 
ASATOO2TA*ASATO2TA ------ + + + + + - + + + + - - - - + 
ASAT003TA*ASATO3TA + + + + - + + + + - + - + - + + + 
AJATOO1TA*AJATO1TA + + + + + - - - + - - - - + - + - + - - - + 
AJATOO2TA*AJATO2TA + + + + + + + - - + + - - + - + + + - + + 
AJAT003TA*AJATO3TA + + + + + + + + - - + - + + N N - N + + - - 
AJATOO4TA*AJATO4TA + + + + + + + - - + + + + + - - + - + - + - + + + 	+ 
ASATOO1TT*ASATO].TT ------ + + + - + + + - - + - + + + - + + 
ASATOO2TT*ASATO2TT - + - - N - - - + - + + N + + - - - + + + + - + + + + 	+ 
ASAT003TT*ASATO3TT + + + + N + + - + + + + N - N - - + + - - - N 
ASATOO4TT*ASATO4TT - - - - N - + + + - + + + + - + - + + - - + + 
AJATOO1TT*AJATO1TT + + + + + + - - - + - - - + + - + - - - + - - 
AJATOO2TT*AJATO2TT + -+ + + + + + - + - + - - + + - + - + + + + - + + + 	+ 
AJAT003TT*AJATO3TT - - + + - + - - + - - + + - + - - + - - + - + 
ASATOO1TC*ASATO1TC + N + + + + - + + - - + + + + + + 
ASATOO2TC*ASATO2TC + N + + - + + + + - - + ----- + 
ASAT003TC*ASATO3TC - N + - - - - - - + + - - - + - + + + + - + - 	+ 
ASATOO4TC*ASATO4TC + N + + + - - + - - + + + + ------ 
AJATOO1TC*AJATO].TC - N + + + + + + - - + + - + + + + + + + + + 	+ 
AJATOO2TC*AJATO2TC - N + + + + + + - - - - + + + + + + + - - - 
ASATOO2TG*ASATO2TG - + - - - - - - + - + - N + - - + + + - - - + 
ASAT003TG*ASATO3TG - + N - N - + + + - + - N - + + + - + + + - 
ASATOO4TG*ASATO4TG - - + - N - + + - + + - N - + + - - + + + - 
AJATOO1TG*AJATO1TG + - + + + + + + - + - + N - + + - - - + + + 
AJATOO2TG*AJATO2TG + - + + + + - - - + - + N + - - - + - - - + + 
00 
AJAT003TG*AJATO3TG - + + + N + + + + - - + N + - + + + + + - + - + - - - 	+ 
AJATOO4TG*AJATO4TG + - N + N + + + + + - + N - + + - + - + + + N N + + + 	+ 
AJATOO5TG*AJATO5TG - + + + N + + + + - - + N - + + - + - - + - + + + + + 	+ 
ASATOO1CA*ASATO1CA + + + + + - - + - - + + + + + - - + + - - + + - - - 	- 
ASATOO2CA*ASATO2CA - - - - - + - - N - - - - + + - + + - + - - + + - - + 	- 
ASAT003CA*ASATO3CA N + + + - - N - - + + - + - + - - - + - + - + + - 	+ 
AJATOO1CA*AIJATO1CA . + + + + - + + N + + + + - - + - - + - + + - - + + - 	+ 
AJATOO2CA*AJATO2CA + + + + - - - N + + + + - - + + - - + - - - + - + - 	- 
ASATOO1CT*ASATO1CT + + ----- + + + + + + N - - + N - - + + + - + + 	+ 
ASATOO2CT*ASATO2CT - - - - - - + + + + N + + + N + . . + - + - - 	+ 
AJATOO1CT*AJATO1CT + + + + + + + + + + + - - N - + + - + + + N 	+ 
AJATOO2CT*AJATO2CT + + + + + + + + N + - - N - - - - + + + - 	+ 
AJAT003CT*AJATO3CT + + + + - - - - - - - - N - + + + + . + + + + + - 	+ 
AJATOO4CT*AJATO4CT + + + + + + + ------ N + + - N + - - + - + - - 	- 
AJATOOGCT*AJATO6CT + + + + + + ----- + + - + + + + - + + - + - N 	- 
ASATOO1GA*ASATO].GA + + + + - N - N - + + + + + + - - - + - 	+ 
ASATOO2GA*ASATO2GA + + + + - + N - N + + + + + + + 
ASAT003GA*ASATO3GA ------ + + + + N + N + + + - - - - - - - - - - + 	+ 
ASATOO4GA*ASATO4GA + + + + + + - N - N + + + + + + - - - 	+ 
AJATOO2GA*AJATO2GA + + + + - - + - N + N - - + N + + + + - + 	+ 
AJATOO1GT*AJATO]GT + + + + + + + + - - - + - - + + + + - + + + - + + + + 	N 
AJATOO2GT*AJATO2GT . - + + + + + + + + - + + - + + - - - + + + - + + + + 	- 
AJAT003GT*AJATO3GT + + - + + + - - + + - + + + + - + + + + - + + + + + + 	+ 
ASAC003AA*ASACO3AA - - + ----- + - + + + + - - - + + - - + + - - + + 	+ 
ASACOO5AA*ASACO5AA N + - - + - - - + - + + + + - - + + + - - - + + + - - 	- 
ASACOO6AA*ASACO6AA N - - + - + + + + + + - + + 
AJACOO1A*AJACO1AA - + + + - + + + + + + - + + 
AJACOO2AA*AJACO2AA - - - + - + -- - - - + - - + - + 
AJACOO4AA*AJACO4AA N - + + - + + + + - + - - + 
AJAC003AA*AJACO3AA - + + + - + + + + + + - + + - - 
ASACOO1AT*ASACO1AT - - + -- - - - + + + + N + + + 
ASACOO2AT*ASACO2AT + - + + + N + + + + 
ASAC003AT*ASACO3AT - + + -- - - - - + + - N - + - - - -- - + + + + + + 
AJACOO1AT*AJACO].AT + + + + + + + + N + - - - N - - - - - + + + 	- 
AJACOO2AT*AJACO2AT + + - + + + ------ N - + - - N 
AJAC003AT*AJACO3AT + + - + + + + + - - - - N - + + - - 
AJACOO4AT*AJACO4AT + + + + + + - - + - - + N + - - + + 
AJACOO5AT*AJACO5AT + - + + + + + + - + - - N - - + + + - - - + ------ 
AJACOO2AC*AJACO2AC - - - + - + -- - - - + - + + - + - 
ASACOO1AG*ASACO1AG - + + - - - - - - + + - - - + - - - - - - + + + - + - 	+ 
ASACOO2AG*ASACO2AG - + -- - - - - + - + + + + + - - + + + + + + + + 	+ 
AJACOO1AG*AJACO1AG + + + + + + + - - + + + - - - + -- - - - + - + + 	- 
AJACOO2AG*AJACO2AG + + + + + + - - - - + - - + 
AJAC003AG*AJACO3AG - + -- - - - - + - + + + + + 
ASACOO1TA*ASACO1TA + - - - + - - - + N + + + + - - - + 
ASACOO2TA*ASACO2TA - - + - - - + + + N + - + + - + - - - 
AJACOO1TA*AJACO1TA + + - + + + - - - N - + - - + - + + + 
AJAC003TA*AJACO3TA - + - + - + + + - N - - - + - + + . + + + + + - - + + 	+ 
AJACOO4TA*AJACO4TA - + + + - + - - + - - + + - N - - + 
AJACOO5TA*AJACO5TA + + + + + + + + - + - + - - N + + + + + + - - + + - + 	+ 
CD 
ASACOO1TT*ASACO1TT - + - + - + + + - + - - + - + + + - 
ASACOO2TT*ASACO2TT + + - - + - - - + - + + + + - - - + + - - + + - - - 	- 
ASAC003TT*ASACO3TT + + - - + - - - + + + + + + - - - + + - + + - - - + + 	+ 
AJACOO1TT*AJACO1TT - - + + - + + + - + - - - + - + + + - + - + ------ 
AJACOO2TT*AJACO2TT - + + + - + + + - + - - - - + + + - - + + + + - + - - 	+ 
AJAC003TT*AJACO3TT + - - + + + - - - + - + - - + - - + - - - + - + - + 	- 
ASACOO1TG*ASACO1TG - - + - - - + + + + + + + + - + + + - + + N N + - + + 	+ 
AJACOO].TG*AJACO1TG + + N + + + + + N + N - N + + + + + - + + N N + + + - 	N 
AJACOO1CA*AJACO1CA + + + + + + -- - - - - - - + - + N + + + + + + + + - 	+ 
ASACOO1CT*ASACO1CT - + -- - - - - + + + + - - + + + + - - + - - - + 	- 
ASACOO2CT*ASACO2CT - + + -- - - - + + + + + + - - - + + - - + - + - + + 	+ 
ASAC003CT*ASACO3CT + - + + + + - - + + - + - + - + - - - 	- 
AJACOO1CT*AJACO1CT - + + + + + + + + + - + + - - + - + - + - + + + 	+ 
AJACOO2CT*AJACO2CT - - + + + + + -- - - - + + + - - + - - + + + - - - 	- 
ASACOO1GA*ASACO].GA + - - - + - + + - + + - - + - + + - + + - + - - - + - 	- 
ASACOO2GA*ASACO2GA - + -- - - - - - + + + - - - + - - + - + - + - 	+ 
AJACOO1GA*AJACO1GA + - - + + + + + -- - - - - + + + - - + + - + - + - - 	- 
ASACOO1GT*ASACO1GT - - - - - - - - - + + - - + N - - - + --------- 
AJACOO1GT*AJACO1GT - + + + - + + + + - - + + - N + - + + + - + + + - + - 	+ 
ASAGOO1AA*ASAGO1AA - + - + - + - - - + - + - - + - + + + - + + - - + + + 	- 
ASAGOO2AA*ASAGO2AA + + - - + - - - + - + + + + - - - + + - + + N - - + + 	+ 
AJAGOO1AA*AJAGO1AA - + + - - - + + + - + - + + - + + - + + + + N + - + - 	+ 
ASAGOO1AT*ASAGO1AT - - + - - - - - + - + - + + - - - - - - - + + - - - - 	+ 
ASAGOO2AT*ASAGO2AT - + + - + + - - - + + + - + + + + + - + - - 	+ 
ASAG003AT*ASAGO3AT - + + - - - + + + - + - + + - + - - - + + + - + - + - 	+ 
AJAGOO1AT*AJAGO1AT + + - + + + + + - + - + - - + + + + + + + - + + + + 	- 
AJAGOO2AT*AJAGO2AT - - + + - + + + - + - - - + - + + + - + - + ------ 
AJAG003AT*AJAGO3AT + - + + + + + + - + - + - - + + - - - - + + - + - - - 	+ 
ASAGOO1AC*ASAGO1AC - + + - - - + + + - + - + - + + - - - + + + -- - - - + 
AJAGOO2AC*AJAGO2AC - - + + - + + + + - + -- - - - + + + + + - + 	+ 
AJAG003AC*AJAGO3AC - - - + - + -- - - - + - + + - + - + - - + - + + + + 	+ 
ASAGOO1AG*ASAGO1AG - - N - - - + + + - + + + - - + - - - + + + N - - - - 	N 
ASAGOO2AG*ASAGO2AG + - N - + - + + + + + - + + + + + + + + + + + - + - + 	+ 
AJAGOO1AG*AJAGO1AG + + N + + + + + - - - + - - + + + N - + + + - + + + + 	+ 
AJAGOO2AG*AJAGO2AG - + N + - + + + + - - + + - - + - + + + - + N - - + - 	+ 
AJAG003AG*AJAGO3AG + + N + + + - - - + - - - N + - + + N - - - N N N + + 	N 
AJAGOO4AG*AJAGO4AG + - N + + + - - - + - + - + - - - + + - - + + + + + + 	- 
ASAGOO1TA*ASAGO1TA - N + - - - N + + + + - + + N + - - - - + - - + - + + 	+ 
AJAGOO1TA*AJAGO1TA + N - + + + N - - - - + - - N - + + + + - + + - + - - 	- 
AJAGOO2TA*AJAGO2TA - N + + - + N - + - - + + - N - - + - - + - + + + + + 	+ 
ASAGOO1TT*ASAGO1TT - + - N - - - - + - + + N + + - + - + + + - - + + + + 	+ 
AJAGOO1TT*AJAGO1TT + - N + + + + + + - - + N N - + + + - + + - N N N + 	N 
AJAGOO2TT*AJAGO2TT + - + + + + + + - + - N N - - + + + - - - + + ----- 
AJAGOO1TC*AJAGO1TC N - + + - + + + + - - + + + + + - - + - + - + - + + + 	+ 
AJAGOO2TC*AJAGO2TC N + - + - + + + - + - - - + - + + + + + + + + - - + + 	+ 
ASAGOO1TG*ASAGO1TG + - N - + - - N - + N - N - + - - - + - + - + - + + + 	N 
AJAGOO1TG*AJAGO1TG N - N + - + + N - + N - N - + + + - - + - - - + + - + 	N 
0 




2AG002CA*ASAG03CA N + - - + - - - + - + + + + - + + + - + - + + 	- 
ASAG003CA*ASAGO2CA N - - - + - + + + + + + + + - + -- - - - - - - - - + 	- 
AJAGOO2CA*AJAGO2CA N - + + - + + + - + - - - - + + + + + + - + 
ASAGOO1CT*ASAGO1CT + - - - + - + + - + + + - - + + + + + - - - N + N + - 	- 
AJAGOO1CT*AJAGO1CT - + - + - + + + + N N + + N N + N + + + - + + + N + N 	+ 
AJAGOO2CT*AJAGO2CT - + + + - + + + + N N + + N N + - + + + - + + + N + N 	+ 
AJAGOO1CC*AJAGO1CC - + + + - + - - + - - - + + - + - - - + + + + - + - + 	+ 
AJAGOO2CC*AJAGO2CC + - - + + + - - - + - + - - + - + + + - - - + - + - + 	- 
ASAGOO1GA*ASAGO].GA - + - - - - - + + - + - + + N - + + + + - - + - - - + 	- 
AJAGOO1GT*AJAGO].GT - - N + - + + + - + - - N N + + - + + + + + N - - + + 	+ 
ASAGOO1GG*ASAGO].GG + + - - + - - N N N + N N N N - + - - - - - N - - - + 	- 
AJAGOO1GG*AJAGO].GG - + + + - + + N N N - N N N N + - + + + + + N - - + - 	- 
ASTAOO1AA*ASTAO1AA + + - - + - + + N + + - - - + + + - + + + - - + + + + 	- 
ASTAOO2AA*ASTAO2AA N - N + + N - + + + - - + N + + - - + + + - + - 	+ 
ASTA003AA*ASTAO3AA - - - - - - + + N - + + + - - + - + + - - + + + 
ASTAOO1AT*ASTAO].AT - - + - - N + + + - + + + + + + + + + - - + + 	+ 
ASTAOO2AT*ASTAO2AT + - + - + - - - + - + + + + - - - - - - - - + + - - 	- 
AJTAOO1AT*AJTAO1AT + + + + + + - - + - - + + -- - - - - + - + + - + + 	- 
AJTAOO2AT*AJTAO2AT + + + + + + - - + - - + + + - + -- - - - + - + + 	- 
tj 
CD 
AJTA003AT*AJTAO3AT - + - + - + + + - + - + + + + + + + + - - + + 	+ 
AJTAOO4AT*AJTAO4AT + + - + + + - - - + - - - - + - - + + - - - + + + - - 	- 
AJTAOO5AT*AJTAO5AT + + + + + + + + + - - + + + - + + - + - + - - - + - - 	+ 
ASTAOO1AC*ASTAO1AC - + - - - - - - - + + - - - + - - - - - - + + + - + - 	+ 
AJTAOO1AC*AJTAO1AC + - + + + . + + + - - + + + - + + + + + + - - + - + 	- 
AJTAOO2AC*AJTAO2AC - + + + - + + + + - - + + + - + + + - + - + - + 
AJTA003AC*AJTAO3AC + - + + + + + + - + - - - + - + + + - + - + ------ 
ASTAOO1AG*ASTAO1AG - + + N - - + + + - + - + - + + + - + + + ------ + 
ASTAOO2AG*ASTAO2AG + + + - + - + + + + + - + + - + - + - + + - + + - - - 	- 
AJTAOO1AG*AJTAO1AG + - - N + + - - - + - + - + - - - + - - - + + + + + + 	- 
AJTAOO2AG*AJTAO2AG + + - + + + + + - + - - - + . + + + - + + + + + + + + 	- 
ASTAOO1TA*ASTAO1TA ------ + + + + N - N + + + + - + - + + 	+ 
ASTAOO2TA*ASTAO2TA + + + + + + + - - + + + + + + ----- + - 	- 
ASTA003TA*ASTAO3TA - + + + + - + - + - + + + + + + - - - + - 	+ 
ASTAOO4TA*ASTAO4TA - + + - - --- + + + + + + + + + + - + - + + 	+ 
ASTAOO5TA*ASTAO5TA - + + - - ---- + + - - - + - - - - -- + + + + + - 	+ 
ASTAOO6TA*ASTAO6TA + + + + + + + + + + + + + - - - + + 	+ 
AJTAOO1TA*AJTAO1TA + + + + + + - N + N - + + + + + + - + - - 	- 
AJTAOO2TA*AJTAO2TA - - + + + + + + - - - - + + + + + + + - - - + - 	+ 
AJTA003TA*AJTAO3TA + + + + + + - - - - + + + - + + - + 	- 
AJTAOO4TA*AJTAO4TA + - + + + + + + + - - - + + + + + + ------ 
ASTAOO1TT*ASTAO].TT + - + - + - - - + - + + + - + -------- + + - - 	- 
AJTAOO1TT*AJTAO1TT + + + + + + - - ------ + - + + + + + + + + + + - 	+ 
AJTAOO2TT*AJTAO2TT - + - + - + + + - + - - - + - + + + + + + + + - - + + 	+ 
AJTAOO1TC*AJTAO1TC + - + + + + - - - + - + - + - - - + - - - - + + + - N 	- 
C 
ASTAOO1CA*ASTAO1CA - + + - + + - - + - + + + + - + + - - + - - 	+ 
ASTAOO2CA*ASTAO2CA + + - - + - + + - + + - - - + + - - + + + N - - + + + 	- 
AJTAOO1CA*AJTAO1CA - - + + - + + + - + - - - - + + + - - + + + - - + + + 	+ 
AJTAOO2CA*AJTAO2CA + + + + + + + + + + + + + + + + + + + + + + + + + + + 	+ 
ASTAOO1CT*ASTAO1CT - + + - N - + + + - + - + + - + + N + + + + N + - N - 	+ 
AJTAOO1CT*AJTAO1CT + - - + N + - - - + - + - - + - - N - - - - N - + N + 	- 
AJTAOO1GA*AJTAO1GA - - + + - + - - + - - + + + - - + + - - - + + + 
AJTAOO2GA*AJTAO2GA - + + + - + + + + - - + + - + + + + + + - + - + 
ASTAOO1GT*ASTAO1GT + + - - - + + - - + + + + + ------ 
ASTAOO2GT*ASTAO2GT + + + - - + + + + + - + -------- + + - - 	- 
ASTA003GT*ASTAO3GT ------ + + - + + - - + + + + + + + - - + 
ASTAOO4GT*ASTAO4GT + N - - + N + N - N N + + - - - - - + 	- 
AJTAOO1GT*AJTAO1GT + + + + + + + - - + + - + + + + + + + + + 	+ 
AJTAOO2GT*AJTAO2GT + + N + + + + - N - N - N + N - - - - - - + ----- 
ASTTOO1AA*ASTTO1AA + + + - + + + - - + + - N - - - 	- 
ASTTOO2AA*ASTTO2AA ------ + + + + + + + + - + ---------- + 	- 
ASTT003AA*ASTTO3AA + + + + - + + - - - + + + - - - - - - + - 	- 
ASTTOO4AA*ASTTO4AA + N + + + + + + + + + + - + N + + N - - - + + 	- 
ASTTOO5AA*ASTTO5AA + ------ + - + - + + - + + + + + N - - + 	- 
ASTTOO6AA*ASTTO6AA - - ---- + + - + + - - - + + + + + + + + - + - - 	+ 
ASTTOO7AA*ASTTO7AA + + + + - + - + - + + + + + + ----- + 
ASTTOO8AP*ASTTO8AA - - - - - - + + + + + + + + - + - - - - - - - - - - + 	- 
AJTTOO1AA*AJTTO1AA + + + + + + - - + + + - + + + + + - + - + 	+ 
AJTTOO2AA*AJTTO2AA + + + + + - + - + - - + + + - + + + - 	- 
AJTT003AA*AJTTO3AA + + + + + + - + - - - - + + + + + + + + + + + + 	+ 
AJTTOO4AA*AJTTO4AA 	- + + + - + - - + - - + + + - - + N 	 + + + - - - + 
AJTTOO5AA*AJTTO5AA + - + + + + + + - + - + - - + + - 	 + + + - N +  
AJTTOOGAA*AJTTO6AA + N + + + + + + - + - + - - + + - 	 + + - +  
AJTTOO7AA*AJTTO7AA 	+ + + + + + - - + - - + + + - - - + -----+  
0 
AS TT OO1AT *ASTT01AT 
AS TT 002 AT *ASTT02AT 
AS TT 003 AT *ASTT03AT 
AS TT 004AT *ASTT04AT 
AJTT OO1AT *AJTT01AT 
AJ TT 002 AT *AJTT02AT 
AJTT 003 AT *AJTT03AT 
AJTT 004 AT *T04AT 
AJTT 005AT *AJTT05AT 
AJTT 006AT *AJTT06AT 
AJTT 007 AT *AJTT07AT 
- + N - - - N + + 	+ + + 	+ + - - + - + - + + + + + + 
- - N - - - N + 	 + 	N + - + - - - + - - + +  
+ + N + + + + + + + + + + + + + + + + + + + + + + + 
- + N - - - N + + 	+ 	+ + - + + - + + + + - +  
- + N + - + N 	+ + 	+ + 	+ - + + + - + + - -  
+ + N + + + N + + - + - + - - - - +  
+ + N + + + N -------+ - + + + + + + + +  
+ - N + + + N + ------+ + + - - + - - + +  
- + N + - + N + + + + - + - + + + - + + +  
- - N + - + + + 	+ 	 + + + - - + + + - - + + + + 
+ + N + + + 	 + + - + - + - - - + +  
ASTTOO1AC*ASTTO1AC + N - - + - - 	N - N + - - - + + + + + - 	+ - - + 
AJTTOO1AC*AJTTO1AC + N + + + + - 	N + N - + + + + + - + -- - - - + 
AJTTOO2AC*AJTTO2AC - N + + - + - 	N + N - + + + - - - + - - 	- + + N 
ASTTOO1AG*ASTTO1AG + - - - + - - 	- + - + + + + - - - + + - 	- - - + 
ASTTOO2AG*ASTTO2AG N N - - + - + 	+ - + + - - - + + + - + + 	+ - - + 
AJTTOO1AG*AJTTO1AG N N + + - + - 	- + - - + + + - - - + - - 	- + + - 	- - - 	+ 
ASTTOO1TA*ASTTO1TA N N + + 	+ + - - - + + + - + + 	+ - - + 
ASTTOO2TA*ASTTO2TA N N - - - - - 	- - - + - - + - - + + + - 	- - + + 	- - - 	+ 
AJTTOO1TA*AJTTO1TA N N + + + + - - + + - - + - - + 	+ + + 
AJTTOO2TA*AJTTO2TA N N + + + + + - + + + - - - + - - 	- + + 
AJTT003TA*AJTTO3TA + N + + + + + 	+ + + - + + - + + - - - + 	+ + - + 	+ + + 	- 
0 
C' 
AJTTOO4TA*AJTTO4TA + N + + + + - + - - - - + + + + + + + - + + - 	- 
ASTTOO1TT*ASTTO1TT + + + - + - + + + + + + + - + - + + - + 
ASTTOO2TT*ASTTO2TT + - - - + - - - + + + -- - - - + + - + - + - + - - + 	- 
AJTTOO1TT*AJTTO1TT + + + + + + - - - + + + + - - - + - - - + - + 	- 
AJTTOO2TT*AJTTO2TT + - + + + + - - - + + + - + - - - + + + + - + 	- 
ASTTOO1TC*ASTTO1TC + + + - + - + + N + + + - + - + - + - - + - + 
ASTTOO2TC*ASTTO2TC - + + - - - + + N + + + + - - - + + + - + - - - 	+ 
AJTTOO1TC*AJTTO1TC + - + + + + + + N + -- - - - + + + + + + + - - - + - 	- 
AJTTOO1TG*AJTTO1TG + + + + + + + + - + - + - - - + - + + - + - - + + - + 	+ 
AJTTOO2TG*AJTTO2TG + - + + + + - - - + - + - + - - - + - - - + + + + - + 	- 
AJTT003TG*AJTTO3TG - - + + - + + + - + - - - - + + - + - + + + - - - + - 	+ 
ASTTOO1CA*ASTTO1CA + - - - + + + + - - - - - - - - + - - + + 	- 
ASTTOO2CA*ASTTO2CA - + - - - + + + + + + + + - + + + - - - - + - 	+ 
ASTT003CA*ASTTO3CA + + - - + + + + + + - - - + + - - - + + - - - 	- 
ASTTOO4CA*ASTTO4CA - + - - - + + + + + + + + - - + - + - + + + + + 	+ 
ASTTOO5CA*ASTTO5CA + - - - + + + + - - + + - + - + - + - - - 	- 
AJTTOO1CA*AJTTO1CA - + + + - + + + + + + + + + + + + + + - + + - - 	+ 
AJTTOO2CA*AJTTO2CA + - + + + + + + + - - - + - - - + + + + - + 	- 
AJTT003CA*AJTTO3CA + + + + + + -- - - - - - - + - + + + + + + + + + + - 	+ 
ASTTOO1CT*ASTTO1CT N - - - + - + + - + + + N - + + + + - - - + + - - 	- 
AJTTOO1CT*AJTTO].CT N - - + + + + + - - - - N - + + + + + - - - + - - 	- 
AJTTOO2CT*AJTTO2CT N - + + + + + N - + + - N - N + + + + + + + N - - + - 	N 
AJTT003CT*AJTTO3CT N - + + - + - - + - - + + - + -- - - - + + + + + - + 	+ 
ASTTOO1GA*ASTTO1GA N N N - - N + N - + + - - - + + - - + + + - - - + + + 	- 
AJTTOO1GA*AJTTO1GA 	N N N + - N - N - - - + - + - - - + - - - - + - + - - - 
AJTTOO2GA*AJTTO2GA N N + + + N - N - - - - N - + - + + + + + + + + + + - + 
AJTT003GA*AJTTO3GA N N N + - N - N + - - - + - + + + - - + + + N - - + + + 
AJTTOO1GT*AJTTO]GT 	+ - + + + + - - - + N - - + - - + + - + - + ------ 
AJTTOO2GT*AJTTO2GT + - + + - + + + - N N - - + + + + + + + - - + - + + + + 
ASTCOO1A1*ASTCO1AA 	- + + + - - + + + - - + N - - - + + + + + + -----+ 
ASTCOO2AA*ASTCO2AA + - + - + - + + + - + + N - + - - + + - - 4- + + + - + + 
AJTCOO1AA*AJTCO1AA 	+ - - + - + - - - + - + N + + - . + + - - + + + + + + - 
AJTCOO2AA*AJTCO2AA - + + + + - - - + + - + N - - - + + + + + + - - - + - - 
AJTCOO1AT*AJTCO1AT 	- + - + + + - + N - - - - - - - + - - + + - - - + + - - 
AJTCOO2AT*AJTCO2AT - + - - + - + - - - - + + + - + - - + + + - - - N + - - 
ASTCOO1AC*ASTCO1AC N N - N N - N N N + N - + + + + - - - - + - - + - + + + 
ASTCOO2AC*ASTCO2AC 	N N - N + - + + N + + + + + - + ----------+ - 
AJTCOO1AC*AJTCO1AC N N - N N + N N N - N + N N N - - - - + - - + - + - - - 
AJTCOO1AG*AJTCO1AG N N N + - N + N + N N - N - N + + - - + + + + - + - + + 
ASTCOO1TA*ASTCO1TA 	+ + - - + - - - + - + + + + - - - + + - + + + - - + + + 
AJTCOO1TA*AJTCO1TA - - + + - + + + - + - - - - + + + - - + - - - + + - - - 
AJTCOO2TA*AJTCO2TA 	+ - + + + + + + + + - - + - + + - - - + + + - - + + + - 
ASTCOO1TT*ASTCO1TT 	N N - N - - - - + + - - + - - - - + ---------- 
ASTCOO2TT*ASTCO2TT + - - N - + + - + + - - - - - - - - - - - - - - + - + - 
ASTCOO1TC*ASTCO1TC 	N N - - N - - - - N + N N + + - + - - - + - - - + - + - 
ASTCOO2TC*ASTCO2TC N N + - - - - - - - + + - + - - + + + - - - + + - - - + 
t'J 
00 
AJTCOO1TC*AJTCO1TC N N + + N + + + + N - N N - - + + + + + + + + - 	+ 
AJTCOO1TG*AJTCO1TG N N N + + + - - - + - - - - + + + + + - + 	- 
ASTCOO1CA*ASTCO1CA - - - - - - + + + N + + + + + + - - - - - - - - - - N 	+ 
ASTCOO1CT*ASTCO1CT - - + - - - + + + - + + + + - + - + - + + + + - - + - 	+ 
AJTCOO1CT*AJTCO1CT + + - + + + + + - + - - - - + + + - - + + - - + - - N 	- 
AJTCOO2CT*AJTCO2CT - + + + - + + + + - - + + + - + - + + + - + + + - + N 	+ 
ASTCOO1GA*ASTCO1GA - + - - N N - N + - + + N + + - - - + + + - + + + + N 	+ 
AJTCOO1GA*AJTCO1GA + - + + N N - N - + - + N + - - - + - - - + + + + - N 	- 
ASTCOO1GT*ASTCO1GT N N - - - N - - - - N + - + - - + + + - - - + + - - - 	+ 
AJTCOO1GT*AJTCO].GT N N + + - + - - + N - - + + - - + - - + + + + - - + + 	+ 
AJTCOO2GT*AJTCO2GT N N + + + N+ + + + N - + - + + - - - + + + - - + + + 	- 
ASTGOO1AA*ASTGO1AA N N + - + - N - + - + + + - - - - - - - - - - + + - + 	- 
ASTGOO2AA*ASTGO2AA N N + - - - N + + - N + N N - + - + - + + + - - - + + 	+ 
ASTG003AA*ASTGO3AA N N - - - - + + + - + - + - + + + - + + + - - - - + - 	+ 
AJTGOO1AA*AJTGO].AA N N - + - + N + - + - - - + + + + + + + + + + - - + - 	+ 
AJTGOO2AA*AJTGO2AA N N - + - + - + + - N + N - - + - + + + - + + + - + - 	+ 
AJTG003AA*AJTGO3AA N N - + + + - - - - N - N - + - - N + - - + + + + + - 	- 
AJTGOO4AA*AJTGO4AA N N + + - + - + - + N - N + - + + N - + - - - - + - - 	- 
ASTGOO1AT*ASTGO1AT N - - - + - - - - + + - - + + - + N - - + - - - + - + 	- 
AJTGOO1AT*AJTGO1AT N + + + - + -- - - - + - + - - - N - - - - - + - + - 	- 
AJTGOO2AT*AJTGO2AT N - + + - + + + - + - - - - + + - N + + + + - - - + - 	+ 
AJTG003AT*AJTGO3AT N + + + - + - - + - - + + - + - - N + - + - + + - - + 	+ 
AJTGOO4AT*AJTGO4AT N + + + - + + + + - - + + + - + - N - + + + + - + - + 	+ 
110 
AJTGOO5AT*AJTGO5AT 	N + + + + + 	 - + - - - - + N + + - + + - + - - - 
AJTGOO1AG*AJTGO1AG 	- - + + - + + + ------+ + - + - + - + + - +  
AJTGOO2AG*AJTGO2AG + - + + + + - - - + - + - + - - - + - - - + + + +  
ASTGOOJ.TA*ASTGO1TA 	N - - - - - + + + + + - + + + + - - - - + - - + - + + + 
ASTGOO1TT*ASTGO1TT N - - - + - N N - + + + - - N + - + + - N - - + - + - - 
ASTGOO2TT*ASTGO2TT 	N + - - + - + + - - + - - - + + + - + + N - - + - + - - 
AJTGOO1TT*AJTGO1TT N + + + - + N N + - - - + + N - + - - + N. + + - +  
ASTGOO1TC*ASTGO1TC 	+ + - - + - - - + - + + + + - - + -----+ + +  
AJTGOO1TC*AJTGO1TC - - + + - + + + - + - - - - + + - + + + + + - - - + - + 
AJTGOO1TG*AJTGO1TG 	+ - - N + + - - - + - + - - + - + + + - - - + N + N + - 
ASTGOO1CA*ASTGO1CA 	+ N + N N - + N + + + - + - - N - + - + + - + + - - - - 
ASTGOOJ.CT*ASTGO1CT 	+ - - N + - + + + + + - + - + + + - + + + + + - + - + + 
ASTGOO2CT*ASTGO2CT - + - N - - - - + - + - + + - - + + + + - - + - - - + - 
ASTG003CT*ASTGO3CT 	+ + - N + - - - + + + + + + - - + - + - + - - + - + + - 
AJTGOO1CT*AJTGO1CT + - + N + + + + - + - + - - + + - - - - + + - + + + - + 
AJTGOO2CT*AJTGO2CT 	+ + + N + + - - - + - - - + + - + - - + + - - - + - + - 
ASTGOO1GA*ASTGO1GA 	- - ------+ - + - + + + - + - - + - + + - N + - - 
AJTGOO1GA*AJTGO1GA - - + + - + + + ------+ + - + - + - + + - N - - + 
AJTGOO2GA*AJTGO2GA 	+ - + + + + - - + - - + + N - - - + - - - + + - N - + - 
AJTGOO1GT*AJTGO1GT 	+ + - + + + + + - - - - - + - + + + + + + + + - - + + + 
t.J 
0 
ASCAOO1AP*ASCAO1AA - - N 
ASCAOO2AA*ASCAO2AA N N N - - - + + 
AJCAOO1AA*AJCAO1AA + + N + + + - 
AJCAOO2AA*AJCAO2AA + + N + + + + + 
AJCA003AA*AJCAO3AA + - N + + + - 
AJCAOO4AP.*AJCAO4AA N N N + - + N + + - - - - - + + + - + - + ------ 
ASCAOO1AT*ASCAO1AT - N - - - - - - - + + + + + - + - + - 	+ 
ASCAOO2AT*ASCAO2AT + N + - + N + + + + - - - - - - - - - - - + - + 	- 
ASCA003AT*ASCAO3AT + N - - + + + + 
ASCAOO4AT*ASCAO4AT - N - - - + + 
AJCAOO1AT*AJCAO1AT + N + + + + + + 
AJCAOO2AT*AJCAO2AT - N - + - + 
AJCA003AT*AJCAO3AT - N + + - N + + 
AJCAOO4AT*AJCAO4AT - N + + - + 
ASCAOO1AC*ASCAO1AC N N N N + - - N 
ASCAOO1AG*ASCAO1AG N N N - - - - N 
AJCAOO1AG*AJCAO1AG N N N + + + - N 
AJCAOO2AG*AJCAO2AG N N N + + + + N 
AJCA003AG*AJCAO3AG N N N + + + - N - + - - - - + - - + + - - - + + + - - 	- 
ASCAOOJ.TA*ASCAO1TA N - + - N - - N 
ASCAOO2TA*ASCAO2TA N - - - N - + N 
ASCA003TA*ASCAO3TA N - - - N - - N 
ASCAOO4TA*ASCAO4TA N - - - N - - N + 
AJCAOO1TA*AJCAO1TA N + + + N + + N + 
AJCAOO2TA*AJCAO2TA N - - + N + - N + 
AJCA003TA*AJCAO3TA N - + + N + + N - + - - - + - + + + - + - + - - - - - 	- 
AJCAOO4TA*AJCAO4TA N - + + N + N N - + - + - - + + + - - + - - - + + 
AJCAOO5TA*AJCAO5TA N - + + N + + N - + - - - + - + + - - + - - - - + - - 	- 
ASCAOO1TT*ASCAO].TT N N N - - - - N + + + + + N - + + + + + 
ASCAOO2TT*ASCAO2TT N N N - - - - N + - + - + N - + + + + N - - - 	- 
ASCA003TT*ASCAO3TT N N N - - - + N + + + - + N + + - - - - - - - + - - + 	+ 
ASCAOO4TT*ASCAO4TT N N N - N - + N - + + - - N + + + + + - - + + + 	- 
AJCAOO1TT*AJCAO1TT N N N + + + + N + + - - + N + + + + + - - + 
AJCAOO1TC*AJCAO1TC N N N + + + + + + - - + + + - + + + - + + - + - + 
ASCAOO1TG*ASCAO1TG - N ------ + + + + + + - - - + + + - - + + + + 	+ 
ASCAOO2TG*ASCAO2TG - N + ----- + + + + + + - - + + - + + + 
AJCAOO1TG*AJCAO].TG + N + + + + + + + + + + - - - + + + - - + 
AJCAOO2TG*AJCAO2TG + N + + + + + ------ + + - - + - - - + + + 
ASCAOO1CA*ASCAO1CA - + ------ + + + + + + - - - + + - - + + N + + 	+ 
AJCAOO].CA*AJCAO1CA + + + + + + ----- + - + + + + - + + - N - - 	- 
AJCAOO2CA*AJCAO2CA + - + + + + + + + ----- + + + + - + + - - N - - 	- 
AJCA003CA*AJCAO3CA + + + + + + + + + + + + + + + + + + + + - - - N 
ASCAOO1CT*ASCAO].CT + - - - + - + + + + + + + + - + ---------- + 	- 
ASCAOO2CT*ASCAO2CT - + - - - -- - + - + - + + - - + + + - - - + + 
ASCAOO1GA*ASCAO1GA + - - - + - + + + + + + + + - + ---------- + 	- 
ASCAOO2GA*ASCAO2GA - + - - ----- + + + - - - + - - + - + 
AJCAOO1GA*AJCAO1GA + - - + + + + + ------ + + + - - + + - - - + - - 	- 
ASCAOO1GT*ASCAO1GT - + - - - - + + + - + - + - + + + - + + + - - - - 
AJCAOO1GT*AJCAO1GT - + + + - + + + + - - + + + + + - - + - + - + - + + + 	+ 
AJCAOO2GT*AJCAO2GT + + + + N + - + - - - - + + + + + + + - + + - 	- 
AJCA003GT*AJCAO3GT - - - + N + - - + - - - + - + - + - + + - + + + + + + 	+ 
AJCAOO4GT*AJCAO4GT + + + + + + + + - - - - - - + + + - - + + + - + + + + 	+ 
ASCTOO1AA*ASCTO1AA + - - - + - - - - + N - - - + - - - + - + - + - + + + 	- 
ASCTOO2AA*ASCTO2AA + N - - + - + + - + N + N - + + - + + - - - - + + - - 	- 
AJCTOO1AA*AJCTO1AA - + + + - + + + + - N + + + - + + + - + - + - + - - - 	+ 
AJCTOO2AA*AJCTO2AA - N + + - + - - + - N - N + - - + - - + + + + - - + + 	+ 
AJCTOO1AT*AJCTO1AT - + + + - + - - + - - - + + - - + - - + + + + - - + + 	+ 
AJCTOO2AT*AJCTO2AT + - + + + + + + N + - - - - - + N + + - + + N N N N N 	N 
AJCT003AT*AJCTO3AT + + - + + + + + - + - - - + + + N + - + - + + + + + - 	- 
ASCTOO1AC*ASCTO1AC + N N N + N - - - + + - - - - - + + - + - + - + - - - 	- 
AJCTOO1AC*AJCTO1AC - N N N - N - - - - - + - + - - - + - - - - - + - + - 	- 
AJCTOO2AC*AJCTO2AC + N N N + N + + - + - + - - + + - - - - + + - + + - - 	+ 
AJCTOO1AG*AJCTO].AG + - - + + + + + + + - - + - + + - - - + + + - - + + + 	- 
ASCTOO1TA*ASCTO].TA - N + - - - + + + - + - N + - + - - - + + + - + - + - 	+ 
ASCTOO2TA*ASCTO2TA - N + - - - + + + - + + N + - + + - - + + + - - - + + 	+ 
AJCTOO1TA*AJCTO].TA - + + + - + + + + - - + + - - + - + + + - + + + - + - 	+ 
AJCTOO2TA*AJCTO2TA - N + + - + + + + - - + N + - + + + + + - + - + - - - 	+ 
AJCT003TA*AJCTO3TA + N - + + + - - - + - + N - + - + + + - - - + - + - + 	- 
AJCTOO4TA*AJCTO4TA + N - + + + - - - + - - N - + - - + + - - - + + + - - 	- 
ASCTOO1TT*ASCTO1TT ------ + + ------ + + + + + + + + + - + - N 	+ 
ASCTOO2TT*ASCTO2TT + - + N - - - - - - + + - + - + - + + N 	- 
ASCT003TT*ASCTO3TT - - - - - - - N + N - - - - - + - - - - + + N 	- 
ASCTOO4TT*ASCTO4TT + - - - - - - + + + + - - + - + + + N 	+ 
AJCTOO1TT*AJCTOITT 	+ + + + + + 	 + + - + - - - + - - - + + N - 
AJCTOO2TT*AJCTO2TT - + + + - + - - + 	 + + 	- + - - + + + + - - + N + 
AJCT003TT*AJCTO3TT 	+ - + + + + + + - + -----+ + + + + + + - - - + N - 
AJCTOO4TT*AJCTO4TT - + + + - + - - + 	+ + 	+ - - + + - + - + + - - N + 
AJCTOO1TC*AJCTO1TC 	+ + + + + + -----+ 	- - + + + + + + + - + + - - 
AJCTOO2TC*AJCTO2TC - - + + - + + + 	+ 	 + + - - - + + + - - + + + + 
AJCT003TC*AJCTO3TC 	+ + + + + + --------+ - + + + + + + + + + + - - 
ASCTOO1TG*ASCTO1TG 	+ - + + + - + + - - + - - + - + - - - + - - + + - - - + 
ASCTOO2TG*ASCTO2TG - - + -----+ - + + + + - - - + + - - + + - + + + + 
ASCT003TG*ASCTO3TG 	+ - - - + - + + + + + + + + - + ----------+ - 
AJCTOO1CA*AJCTO1CA 	- - + + - + + + - + - - - - + + - - - + + + - - - + + + 
ASCTOO1CT*ASCTO1CT 	- - + -----+ - + + + + - - - + +  
ASCTOO2CT*ASCTO2CT - + ------+ - + + + + + -------+ + + - + + 
AJCTOO1CT*AJCTO1CT 	+ + - + + + + + - + - - - - + + + - - + + - - - + - - - 
AJCT 001GT *AJCT01GT 
	
+ + + + + + - - + - - + + + - - + + - - - + + N - - - + 
AS CC 001AA *ASCC01 
AS CC 002 AA *ASCCO2 
AJCC 001AA *AJCCOIAA  
AJCC 002 AA *AJCCO2 
AJCC 003AA *AJCC03J&J 
AJCC 004AA *AJCC04 
AJCC 005AA *AJCCOSAA  
N + + - - - - - - + + 	 + - - - - - N + + +  
AS CC 001AC *ASCCO1AC 	- + -- - - - + - + + + -- - - - + -- - - - - - + + 
ASCCOO2AC*ASCCO2AC + - - - + - - - - + + - - + - - + + - + - + - + - - - 	- 
ASCCOO1AG*ASCCO1AG + - - - + - + + - + + - - + - + + - - + - + - - + + - 	- 
ASCCOO2AG*ASCCO2AG + + - - + - + + - - + - - - + + + - + + + - - + - + - 	- 
AJCCOO1AG*AJCCO].AG - - + + - + - - + - - + + + - - - + - - - + + - - - - 	+ 
AJCCOO2AG*AJCCO2AG - + + + - + + + + - - + + - + + + + + + - + - + - - - 	+ 
ASCCOO1TA*ASCCO1TA ------ + + + + + + - - + + + - - - + + + 	- 
ASCCOO2TA*ASCCO2TA - + -------- + + + - - + + + - - - + + - - - 	+ 
AJCCOO1TA*AJCCO1TA + + + + + + + + + - + + + - - + + + + + + 	- 
AJCCOO2TA*AJCCO2TA + + + + + + + + + + + + - - - + + + - - + + + 	- 
AJCC003TA*AJCCO3TA - + + + + + + + - - - N - - N + + - - - 	N 
AJCCOO4TA*AJCCO4TA - + + + + + ------ + + + - - + - - + + + + - 	- 
ASCCOO1TT*ASCCO1TT - + + ------ + + + - - - - + + + + N + + 	+ 
AJCCOO1TT*AJCCO1TT + - + + + + N N N + N - - + + - + + + - N - - 	- 
AJCCOO2TT*AJCCO2TT + - - + + + + + + + + + - + + + + - + - - + - - 	- 
AJCC003TT*AJCCO3TT + + - + + + + + - + - + - + + + - + 	- 
AJCCOO4TT*AJCCO4TT + + + + + + -------- + - + + + + + + + + + + - 	- 
AJCCOO5TT*AJCCO5TT + - - + + + + + + + + + - + + + + - + ----- + 	- 
ASCCOO1TC*ASCCO1TC + - - - + - - - - + + - - + + - + - - - + - - - + - + 	- 
ASCCOO2TC*ASCCO2TC + + - - + - + + - + + - - - + + + - + + + - - + + + + 	- 
AJCCOO1TC*AJCCO1TC + + - + + + + + - + - - - - + + + - - + + - - + - - - 	- 
ASCCOO1TG*ASCCO1TG + + - - + - + + - + + - - + + + + + + - - N - - + - 	- 
AJCCOO1TG*AJCCO].TG - - + + - + - - + - - + + - + ----- + + N + + - + 	+ 
AJCCOO2TG*AJCCO2TG - + - + - + + + - + - - - + + + + + + + + N - - + + 	+ 
AJCC003TG*AJCCO3TG + - - + + + - - - + - + - - + + - - N - + - + 	- 
(Il 
ASCCOO1CA*ASCCO1CA - - + - - - + + + - N - + - + + + - 	+ 
ASCCOO2CA*ASCCO2CA - + - - - - + + + - N + + + + + + + - - + + + + 	+ 
AJCCOO1CA*AJCCO1CA + + + + + + - - + - N + + + + + - + + + - - - 	+ 
AJCCOO2CA*AJCCO2CA + + + + + + + + + - N + + - + + + + + + + + + + + + - 	+ 
AJCC003CA*AJCCO3CA - - - + - + - - - - N + - - + + + - + - - + + + 	+ 
AJCCOO4CA*AJCCO4CA - + + + - + + + + - N + + - + + + + - + - + + + 	+ 
AJCCOO5CA*AJCCO5CA - - + + - + - - + - N + + - + ----- + + + + 
AJCCOO1CT*AJCCO1CT + - + + + + + + - + N + - - + + - - - - + + - + 
ASCCOO1GA*ASCCO1GA + - - - + - + + + + N - + - + + + - + + + + + - + N + 	+ 
ASCCOO2GA*ASCCO2GA - + - - - - - - + - N + + + + - - - + - + - - + + + + 	+ 
AJCCOO1GA*AJCCO1GA + - + + + + + + + - N + + + - + + + - + + - + - + 
ASCCOO1GT*ASCCO1GT + + + - + - + + + + N - + + - + - + - + + - + + - - - 	- 
AJCGOO1Al*AJCGO1AA + - - + + + - - - + N + N N + - + + + - - N + - + + + 	- 
AJCGOO2AA*AJCGO2AA - + + + - + - - + - N - N N - - + - - + + N N - - + + 	+ 
AJCG003AA.*AJCGO3AA + - - + + + + + - - N - N N + + + - - + + N N N + + - 	- 
ASCGOO1AT*ASCGOI.AT + - - N + - - - - + N - - + + - + - - - + - - - + - + 	- 
ASCGOO2AT*ASCGO2AT - - - N - - + + + - N + + - - + - + + - - + + + - + - 	+ 
AJCGOO1AT*AJCGO1AT - - + + - + - - + - N + + + - - + + - - - + + + - - - 	+ 
AJCGOO2AT*AJCGO2AT + + + N + + - - - N N - - - + - + + + + + + + + + + - 	- 
AJCGOO1AG*AJCGO1AG N N + + - + - - + - - - N + - - + - - + + N + - N + + 	+ 
ASC0001TA*ASCGO1TA ------ + + + + N + + + - + - - - - - - - - - - + 	+ 
ASCGOO2TA*ASCGO2TA + + + - + - - - - + N + - - + - + + + - - - - + + + - 	+ 
AJCGOO1TA*AJCGO1TA + + + + + + + + + + N + + + + + + + + + + + + + + + + 	+ 
AJCGOO2TA*AJCGO2TA + - + + + + + + - + N - - - - + + + - - - + - 
AJCG003TA*AJCGO3TA - - + + - + + + - + N - - - + + + - - + + + 
AJCGOO4TA*AJCGO4TA + - - + + + + + + - N + + + - + - + + + + + + - - - + 	- 
ASCGOO1TT*ASCGO1TT - - - - - - + + + - N + + - N + - + + - - + 
AJCGOO1TT*AJCGO1TT - - + + - + + + - + N + - - N + + - - + - - 
AJCGOO2TT*AJCGO2TT - + - + - + + + - + N - - + N + + + + + + + + - - + + 	+ 
ASCGOO1TC*ASCGO1TC - + + ----- + + + + + + - - - + + - - + 
AJCGOO1TC*AJCGO1TC + - - + + + + + ------ + + + - - + + - 
ASCGOO1TG*ASCCO1TG N - - - N + + + - N + - - - + + N + + + + + + - + - - 	+ 
AJCGOO1TG*AJCGO1TG + + + + N + + + + N - + + + - + N + + + - + 
AJCGOO1CA*AJCGO1CA - + + + - + + + + - + - - + - - + - + + + + + 	+ 
AJCGOO1CT*AJCGO1CA - - - + - + ----- + - + + - + - + - - + 
ASCGOO1GT*ASCGO1GT + - - - N - - - - + + - - - - - + + - + - N 
AJCGOO1GT*AJCGO1GT - + + + N + + + + - - + + + + + - - + - + N 
AJGAOO1AA*AJGAO1AA - + - + - + - - - + - + - - + - + + + - + + 
AJGAOO2AA*AJGAO2AA + - - + + + - - - + - + - + - - - + + - N + + + + + + 	- 
ASGAOO1AT*ASGAO1AT - - - - - - + + - + + N + + + - + + + + 
ASGAOO2AT*ASGAO2AT - + + - - - + + + N ----- + + - - + + + 
AJGAOO1AT*AJGAO1AT - - + + - + + + - + + + + + - + - + ------ 
AJGAOO2AT*AJGAO2AT + - + + + + + + - + + N + + N - - - + + - + - - - 	+ 
AJGA003AT*AJGAO3AT + + - - + + - + + + + + + + + - - - + - + 
ASGAOO1AC*ASGAO1AC + + - - + - + + - + + - - + + + + + + - + - 	- 
ASGAOO2AC*ASGAO2AC - - + - - - + + + - + + + + + + + + + - - - + + 	+ 
ASGA003AC*ASGAO3AC + + - - + - + + - N N N N + + + + + - + - - + + - 	- 
AJGAOO1AC*AJGAO1AC - - + + - + - - + N N N N - + + + - + + - - + 	+ 
AJGAOO2AC*AJGAO2AC - - + + - + - - + - - + + - + -- - - - + + + + + - + 	+ 
AJGA003AC*AI]'GAO3AC - - + + - + + + - + - - - - + + + + + + + - - - + - 	+ 
ASGAOO1AG*ASGAO1AG + - + + + + + - - + - + + - + + - + - - - + - 	- 
ASGAOO2AG*ASGAO2AG - + + -- - - - + + + + + + - - - + + - - + + + - + + 	+ 
AJGAOO1AG*AJGAO1AG - + + + + + + + - + - - + - - + - + + + - + 	4- 
AJGAOO2AG*AJGAO2AG + - + + + + + + - + - - - + - - - + + + + - + 	- 
AJGA003AG*AJGAO3AG - - + + -- - - - + - - + - + - + - - + - - + + + 	+ 
ASGAOO1TA*ASGAO1TA - - - - - - - - + + + + + - + - - + - + + - - + - 	- 
ASGAOO2TA*ASGAO2TA - + - - - - + + + + + + + + - + + + - - - + - 	+ 
AJGAOO1TA*AJGAO1TA - + - + + + + + - + + + + + + - + + N 
AJGAOO2TA*AJGAO2TA + - + + + + + + - + -- - - - + + + + - + + ------ 
ASGAOO1TT*ASGAO1TT + N N N + N N + + + + N + + N + + - - + + + + N + + + 	+ 
AJGAOO1TT*AJGAO1TT - - - + - + -- - - - + - + + - + - + - - + - - + + + 	+ 
AJGAOO2TT*AJGAO2TT + + + + + + -- - - - + - - - - + + + + + + + - + + - 	- 
ASGAOO1TC*ASGAO1TC + + + - + - + + + + + - + - - + - + - + + - N + - - - 	- 
AJGAOO1TG*AJGAO1TG + + + + + + + + - + - + - - - + - + + - + - - + + - + 	+ 
ASGAOO1CA*ASGAO].CA + + + + + + + + + - + + - + - + - + + - + + - - - 	- 
ASGAOO2CA*ASGAO2CA - + + -- - - - - - + + - + - - + + + + - - + + - - - 	N 
ASGA003CA*ASGAO3CA - + + + + + - + - + + + - + + + - - - - + - 	+ 
AJGAOO1CA*AJGAO1CA - - + + -- - - - + - - + - + - + - - + - - + + + 	+ 
AJGAOO2CA*AJGAO2CA - - - + - +  
ASGAOO1CT*ASGAO1CT 	- - - - - - - - - + + - - + - - - - + --------- 
AJGAOO1CT*AJGAO1CT + + + + + + + + - + - + - - - + - + + 	+ 	- +  
AJGAOO2CT*AJGAO2CT 	+ - + + + + - - - + - + - + - - - + - - - + + +  
ASGAOO1GA*ASGAO1GA 	- - - - - - - - + - + - + + + - + - - + - + + - - + - - 
ASGAOO2GA*ASGAO2GA + - - - + - - - - + + -------+ - + - +  
AJGAOO1GA*AJGAO1GA 	+ - + + + + - - - + - - - + - - + + - + - + ------ 
AJGAOO1GT*AJGAO1GT 	- - + + - + - - + + - + + + - - - + - - - + + - + - + + 
AJGAOO2GT*AJGAO2GT - - + + - + + + - + - - - - + + - + + + + + -  
00 
ASGT 001AA *ASGTOlAA  
ASGT 002 AA *ASGT02 
ASGT 003AA *ASGT03AA  
ASGT 004 AA *ASGT04AA  
ASGT 005A *ASGT05 
ASGT 006AP *ASGT06 
AJGT 001AA *AJGTOlAA  
AJ GT 002 AA *AJGTO 2AA 
AJGT 003AA *AJGT03AA  
AJGT 004AA *AJGT04AA  
AJGT 005AA *AJGTOSAA  
AJGT 006 AP *AJGT06 
- + + 	 + + + 	N 	N N - + - - - + + + 	+  
+ - 	+ 	 + N + - - + - - + - + - - - - - -  
+ + + + + N N N N N N - + + - - 	+ + - - - - 
+ - 	+ + + + + 	 N 	+ + + - - + + 	N  
+ + 	+ + + + + + 	 + + + - + - + + + + + + - - - + - 
ASGTOO1AT*ASGTO].AT 	- + 	 + + + - + - + - + + + - + + + - - - -  
ASGTOO2AT*ASGTO2AT - + + - - - - - + + + + + + - - - + + - - + + +  
ASGT003AT*ASGTO3AT 	- + + 	 + + + - + - + + - + + - + + + + - +  
ASGTOO4AT*ASGTO4AT - + ------+ - + - + + - - + + + + - - + -  
ASGTOO5AT*ASGTO5AT + - + + - - - + - + - + + + - 	+ 
ASGTOO6AT*ASGTO6AT + + + + + - + - + + + + 
ASGTOO7AT*ASGTO7AT ------ + + - + + - - - + + 
ASGTOO8AT*ASGTO8AT + + + + - + + + + - + 
AJGTOO1AT*AJGTO1AT + + + + + - - - + - + - + 
AJGTOO2AT*AJGTO2AT + + + + + + + - + - + - - + + 
AJGT003AT*AJGTO3AT + + + + + + + - - + + + - + 
ASGTOO1AC*ASGTO1AC - + ------ + + + + + + 
ASGTOO2AC*ASGTO2AC + + + - + - + + - + + + - + - + 
AJGTOO1AC*AJGTO1AC + + + + + + ----- + - - - - 
ASGTOO1AG*ASGTO1AG + + + - - + - - - + N 
ASGTOO2AG*ASGTO2AG - - - - - - - - + - + - + + + N 
ASGT003AG*ASGTO3AG + + + + + + + - + + + N 
AJGTOO1AG*AJGTO1AG + + + + - + - + - - + N - 
AJGTOO2AG*AJGTO2AG + + + + - - + + + - N - 
AJGT003AG*AJGTO3AG + + + + + + + - + - + - - + N - 
ASGTOO1TA*ASGTO1TA + + + + + - - + - - - + + 
ASGTOO2TA*ASGTO2TA - + - - - - - - + - + - + + N - 
ASGT003TA*ASGTO3TA - + + + + + - + - + + - + 
AJGTOO1TA*AJGTO1TA - + + + + + + + - - + + + - + 
AJGTOO2TA*AJGTO2TA + + + + + - + - - - - + 
AJGT003TA*AJGTO3TA + + + + + - + - - - + 
ASGTOO1TT*ASGTO1TT - + + ----- + + + + + + 
AJGTOO1TC*AJGTO].TC - - - + - + - - + - - - + - + 
ASGTOO1TG*ASGTO].TG - 
ASGTOO2TG*ASGTO2TG + 	- 	- 	- 	+ 	- 	+ 	+ 	+ + 	+ 	- + + 	+ 	+ 	+ 	- 	+ 	+ 	+ 	+ 	+ 	- 	+ - 	+ 	+ 
ASGT003TG*ASGTO3TG + 	+ 	- 	-  
AJGTOO1TG*AJGTO1TG + 
AJGTOO2TG*AJGTO2TG - 
ASACO61TT*ASAC61TT - 	- 	- 	- 	- 	- 	+ 	+ 	+ + 	+ 	+ + + 	- 	+ 	- 	- 	- 	- 	- 	- 	- 	- 	- - 	+ 	- 
C 
APPENDIX 3: Unassigned Linkage Groups 
Group A 
40 Markers 









ASGT01TG AJAA01TA ASCA01CA 
11.8 
AJTTO1TC ASCT02CT AJCT03TT 
5.0 
AJCT02AT AJCA02CA AJGA02TA 
8.8 




AJCC01TF AJCC04AA AJCC04AA ASCCO2CA 
7.5 
AJTF01GT ASTF04CA AJGA01GA AJGT03TA ASTT01AT 
4.4 












Total size: 80.2 cM 






AS GAOl AT 
3.9 
AJACO1AT AJTF07AA ASAA03CT AJAC01AG ASAT11AA 
















Total Size: 234 cM 




ASGAO1TA ASACO1TT AJTTO1TG 








Total Size: 47 cM 




AJCT04TT ASCC01AG AJTG03AT ASAT08AA 
11.3 
AJAC04TA ASAC01GA AJGA01AG ASGA01AG ASAT09AA 
4.2 




AJT03CT AJGA02AC AJAG02AC ASTA02TA ASGA01AC 
ASCC01TG AJCC01TG 
12.8 




Total Size: 15.5cM 
ASTAO3AA 
4.0 









Total Size: 74.5 cM 
4.4 	
IAJTGOlTr  
 AJCGO1 AC 
8.1  
ASTG01U ASAT04AC AJAT03AC 
ASTFO1CT AJCG02AA AJCT02AA ASCT02AA 






















Total Size: 92.7 cM 
AJCAO1TF 
4.6 
ASGA02CA AJAT03TA AJCT01AG ASTCO2TC 
4.2 
ASTC01GT ASAA04TC AJTCO2GT ASAA01GA AJCCO2TA ASCCO2TA 
4.2 AJAT01AC AJTCO2TA AJAT02AA AJAA01GT 
ASTF02TA 
3.9 








AJCA01TG AJCA01AT ASCA02CT ASAA03TC ASAA01GC AJAT01TG 
3.9 








AJATO1CT ASGT02TA AJGT03AG ASAC01CT ASTT05AA AJTT06AA 
4.2 AJTGO1CT ASTG02CT 
AJCT02AC 
4.4 
AJCCO1CT AJGT02AT AJAG03AT ASGT04AT AJGA02AT 
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APPENDIX 4: Publications and conference abstracts 
Publications 
Grech K, Martinelli A, Pathirana S, Walliker D, Hunt P, and Carter R (2002). 
Numerous, robust genetic markers for Plasmodium chabaudi by the method of 
amplified fragment length polymorphism. Mol. Biochem. Parasitol., 123: 95-104. 
Conference abstracts 
Scottish Universities Molecular Parasitology Group Seminar Meeting, 
Kindrogan, Scotland, May 2001. 
Poster presentation: Identification of alternative alleles of fragments generated by 
amplified fragment length polymorphism in P. chabaudi. 
British Society for Parasitology Meeting, University of Leeds, England, 10th_12th 
September 2001. 
Poster presentation: The identification of loci linked to genes determining antigenic 
selection using Amplified Fragment Length Polymorphisms (AFLP) in Plasmodium 
chabaudi. 
Axel Martinelli, Katrina Grech, David Walliker, Paul Hunt, and Richard Carter 
Scottish Universities Molecular Parasitology Group Seminar Meeting, 
Kindrogan, Scotland, May 2002. 
Oral presentation: Proportional AFLP and its application in immune and genetic 
studies of Plasmodium chabaudi chabaudi. 
Axel Martinelli, Paul Hunt and Richard Carter 
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bstract 
We have used the method of amplified fragment length polymorphism (AFLP) to identify genetic polymorphisms between two 
oned isolates of the rodent malaria parasite Plasmodium chabaudi chabaudi. The method employs polymerase chain reaction 
CR)-amplification of genomic DNA fragments cut with specific combinations of restriction endonucleases; we used Eco RI and 
ru 11 (isoschizomer of Mse I). We have identified 819 parasite clone-specific AFLPs between P. c. chabaudi clones AS and AJ. Of 
Lese, 403 fragments were specific to AS and 416 to AJ. In preparing blood stage parasites for DNA, nucleated host cells were 
moved by successive filtration of infected blood through powdered cellulose and Plasmodipur TM filters. This reduced nucleated 
)st cell contamination to around 1-10 per million parasite nuclei and reduced host DNA to below the limit of detection by the 
FLP method. Analysis of our results showed that the total number of PCR-amplified fragments of parasite DNA was consistent 
ith the predicted number ofEcoRl sites in the parasite genome. 19.4% of all amplified fragments were P. c. chabaudi clone-specific. 
rom this figure we estimated that the diversity between clones AS and AJ, measured as the probability of a sequence difference, 
as between about 8 x 10 -3 and 4.6 x 10" per base pair. This is consistent with the sequence diversity found between alleles of 
indidate drug resistance genes from P. c. chabaudi clones AS and AJ identified and sequenced in this laboratory. (0 2002 Elsevier 
ience B.V. All rights reserved. 
ywords: Malaria; Genetic markers; Amplified fragment length polymorphism; Plasmodium chabaudi chabaudi 
Introduction 
Previous investigations on malaria parasites have 
)mbined classical and molecular genetic methods to 
Abbreviations: AFLP, amplified fragment length polymorphism; 
APD, random amplified polymorphic DNA; APAD, anchored 
imer amplification of DNA; RBC, red blood cell; SDS, sodium 
decyl sulphate; DNA, deoxyribonucleic acid; TE, Tris—EDTA 
iffer; EDTA, ethylenediaminetetraacetic acid; PBS, phosphate 
iffered saline; PCR, polymerase chain reaction; ATP, adenosine 
phosphate. 
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search for genes which determine specific phenotypes 
e.g. chloroquine resistance in Plasmodium falciparum 
[1,2] and Plasmodium chabaudi chabaudi [3], and malaria 
gametogenesis in P. falciparum [4]. Genetic studies on 
malaria parasites are now entering the 'post genomic' 
era [5] in which bioinformatic approaches will be widely 
applied to look, for example, for orthologues of genes of 
known function in different organisms. This approach 
will be of little value, however, in identifying genes 
which underlie genetically undefined, organism-specific, 
and often biologically complex, phenotypes. Here clas-
sical genetics will remain an essential tool. Using genetic 
crosses between parents of distinct phenotypes (e.g. 
growth rates, drug sensitivity), genes which underlie a 
particular phenotype can be traced among the cross 
progeny by the analysis of large numbers of genome-
wide genetic markers. Those markers which follow the 
expression of a phenotype in the recombinant progeny 
66-6851/02/$ - see front matter © 2002 Elsevier Science B.V. All rights reserved. 
1:50166-6851(02)00142-1 
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will usually be closely linked to the genes which 
determine its expression. 
In previous genetic studies on the human malaria 
parasite P. falciparum, around three hundred micro-
satellite markers have been utilised in the analysis of a 
cross[1,6]. However, genetic studies with human malaria 
parasites present major practical difficulties. As an 
alternative the rodent malaria parasite P. c. chabaudi 
has many advantages for genetic work; it is easily 
maintained in the laboratory and important phenotypes 
such as strain-specific antigenicity, growth rate differ-
ences and drug resistance are available for study [7-9]. 
So far, however, only about 50 RFLP markers have 
been identified in this parasite [3]. It is of obvious benefit 
to genetic linkage studies to increase the number of 
available markers. 
In addition to microsatellite markers [6], large num-
bers of genetics markers have been generated for 
Plasmodium species by polymerase chain reaction 
(PCR)-based methods. These include RAPDs [10] and 
APADs [11]. Both methods amplify DNA using ran-
domly, or semi-randomly, designed primers for PCR. 
Both methods generate large numbers of markers but 
may lack the degree of reproducibility required for 
accurate genetic analysis. Here we have investigated the 
method of amplified fragment length polymorphism 
(AFLP) [12,13] as a means of generating large numbers 
of reliable genetic markers between cloned isolates of P. 
c. chabaudi. 
The AFLP method has been used successfully in 
detailed genetic analysis of the protozoan haemoflagel-
late parasite Trypanosoma brucei [13,14] and the api-
complexan parasite of chickens, Eimeria tenella [15] and 
to type different isolates of the human malaria parasite 
P. falciparum [16]. It has yet to be applied to genetic 
studies on malaria parasites. The method is based upon 
PCR-amplification of DNA cut with pairs of restriction 
endonucleases. Each pair of enzymes can provide 
material for the identification of several hundred genetic 
markers between any two genetically unrelated parasite 
clones from within a parasite species ([13-15], and 
present results). Since there are at least half a dozen 
different restriction endonuclease pairs that can be used 
for AFLP, there is the potential to identify several 
thousand genetic markers between any two unrelated 
clones of parasite. This number of markers would allow 
high density gene mapping within a genome the size of 
that of Plasmodium spp. of about 2.5 x I0 7 base pairs. 
Three thousand markers, for example, would cover the 
genome at intervals of, on average, 10 kilo base pairs. In 
a first sweep of the genomes of two distinct cloned 
isolates of P. c. chabaudi using a single pair of restriction 
endonucleases, EcoRI and Trull (isoschizomer of 
MseI), we have identified approximately 800 AFLP 
markers.  
2. Materials and methods 
2.1. Parasite material and preparation of DNA 
Cloned lines of P. c. chabaudi 'isolates' AS and A 
were used as the source of parasite DNA in this studs 
AS and AJ are independent parasite isolates from wild 
caught Thamnomys rutilans (thicket rats) captured ii 
1969 near the town of Bangui in the Central Africaj 
Republic, grown subsequently by passage in laborator 
mice at the University of Edinburgh and stored a 
frozen stabilates in liquid nitrogen [17]. 
For the present work, the parasites were grown a 
blood infections in 5-8 week old, inbred female CBI 
mice. Parasites were harvested and prepared for isola 
tion of pure parasite DNA as follows. Whole bloo 
from 5 mice per preparation, was collected unde 
general anaesthesia by exsanguination from the brachia  
vessels into physiological citrate saline (0.9% NaG 
1.5% tri sodium citrate dihydrate, adjusted to pH 7.2 
when parasitaemias exceeded 20% but before the 
reached 60%. White blood cells were removed by firs 
filtering 5 ml of blood cell suspension (20% v/v packe 
blood cells in citrate saline) successively through two 2 
ml columns of moderately packed cellulose powde 
(CFI 1, Sigma). Red blood cells were washed throug] 
with additional citrate saline, the final volume collecte 
being about 40 ml. To remove any remaining contain 
mating nucleated host cells, the filtered blood was the 
passed successively through two Plasmodipur TM filter 
(Euro-Diagnostica). This process reduced the number o 
contaminating white blood cells in a preparation b 
more than 1000-fold and to the order of 1-10 whit 
blood cells per 106  parasite nuclei. 
Parasites were released from their host RBCs b: 
saponin lysis as follows. Packed cells were resuspende 
in 0.5 volumes of 0.15% saponin (Sigma) in phosphat 
buffered saline, pH 7.5 (PBS) and agitated for 1-2 mu 
until the suspension became a clear red colour. Th 
suspension was then diluted with at least 20 volumes o 
PBS and the released parasites were pelleted by cen 
trifugation [18]. 
For extraction of DNA the released parasites wer 
resuspended in cell lysis solution (10 mM Iris pH 8.0, Si 
mM EDTA, 0.01% SDS, I mg/ml Proteinase K) am 
incubated at 37 °C overnight. DNA was extracted wit] 
several rounds of phenol chloroform treatment [19] am 
precipitated from the final aqueous supernatant by th 
addition of 0.1 volumes of 3 M sodium acetate (pH 5.2 
followed by 2 volumes of ice-cold absolute ethanol. Th 
DNA was then pelleted at high speed on a microfugc 
washed in 70% ethanol and resuspended in TE buffe 
(10 mM Iris—Cl, 1 mM EDTA, pH 8.0). RNA wa 
removed by RNAse treatment. The DNA was quanti 
fled by spectrophotometry. 
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The AFLP method 
The AFLP method was carried out according to the 
nethod of Vos et al. [121 with slight modifications, as 
ollows. Five hundred nanogram of target DNA from P. 
chabaudi AS or AJ, prepared as described above, was 
Jigested with 10 U EcoRI at 37 °C for 1 h and 
;ubsequently with 5 U Trull (MseI isoschizomer) at 
55 °C for 3 h, in a 40 l.tl reaction using the supplier's 
reaction buffer (both enzymes from MBI Fermentas). 
Pre-annealed, restriction site-specific double stranded 
DNA adapters (5'-GACGATGAGTCCTGAG-3' and 
3'-TACTCAGGACTCAT-5' (MseI site-specific adap-
ter) and 5'-CTCGTAGACTGCGTACC-3' and 3'-
CATCTGACGCATGGTTAA-5' (Eco RI site-specific 
adapter) (all primers from MWG Biotech) were ligated 
to the cut DNA for 3 h at 37 °C and overnight at 15 °C 
as follows. Five picomoles of the Eco RI-specific adap-
ter, 50 pmoles of the Mse I-specific adapter, 25 nmoles 
ITP and 5 U of T4 DNA ligase (Promega) were added 
to the digestion mixture and the final volume adjusted to 
50 j.tl with water. For subsequent PCR, this DNA was 
diluted to 1 ng/tl. 
PCR primer sequences (MWG Biotech) were as 
described by Vos et al. [12] and complement the 
synthetic adapters at either the MseI (primer sequence, 
5'-GATGAGTCCTGAGTAA-3') or the EcoRI (primer 
sequence, 5'-GACTGCGTACCAATTC-3') sites ('non-
selective' primers). These primers were used to pre-
amplify the cut and ligated target DNA in 20 Ill PCR 
reactions containing 1 ng of the cut and ligated target 
DNA, and 0.5 U Taq polymerase (Promega) in PCR 
buffer (Promega) containing 1.5 mM MgCl 2, 2 mM of 
all 4 dNTPs (Boehringer) and 0.32 j.tM of each of the 
above 'non-selective' PCR primers. The following PCR 
programme was used: 94 °C for 60 s conducted once, 
followed by 94 °C for 30 s, 56 °C for 60 s, 65 °C for 60 
s, repeated for 20 cycles. This pre-amplified PCR 
material was diluted 50-fold in TE buffer and stored 
at —20 °C. Sub-sets of amplified fragments were then 
further (selectively) amplified from this material using 
adapter-specific 'selective' primers. The 'selective' pri-
mers were of the same sequence as the 'non-selective' 
PCR primers but with the addition of two 'selective' 
bases at the 3' end (Fig. 1). The EcoRI selective primers 
were end-labelled with 33P in 20 j.tl of polynucleotide 
kinase Buffer A (Promega) with 10 U T4 polynucleotide 
kinase (Promega) and 100 RCi [7-33P] ATP (ICN) and 
incubated at 37 °C for at least 1 h. The reaction was 
stopped by adding I j.tl of 0.1 M EDTA pH 8.0 and 
heated at 70 °C for 10 mm. The volume was adjusted to 
50 jil with water and unincorporated [y-33P] ATP was 
removed using G-25 spin columns (TE Micro Select-D, 
Eppendorf-5 Prime Inc.). The 'selective' PCR amplifica-
tions were performed in 20 p.1 PCR reactions containing 
I p.1 of the pre-amplified material and 0.5 U Taq 
' S 
- Genomic P.chabaudi DNA 
Restriction digestion of 
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Fig.  1. Schematic representation of the method of AFLP for genomic 
DNA cut with restriction endonucleases EcoRI and MseI. E and M 
indicate ends cut with EcoRI and MseI, respectively. AC, TG and GT 
in the lower part of the schema are representative 'selective' bases 
added at the 3' end of the primer specific to Eco RI sites; GA, AT and 
CA are representative selective bases added to the primer specific to 
MseI sites (arbitrarily chosen examples). 
polymerase (Promega) in PCR buffer (Promega) con-
taining 2.5 MM  MgC1 2, 2 mM of all 4 dNTPs 
(Boehringer), 0.32 p.M of the selective MseI PCR 
primers and 0.05 p.M of the labelled selective EcoRI 
primer. The following PCR programme was used: 
94 °C for 60 s conducted once, followed by 94 °C for 
30 s, 65 °C for 60 s (reduced by 0.7 °C per cycle) and 
65 °C for 60 s repeated for 12 cycles, followed by 94 °C 
for 30 s, 56 °C for 60 s and 65 °C for 60 s, repeated for 
23 cycles. 
Ten microlitre of 3 x sequencing gel loading buffer 
(Anachem) was added to each 20 p.1 AFLP reaction 
prior to denaturation at 99 °C for 5 min and cooling on 
ice. Five microlitre of each denatured sample was loaded 
onto a pre-warmed, 6% acrylamide gel (Gene Page, 
Anachem) cast in a SequiGen 38 x 50 cm  sequencing 
cell system (Biorad). Electrophoresis was performed at a 
constant power of 110 W after which the gel was 
transfered to 3 mm Whatman paper, dried on a gel 
drier for 2 h and exposed to MXB Kodak film (GRI) at 
—70 °C for 48h. 
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2.3. Estimation of sequence diversity from AFLP data 
The Dice index (SD) [20] was used as a measure of 
the genetic similarity between the genomes of cloned 
strains AS and AJ, where 
SDXY = 	+ (A/2) 	 (1) 
in which n j, is the number of fragments common to 
both strains (AS and AJ) and L, is the number of 
fragments found only in AS or only in AJ. 
This index may be used to estimate the sequence 
diversity [20,21]. Polymorphic bands occur in two ways; 
firstly, by sequence differences in either a restriction 
enzyme site, EcoRI and MseI, or at positions repre-
sented by the selective bases or, secondly, by insertions 
or deletions in an amplified fragment. For the former, 
the probability of sequence difference at a given position 
between the two strains is given by 
d = I - (SD ,,
,)Ilr 	 (2) 
where r =the number of identical bases required for a 
common AFLP band ( = 6 +4+4 = 14, in this case) [21]. 
For the latter (inserts and deletions), to a first 
approximation, the probability of differences in se-
quence is given by 
d = ( 1 - SD XY)/n 	 (3) 
where n = the average size of a fragment in base pairs. 
3. Results 
Using genomic DNA prepared from blood stage 
parasites and restricted with the enzymes Eco RI and 
Tru 11 (MseI isoschizomer), we have applied the AFLP 
method to identify molecular genetic markers that 
differentiate P. c. chabaudi clones AS and AJ. Fig. 2a 
shows a typical AFLP gel using two combinations of 
PCR primers. The clone-specific (genetically poly-
morphic) bands and their corresponding identification 
codes are indicated. Fig. 2b shows a representative 
AFLP pattern in 12 cloned products of a genetic cross 
between P. c. chabaudi AS and AJ. It demonstrates the 
reliability of the AFLP's as reproducible genetic mar-
kers which recombine with each other in the progeny of 
a genetic cross. 
The AFLP bands which we have identified in this 
study as genetic markers of either AS or AJ are robust in 
that both their presence and their general intensities 
were conserved during repeat amplifications. Thus, 
when DNA was prepared from parasites collected 
from more than one set of infected mice, the same 
clone-specific AFLP bands were identified in all pre-
parations of the same clone, i.e. AS or AJ. These bands 
did not, therefore, arise as a result of any form of  
uncontrolled irreproducibility such as, for example, 
varying amounts of contamination with mouse DNA. 
However, in making a final selection of 'robust' 
markers, some clone-specific bands were rejected be-
cause of their low or variable intensity between different 
AFLP reactions or because of other difficulties in their 
use, e.g. proximity to other bands or smearing. 
Using 181 different pair-wise combinations of selec-
tive bases, we have identified 819 P. c. chabaudi clone-
specific AFLP markers-403 for clone AS and 416 for 
clone AJ. Table 1 shows the distribution of markers 
obtained from each of the different possible combina-
tions of the two selective primers. The mean numbers of 
AFLPs (genetic markers) obtained for AS and AJ 
according to the first and second selective base positions 
in the PCR primers, are shown in Table 2. Those 
primers containing an A or a T at the first or second 
selective base in both of the 'selective' primers revealed 
about one and one half times as many markers as those 
containing a C or a G at these positions. This propor-
tion was similar for both AS and AJ and presumably 
reflects the AT-rich composition of the P. c. chabaudi 
genome. Thus, in mining the P. c. chabaudi genome for 
genetic markers by the AFLP method, PCR primers 
with A's and T's at the selective bases are likely to be 
significantly more productive than those with C's and 
G's. 
In order to estimate the genetic similarity between 
clones AS and AJ (Section 2.3), we counted the total 
numbers of amplified bands generated for each of 42 
randomly chosen combinations of 'selective' primers, 
and also the number of amplified fragments which were 
unique (AFLPs) either to AS or to AJ (Table 3). The 
total number of amplified bands counted for these 
randomly chosen 'selective' primer combinations was 
1046. Of these 203 (19.4%) were unique to AS or AJ, i.e. 
they were clone-specific AFLPs. In addition we se-
quenced a small sample of representative amplified 
bands (data not shown), and from these we estimated 
the average length of the AFLP bands to be about 230 
base pairs. 
Using the above values, we calculated the genetic 
similarity between the two clones AS and AJ, as given 
by the Dice index (SD) ), to be 0.893 (Eq. (1)). This 
allowed us to estimate, to a first approximation, the 
probability of sequence difference arising at a given base 
position for either of the two following situations (i) all 
AFLP bands arose by nucleotide substitution at posi-
tions in the restriction sites or positions represented by a 
selective base position (Eq. (2)), or (ii) all AFLP bands 
arose by insertion or deletion events (Eq. (3)). These 
values are 8 x 10 -3 and 4.6 x 10, per base pair, 
respectively. 
The absolute number of amplified bands generated 
with the different primer combinations, was greatest for 
AT-rich 'selective' primers (Table 2). In contrast, the 




______ MseI selective bases used 
AS AJ AS AJ 4 	
P.c.chabaudi clones 
. - 
AS AT 001 TC 	 ( 	) 
AJATOO1TC 
AJATOO2TC  
AS AT 002 TC 
AS AT 001 TG 
AJ AT 001 TG 
AS AT 002 TG 
AS AT 003 TG 
AJ AT 002 TG 
A.J AT 003 TG 
AS AT 003 TC 
c• 
AS AT 004 TG 
AJ AT 004 TG 
AS AT 004 TC 	 10 	 C 	 AJ AT 005 TG 
(a) 
ig. 2. (a) Two AFLP primer combinations used to amplify DNA from P. c. chahaudi clones AS and AJ. A single EcoRl site-specific PCR primer 
vith selective bases A and T at its 3' end, and two Msel site-specific PCR primers with selective bases T and C or T and G at their 3' ends are 
epresented. AFLP markers which distinguish clones AS and AJ are indicated by arrows linked to the names given to the clone-specific markers. The 
irst two letters, in bold, identify the clone to which a marker is specific, the next two letters indicate the EcoRI primer selective bases, the numbers 
dentify the marker for that clone and primer combination in order of its molecular size, and the last two letters identify the Msel selective bases. (b) 
n AFLP gel obtained from the amplification of 12 progeny clones (indicated with the numbers 1-12) of a genetic cross between parental clones AS 
tnd AJ [3]. The amplifications were conducted with the Eco RI site-specific PCR primer with selective bases A and T at its 3' end, and the Mse I site-
pecific PCR primer with selective bases T and C at its 3' end. The 12 progeny clones show recombination between AS and AJ markers. Note that 
narkers [AS AT 002 TC] and [AJ AT 002 TC] appear to be allelic, i.e. alternative markers of AS or AJ at the same gene locus. The non-polymorphic 
and pattern remains the same throughout all the recombinant clones and the parental clones AS and AJ (cf a). 
)roportion of amplified bands which were clone-specific 
AFLPs) was not significantly affected by the base 
omposition, i.e. A, T, C or G, at the selective base 
)OSitiOnS in the 'selective' primers. This proportion 
'aried between 16.8 and 22.2% (Table 3). 
4. Discussion 
Our results show that large numbers of robust genetic 
markers may be efficiently generated in the rodent 
malaria P. c. chabaudi by the method of AFLP [12]. A 
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Fig. 2 (Continued) 
single pair of restriction enzymes, EcoRl and Trull 
(MseI), generated over 800 such markers specific to one 
or other of the two P. c. chabaudi clones, AS and AJ 
(Table 1). The markers were evenly distributed between 
the two clones. Some of these clone-specific AFLP 
markers may prove to be allele pairs, i.e. polymorphic 
at the same genetic locus (Fig. 2b). Thus the total 
number of polymorphic loci represented in this sweep of 
AS and AJ will be less than 819, but may be consider-
ably more than the approximately 400 AFLP bands by 
which each clone was characterised. We chose to use a 
total of four selective base positions in designing the 
PCR primers for the amplification reactions (two 
positions following the EcoRI site and two following 
the MseI site). This number of selective base positions 
represents a compromise between the generation of a 
larger absolute number of genetic markers when a larger 
number of primer combinations are used, and the fact 
that the number of AFLP bands generated per primer 
combination decreases as the number of selective bases 
involved increases. In other words, for the cost and time 
expended, there is a diminishing return of usable genetic 
markers as the number of primer specific selective base 
positions is increased. Additional genetic markers will, 
however, be readily identified by exploiting at least 6 
other pairs of commercially available restriction endo-
nucleases suitable for use in the AFLP reactions. 
To ensure that the amplified fragments which we 
identified were not the result of contaminating mouse 
DNA, particular attention was paid to the removal of 
nucleated host cells during the preparation of the 
parasites. This was done by a succession of cell 
filtrations as described in Section 2. We believe that 
we were successful in avoiding the appearance of 
amplified host DNA fragments among our results for 
the following reasons. One is that different preparations 
of DNA of the same parasite clone, either AS or AJ, 
made from samples of infected blood from different 
mice were consistent in revealing the same clone-specific 
AFLP bands. The bands were, therefore, determined by 
Table I 
The number of AFLP markers identified in P. c. chabaudi clones AS and AJ using EcoRl and MseI site-specific PRC primer combinations having two selective bases each 
Selective bases at MseI primer 
AA 	AT 	AC 	AG TA TT TC TG CA CT CC CG GA GT GC GG 
Total 
AS 
Selective bases at EcoRl primer 
AA 5 3 7 3 3 ND 3 3 5 5 1 5 2 2 ND ND 47 
AT 5 3 4 6 2 ND 4 4 4 2 ND ND 4 ND ND ND 38 
AC 4 3 0 2 2 3 0 1 0 ND ND ND 2 1 ND ND 18 
AG 2 3 1 2 1 I 0 1 3 ND 0 1 2 0 0 2 19 
TA 4 2 2 ND 6 4 1 0 3 2 ND ND ND 3 ND ND 27 
TT 3 4 4 2 ND ND 1 1 4 0 ND ND ND 0 ND ND 19 
TC 3 1 2 0 1 3 3 0 2 I ND ND I I ND ND 18 
TG 6 2 0 4 2 5 2 1 3 2 ND ND 2 1 ND ND 30 
CA 1 4 1 3 4 4 0 2 1 ND ND ND 2 2 ND ND 24 
CT 5 2 2 0 4 5 1 4 2 ND ND ND 1 0 ND ND 26 
CC 2 ND 3 3 2 1 2 1 2 0 ND ND 3 2 ND ND 21 
CO 0 3 0 1 3 1 1 1 0 3 ND ND 0 2 ND ND IS 
GA 9 4 5 2 2 1 1 0 4 ND ND ND 2 0 ND ND 30 
GT 5 2 2 7 5 3 0 4 ND 3 ND ND 1 0 ND ND 32 
GC 6 3 2 0 3 1 1 2 0 6 ND ND ND 2 ND ND 26 
GO 3 3 2 1 1 0 0 0 2 1 ND ND ND 0 ND ND 13 
Total 63 42 37 36 41 32 20 25 35 25 1 6 22 16 0 2 403 
AJ 
Selective bases at EcoRI primer 
AA 2 4 4 1 3 ND 3 3 4 1 0 1 I I ND ND 28 
AT 4 7 3 1 4 ND 2 5 2 6 ND ND 2 ND ND ND 36 
AC 3 5 2 3 4 3 0 1 1 ND ND ND I I ND ND 24 
AG I 3 3 5 2 2 1 2 2 ND 2 1 0 4 0 2 30 
TA 1 4 3 ND 3 1 I 0 2 1 ND ND ND 2 ND ND 18 
U 4 5 5 4 ND ND 1 3 3 3 ND ND ND 2 ND ND 30 
TC 0 1 1 4 3 0 2 2 0 2 ND ND 1 2 ND ND 18 
TG 3 5 0 5 0 1 I 3 0 2 ND ND I I ND ND 22 
CA 4 4 0 2 2 2 1 2 3 ND ND ND 1 3 ND ND 24 
CT 3 5 5 1 6 5 5 0 5 ND ND ND 3 1 ND ND 39 
CC 5 ND 3 2 2 5 0 6 6 1 ND ND 1 3 ND ND 34 
CO 2 3 0 0 4 1 1 3 1 2 ND ND 0 2 ND ND 19 
GA 4 5 5 3 3 2 0 2 4 ND ND ND I I ND ND 30 
GT 7 4 2 6 3 2 4 3 ND I ND ND 1 0 ND ND 33 
GC 2 4 1 1 5 1 I 2 0 2 ND ND ND 2 ND ND 21 
GO 1 2 2 1 0 0 1 0 2 1 ND ND ND 0 ND ND 10 
Total 46 61 39 39 44 25 24 37 35 22 2 2 13 25 0 2 416 
The table shows the number of clone-specific bands (AFLP markers) identified for each PCR primer combination for clone AS (above) and clone AJ (below). Subtotals of the numbers of AFLP 
markers are shown for each of the EcoRI and MseI site-specific PCR primers together with the grand total number of AFLP markers for each parasite clone. The total number of AFLP markers for 
both clones together is 819. 
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Table 2 
The average number of AFLP markers obtained per selective base combination for specific EcoRl and MseI selective primer combinations ar 
shown for P. c. chabaudi clone AS (top) and AJ (bottom) 
Selective bases at Mse I primer 
First selective base  	 Second selective b ase   
A 	T 	C 	G 	A 	T 	C 	G 
AS 
First selective base EcoRI primer 	A 3.3 2.0 2.6 1.7 These combinations were not evaluated 
T 2.0 2.3 1.3 1.5 
C 3.5 1.5 2.7 0.8 
G 2.6 2.1 2.1 1.3 
Second selective base EcoRI primer 	A These combinations were not evaluated 3.5 2.8 2.3 	2.3 
T 2.5 2.3 1.6 1.1 
C 2.0 1.9 0.8 	1.8 
G 3.0 1.6 1.8 2.8 
AJ 
First selective base Eco RI primer 	A 3.2 2.4 2.0 1.3 These combinations were not evaluated 
T 2.6 2.8 3.0 1.8 
C 3.1 1.8 1.7 0.8 
G 3.0 1.5 1.6 1.5 
Second selective base EcoRl primer 	A These combinations were not evaluated 2.5 	2.4 1.9 	1.8 
T 2.6 2.7 1.3 2.6 
C 1.3 	2.1 1.4 	2.6 
G 3.1 2.7 2.7 2.3 
a Base positions are counted 5'-3' 
the genotype of the parasites and so were evidently of 
parasite origin. We have also shown that in mixtures of 
different proportions of AS and AJ DNA, AFLP bands 
specific to one or the other parasite clone became 
undetectable once the proportion of DNA of that clone 
was reduced to less than about 1% of the total DNA in a 
sample (Martinelli, unpublished data). Since our 
method of removal of nucleated host cells reduced 
them to less than 1 per 100000 parasite nuclei, the 
molar concentration of each specific host DNA se-
quence should have been likewise less than 0.001% of 
that of each specific parasite DNA sequence, i.e. mud 
less than the limit of detection of l%. On this basi 
alone, therefore, we would expect that host DNA 
sequences would not be represented among the ampli. 
fled fragments which we detected in our reactions. 
Within a given AFLP reaction, bands can diffej 
greatly in intensity. Some of this variation is certainl 
fragment length dependent, i.e. longer DNA fragment 
are amplified less well than smaller ones. Anothei 
explanation could be that more prominent bands aris 
from the amplification of two or more same-lengtl 
Table 3 
Percent of polymorphic bands (AFLP5) for P. c. chabaudi clones AS and AJ among the total amplified bands in relation to the first or secon 
selective base in the Eco RI primer 
No. of combinations Total amplified bands counted Total polymorphic bands (AFLPs) Percent of bands which 
counted for both AS and AJ counted for both AS and AJ are polymorphic 
Firsta selective A 14 346 65 18.8 
base T 10 304 51 16.8 
C 8 167 37 22.2 
G 10 229 50 21.8 
Total 42 1046 203 19.4 
Second' A 10 265 54 20.4 
selective base T 12 445 82 18.4 
C 10 180 36 20.0 
G 10 156 31 19.9 
Total 42 1046 203 19.4 
a Base positions are counted 5'-3'. 
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agments from different sites in the genome. Fragments 
Duld also be amplified with different efficiencies 
epending upon their specific DNA sequence. Whatever 
e reasons for the differences in intensity of specific 
ands, these intensities were, in most cases, very 
producible between duplicate reactions using different 
imples of DNA from the same parasite clone. Only a 
nall minority of bands showed variation in relative 
itensity between different reactions. We have excluded 
e fainter bands and those of unreliable intensity from 
ur selection of robust AFLP markers. 
We have compared the total number of observed 
ands, all arising from fragments generated using 
coRI, with that expected from the frequency of Eco RI 
tes in the parasites' genome. The best estimate for the 
•equency of Eco RI sites in the P. falciparum genome is 
ne per 5492 base pairs [22]. For a genome size of 2.5 x 
base pairs,* this predicts about 4200 EcoRI sites in 
e P. falciparum genome. Assuming these figures 
pproximately apply to P. c. chabaudi, we would expect 
maximum of about 8400 amplified fragments follow -
ig digestion with EcoRI. The observed number is likely 
) be less than this, however, due to occasional 
agments containing an EcoRI site at both ends, and 
'ose too large for efficient amplification or too small 
r reliable detection. From our observation that about 
5 bands can be detected per four selective base PCR 
rimer combination (Table 3), the predicted number of 
agments amplified using all 256 possible primer 
Dmbinations (for two selective bases per primer) is 
bout 6400. This is in very reasonable agreement with 
ie predicted figure of somewhat less than 8400 given 
bove. 
Our data have enabled us to make estimates of the 
robability that there may be a sequence difference at 
fly given base position between the two clones of P. c. 
abaudi, AS and AJ, based on the use of the Dice index 
0,211. Polymorphisms represented by AFLP fragments 
in arise by point substitutions which generate or 
estroy EcoR! sites (6 base pairs) or MseI sites (4 
ase pairs) and also by the mutation of nucleotides at 
ne of the four selective bases (total of 14 base pairs). If 
was assumed that all AFLPs arise in this way, the 
tean base substitution rate per single site between AS 
nd AJ was estimated to be 8 x l0 — , i.e. approximately 
in 125 nucleotide positions. However, AFLPs can also 
rise from deletions or insertions in the sequence of an 
mplified fragment. This would give a rate of 4.6 x 
D 4 , i.e. about I in 2170 nucleotide positions, at which 
isertionldeletion polymorphisms could arise. These two 
;timations (1 in 125 and 1 in 2170 base pairs) set the 
pproximate limits for the frequency of sequence 
ifferences between clones AS and AJ at point positions 
:ross the genome. The exact value will depend upon the 
lative proportions of these two categories of AFLP 
)oint substitutions versus insertion/deletions). Se- 
quence data from candidate drug resistance genes 
(dhfr, mdrl and crt) sequenced for AS and AJ lie within 
this range (data not shown). 
Although we do not know whether these results and 
estimations for polymorphism rates will be obtained 
with other clones of P. chabaudi, there is no reason to 
suppose that AS and AJ have an unusually high, or low, 
level of polymorphism within this species. Further 
characterisation of a significant number of AFLP 
markers by sequence analysis will be required to 
determine the proportion of different categories of 
AFLP, whether the polymorphisms occur within genes, 
introns or intergenic regions and whether they are 
synonomous or non-synonomous substitutions. 
What degree of variability will be found with other 
species of malaria parasites, including P. fa/ciparurn, is a 
question over which there is currently considerable 
debate [23]. AFLP marker analysis has already been 
used as a means of genotyping field isolates of P. 
Jalciparum [16]. The method should prove very useful in 
evaluating overall levels of polymorphism between 
different cloned isolates of P. Ja/ciparum, as well as 
precise clone identity and phylogenetic relationships. 
Finally, the genetic markers generated for P. c. 
chabaudi by the method of AFLP provide tools for 
powerful genetic analysis of traits such as strain-specific 
antigenicity, growth rates, drug resistance, etc. and for 
the concomitant construction of high density genetic 
linkage maps for P. c. chabaudi. 
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